<SEC-DOCUMENT>0001493152-17-004479.txt : 20170427
<SEC-HEADER>0001493152-17-004479.hdr.sgml : 20170427
<ACCEPTANCE-DATETIME>20170427170021
ACCESSION NUMBER:		0001493152-17-004479
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20170427
FILED AS OF DATE:		20170427
DATE AS OF CHANGE:		20170427
EFFECTIVENESS DATE:		20170427

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Imprimis Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001360214
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				450567010
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35814
		FILM NUMBER:		17790033

	BUSINESS ADDRESS:	
		STREET 1:		12264 EL CAMINO REAL
		STREET 2:		SUITE 350
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
		BUSINESS PHONE:		858-704-4042

	MAIL ADDRESS:	
		STREET 1:		12264 EL CAMINO REAL
		STREET 2:		SUITE 350
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRANSDEL PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	20070912

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Bywater Resources, Inc
		DATE OF NAME CHANGE:	20060421
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>def14a.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SCHEDULE
14A INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proxy
Statement Pursuant to Section 14(a) of the</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Securities
Exchange Act of 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Amendment
No. &nbsp;&nbsp;&nbsp;)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 35%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed by
the Registrant [X]</FONT></TD><TD STYLE="width: 2%"></TD><TD STYLE="text-align: justify; width: 63%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Filed by a Party other than the Registrant [&nbsp;&nbsp;]</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preliminary
    Proxy Statement</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Confidential,
    for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[X]</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive
    Proxy Statement</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive
    Additional Materials</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    Material Pursuant to &sect;240.14a-12</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>IMPRIMIS
PHARMACEUTICALS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
of Registrant as Specified In Its Charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
of person(s) filing proxy statement, if other than the Registrant)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
of Filing Fee (Check the appropriate box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[X]
    </FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    fee required</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee
    computed on table below per Exchange Act Rules 14c-5(g) and 0-11.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of each class of securities to which transaction applies:</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate
    number of securities to which transaction applies:</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Per
    unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(set
    forth the amount on which the filing is calculated and state how it was determined):</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposed
    maximum aggregate value of transaction:</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Fee Paid:</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee
    paid previously with preliminary materials.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
    box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting
    fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date
    of its filing.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
    Amount Previously Paid:</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
    Form, Schedule or Registration Statement No.:</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
    Filing Party:</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
    Dated Filed:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: Red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: Red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
27, 2017</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Stockholder:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
are cordially invited to attend the 2017 Annual Meeting of Stockholders of Imprimis Pharmaceuticals, Inc., which will be held
at the San Diego Marriott Del Mar Hotel, 11966 El Camino Real, San Diego, California 92130, on June 13, 2017, at 9:00 a.m. local
time. We hope you will be able to attend the meeting in person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
attached notice of meeting and proxy statement describe the matters to be acted upon at the annual meeting. If you plan to attend
the annual meeting in person, please mark the designated box on the enclosed proxy card. If you plan to attend the annual meeting
and your shares are held in street name (by a broker, for example), you should ask the record holder for a legal proxy and bring
it with you to the annual meeting, so that we can verify your ownership of Imprimis Pharmaceuticals, Inc. stock. Please note that
if your shares are held in street name and you do not bring a legal proxy from the record holder, although you will be able to
attend the annual meeting, you will not be able to vote at the annual meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Whether
or not you plan to attend the annual meeting personally, and regardless of the number of shares you own, it is important that
your shares be represented at the annual meeting. Accordingly, we urge you to promptly complete the enclosed proxy card and return
it to our Corporate Secretary at 12264 El Camino Real, Suite 350, San Diego, California 92130, or to promptly use the telephone
or Internet voting system. If you do attend the annual meeting and wish to vote in person, you may withdraw a previously submitted
proxy at that time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 50%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sincerely,</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark
    L. Baum</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Chief
    Executive Officer and Director</I></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: Red">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: Red"><IMG SRC="image_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: Red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>12264
EL CAMINO REAL, SUITE 350</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SAN
DIEGO, CA 92130</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF ANNUAL MEETING OF STOCKHOLDERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>To
be held on June 13, 2016</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the Stockholders of Imprimis Pharmaceuticals, Inc.:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTICE
IS HEREBY GIVEN that the Annual Meeting of Stockholders of Imprimis Pharmaceuticals, Inc. (the &ldquo;Company&rdquo;) will be
held on June 13, 2017 at 9:00 a.m., at the San Diego Marriott Del Mar Hotel, 11966 El Camino Real, San Diego, California 92130,
for the following purposes:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.4in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    elect to the Board of Directors the five (5) director nominees named in the accompanying proxy statement to serve until the
    2018 annual meeting of stockholders and until their successors are duly elected and qualified. </FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    ratify the selection of KMJ Corbin and Company LLP as the Company&rsquo;s independent registered public accounting firm for
    the fiscal year ending December 31, 2017.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    approve, the Imprimis Pharmaceuticals, Inc. 2017 Incentive Stock and Awards Plan (the &ldquo;2017 Incentive Plan&rdquo;).</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    transact such other business as may properly come before the meeting or any adjournment or postponement thereof.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing items of business are more fully described in the proxy statement accompanying this notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s Board of Directors has fixed the close of business on April 24, 2016 as the record date for the determination
of stockholders entitled to notice of and to vote at the annual meeting and at any adjournment or postponement thereof. All stockholders
are invited to attend the meeting. You must present your proxy or voting instruction card or this notice for admission to the
meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Order of the Board of Directors,</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark
    L. Baum</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Chief
    Executive Officer and Director</I></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">San
    Diego, California</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    27, 2017</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: Red">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: Red"><IMG SRC="image_003.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: Red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12264
El Camino Real, Suite 350</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">San
Diego, CA 92130</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 40%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROXY
STATEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
Annual Meeting of Stockholders to be held on June 13, 2017</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>General</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
enclosed proxy is solicited on behalf of the Board of Directors (the &ldquo;Board&rdquo; or &ldquo;Board of Directors&rdquo;)
for use at the Annual Meeting of Stockholders (the &ldquo;Annual Meeting&rdquo;) of Imprimis Pharmaceuticals, Inc. (referred to
herein as the &ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;us&rdquo; or &ldquo;our&rdquo;), to be held on June 13, 2017, at
9:00 a.m. local time at the San Diego Marriott Del Mar Hotel, 11966 El Camino Real, San Diego, California 92130, or at any adjournment
or postponement thereof, for the purposes set forth herein and in the accompanying Notice of Annual Meeting of Stockholders (the
&ldquo;Notice&rdquo;). We expect to mail this proxy statement (this &ldquo;Proxy Statement&rdquo;) and the accompanying materials,
including our Annual Report on Form 10-K for the fiscal year ended December 31, 2016 (the &ldquo;Annual Report&rdquo;), the Notice
and a proxy card, to our stockholders on or about April 27, 2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
references to &ldquo;us&rdquo;, &ldquo;we&rdquo;, &ldquo;our&rdquo;, and the &ldquo;Company&rdquo; refer to Imprimis Pharmaceuticals,
Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IMPORTANT
NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE 2017 ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON JUNE 13, 2017</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Copies
of this Proxy Statement, the Notice and the Annual Report can be accessed electronically at: www.iproxydirect.com/IMMY.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Solicitation
of Proxies</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board is soliciting the accompanying proxy. In accordance with unanimous recommendations of our Board, the individuals named in
the proxy will vote all shares represented by proxies in the manner designated, or if no designation is made, they will vote the
proxies FOR the election of all of the director nominees named in Proposal 1 and FOR Proposals 2 and 3. The individuals acting
as proxies will not vote on a particular matter if the proxy card representing those shares instructs them to abstain from voting
on that matter or to the extent a proxy card is marked to show that some of the shares represented by the proxy card are not to
be voted. In their discretion, the proxy holders named in the proxy are authorized to vote on any other matters that may properly
come before the Annual Meeting and at any continuation, postponement or adjournment of the Annual Meeting. As of the date of this
Proxy Statement, the Board does not know of any items of business that will be presented for consideration at the Annual Meeting
other than those described in this Proxy Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stockholders
of Record</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Only
holders of record of shares of our common stock at the close of business on the record date, April 24, 2017, will be entitled
to notice of and to vote at the Annual Meeting and any postponement or adjournment thereof. At the close of business on April
24, 2017, the Company had 19,965,415 shares of common stock outstanding and entitled to vote, held by 255 stockholders
of record. Each holder of record of shares of our common stock on the record date will be entitled to one vote for each share
held on all matters to be voted upon at the Annual Meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
quorum of stockholders is necessary to hold a valid meeting. A quorum will be present if at least a majority of the shares of
common stock entitled to vote are represented at the Annual Meeting, either in person or by proxy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Vote
Required and Method of Counting Votes </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
votes will be tabulated by the inspector of elections appointed for the Annual Meeting, who will tabulate affirmative and negative
votes, abstentions and broker non-votes. Abstentions and shares that are voted by brokers as to any matter considered at the Annual
Meeting will be included in determining if a quorum is present or represented at the Annual Meeting. Any broker holding shares
of record for you is not entitled to vote on matters that are not deemed to be routine unless the broker receives voting instructions
from you. Broker non-votes occur when shares are held by a broker who has not received instructions from the beneficial owner
of the shares on such non-routine matters, the broker does not have discretionary voting power with respect to such non-routine
matters and has so notified us on a proxy form in accordance with industry practice or has otherwise advised us that the broker
lacks voting authority with respect to such non-routine matters. The effects of broker non-votes and abstentions on the proposals
to be brought before the Annual Meeting are discussed below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 90%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 54%; text-align: left; vertical-align: bottom; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposal</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24%; text-align: left; vertical-align: bottom; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Vote
    Required</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: left; vertical-align: bottom; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Broker
    Discretionary Voting Allowed</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal
    1 &ndash; Election of five directors</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plurality
    of Votes Cast</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom">No</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal
    2 &ndash; Ratification of auditors for the 2017 fiscal year</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Majority
    of Votes Cast</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal
    3 &ndash; Approval of the Company&rsquo;s 2017 Incentive Plan</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Majority
    of Votes Cast</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom">No</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to Proposal 1, you may vote FOR or ABSTAIN. Abstentions and broker non-votes, if any, will have no effect on the outcome
of Proposal 1. With respect to Proposals 2 and 3, you may vote FOR, AGAINST or ABSTAIN. Abstentions, if any, will have the same
effect as an AGAINST vote for Proposals 2 and 3. Broker non-votes with respect to Proposal 3 will have will no effect on the outcome
of the vote. Broker non-votes are not expected to result from Proposal 2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>How
to Vote</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
may vote by attending the Annual Meeting and voting in person or you may vote by submitting a proxy. If you are a record holder
of shares of our common stock, you may submit your vote by proxy by completing the proxy card and returning it to our Corporate
Secretary at 12264 El Camino Real, Suite 350, San Diego, California 92130 or by using the telephone or Internet voting systems.
If you hold your shares of common stock in street name, you will receive a notice from your broker, bank or other nominee that
includes instructions on how to vote your shares. Your broker, bank or other nominee may allow you to deliver your voting instructions
via the Internet and may also permit you to submit your voting instructions by telephone.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you plan to attend the Annual Meeting and wish to vote in person, you will be given a ballot at the Annual Meeting. Please note
that if your shares are held of record by a broker, bank or other nominee, and you decide to attend and vote at the Annual Meeting,
your vote in person at the Annual Meeting will not be effective unless you present a legal proxy issued in your name from your
broker, bank or other nominee. Even if you plan to attend the Annual Meeting, we encourage you to submit your proxy to vote your
shares in advance of the Annual Meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Revocation
of Proxies</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
are a stockholder of record if, at the close of business on the record date, your shares were registered directly in your name
with Action Stock Transfer Corp., our transfer agent. If you are a stockholder of record and submit your vote by proxy, you may
revoke it at any time before its use, either by:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
revoking it in person at the Annual Meeting;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
delivering a written notice to our Corporate Secretary at 12264 El Camino Real, Suite 350, San Diego, California 92130 before
the proxy is used; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
delivering a later dated proxy card to us at the address noted above before the proxy is used.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
presence at the Annual Meeting will not revoke your proxy, but if you attend the meeting and cast a ballot, your proxy will be
revoked as to the matters on which the ballot is cast.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you hold your shares through a broker, bank, or other nominee, please follow the instructions provided by your broker or other
nominee as to how you may change your vote or obtain a legal proxy to vote your shares if you wish to cast your vote in person
at the Annual Meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cost
and Method of Solicitation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will bear the entire cost of solicitation of proxies, including preparation, assembly, printing and mailing of this Proxy Statement,
the proxy card and any additional information furnished to our stockholders. Solicitation of proxies by mail may be supplemented
by telephone or personal solicitation by our directors, officers or other regular employees. No additional compensation will be
paid to directors, officers or other regular employees for such services. Copies of solicitation materials will be furnished to
banks, brokerage houses, fiduciaries and custodians holding in their names shares of our common stock beneficially owned by others
to forward to such beneficial owners. We may reimburse such persons for their costs in forwarding the solicitation materials to
such beneficial owners.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stockholder
List</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
complete list of registered stockholders entitled to vote at the Annual Meeting will be available for examination by any stockholder
for any purpose related to the Annual Meeting for the ten days prior to the Annual Meeting during ordinary business hours at our
principal offices located at 12264 El Camino Real, Suite 350, San Diego, California 92130.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>PROPOSAL
NO. 1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ELECTION
OF DIRECTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board currently consists of five directors. Our Board has selected five director nominees for election at the Annual Meeting,
consisting of all of our incumbent directors, upon the recommendation of the Company&rsquo;s Nomination and Corporate Governance
Committee. Each of the nominees is currently a director of our Company and was elected or re-elected by our stockholders at our
2016 annual meeting of stockholders. At the Annual Meeting, stockholders will elect five directors to serve until the 2018 annual
meeting of stockholders and until the directors&rsquo; respective successors are elected and qualified or their earlier death,
resignation or removal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no familial relationships among any of our directors or our executive officers. No arrangement or understanding exists between
any nominee and any other person or persons pursuant to which any nominee was or is to be selected as a director or director nominee
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nominees</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board has selected the following five persons as its nominees for election to the Board at the Annual Meeting. Each of these nominees
has indicated that he is willing and able to serve as a director. If any of the nominees declines to serve or becomes unavailable
for any reason, or if a vacancy occurs before the election (although we know of no reason to anticipate that this will occur),
your proxy may be voted for such substitute nominees as the Board may designate. Set forth below are the names, ages and certain
other information of each director nominee as of April 27, 2017:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="width: 0.1in; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: center; vertical-align: top; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Age</B></FONT></TD>
    <TD STYLE="width: 0.1in; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Position
    &amp; Committees</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark
    L. Baum</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director;
    Chief Executive Officer</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
    J. Kammer</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">67</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    of the Board; Audit Committee</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Richard
    L. Lindstrom</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">69</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director;
    Compensation Committee*; Nomination and Corporate Governance Committee</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stephen
    G. Austin</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director;
    Audit Committee*, Nomination and Corporate Governance Committee, Compensation Committee</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anthony
    J. Principi</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">73</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director;
    Compensation Committee, Audit Committee and Nomination and Corporate Governance Committee</FONT>*</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    of the committee.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Mark
L. Baum, J.D. </B>is a founder, member of the board of directors and Chief Executive Officer of Imprimis Pharmaceuticals, Inc.
In 2011, Mr. Baum led the restructuring and reorganization of Imprimis and since that time has directed the creation, development
and growth of the Company&rsquo;s unique business model. Mr. Baum was appointed as a director of the Company in December 2011,
served as the Chairman of the board of directors from December 2011 to April 2012, and was appointed as Chief Executive Officer
in April 2012. Prior to Mr. Baum&rsquo;s involvement with the Company, from 2001 to 2011, he was the founder and managing director
of TBLF, LLC, a consulting firm and fund manager, where he managed a series of three funds and acted as a principal investor in
financing publicly traded companies or bridge-to-public equity transactions. Before his fund management experience, Mr. Baum founded
and served as the president of YesRx, and practiced as a U.S. securities lawyer focused on public company reporting requirements
and finance-related matters. Mr. Baum serves on the board of directors for Ideal Power, Inc., where he is also chairman of the
audit committee. Mr. Baum is a senior advisor to Curology, Inc., a privately held venture capital backed dermatology focused business.
Mr. Baum brings to the Imprimis Board years of public company executive experience, including knowledge of securities laws, reporting
requirements and public company finance-related issues. Mr. Baum is an active participant in the national drug pricing and accessibility
discussion, contributing through interviews for television, radio and print and advocating for policy changes to help ease the
burden to patients and payors resulting from current drug pricing policies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Robert
J. Kammer, D.D.S.,</B> is a founder of our Company and has served as our director since December 2011 and as Chairman of the Board
since April 2012. In June 2014, Dr. Kammer joined the board of directors of SoftScience Shoe Company as the co-chairman. In January
2015, Dr. Kammer retired from his clinical practice as a dentist, in which he was engaged from 1975 to 2015. He is a retired Diplomate
of The American Board of Orofacial Pain and a Founding Member of The Academy for Sports Dentistry and Colorado Osseointegration
Study Club. From 1979 to 1996, Dr. Kammer was an Associate Professor at the University of Colorado School of Dental Medicine.
Dr. Kammer has also served as a consultant to the Boulder-Denver Pain Control Center and a reviewer for the Journal of Orofacial
Pain. Dr. Kammer recently contributed a chapter to the text &ldquo;Osteoperiosteal Flap&rdquo;, has co-authored multiple scientific
articles, was co-investigator on a Dental Implant Bar Study at the Mayo Institute from 2011 to 2013 and served as a consultant
for Clear Choice Dental Implant Centers from 2010 to 2013. Dr. Kammer received his Bachelor of Science degree in 1971 from Xavier
University, Cincinnati, Ohio. He received his Doctor of Dental Surgery degree from the University of Iowa College of Dentistry
in 1974. Dr. Kammer brings to our Board over 35 years of clinical experience treating patients and leadership experience in a
variety of positions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Richard
L. Lindstrom, M.D.</B> has served as our director since January 2015. Dr. Lindstrom is a founder, director and has been an attending
surgeon at Minnesota Eye Consultants P.A., a provider of eye care services, since 1989. He has served as a researcher, teacher,
inventor, writer, lecturer and highly acclaimed physician and surgeon in the ophthalmology field. He has also served as a member
of the board of directors of TearLab Corporation since 2010 and Ocular Therapeutix, Inc. since 2012. Dr. Lindstrom has also served
as associate director of the Minnesota Lions Eye Bank since 1987 and he is a medical advisor for several medical device and pharmaceutical
manufacturers and serves on the boards of several other privately-held life sciences companies. Dr. Lindstrom previously served
as president of the International Society of Refractive Surgery from 1993 to 1994, the International Intraocular Implant Society
from 2002 to 2004, the International Refractive Surgery Club from 2002 to 2004, and the American Society of Cataract and Refractive
Surgery (&ldquo;ASCRS&rdquo;) from 2007 to 2008. Dr. Lindstrom currently serves on the ASCRS Executive Committee and is a board
member of the ASCRS Foundation. From 1980 to 1989, he served as a professor of ophthalmology at the University of Minnesota, where
he is currently an adjunct professor emeritus. Dr. Lindstrom is also a board member of the University of Minnesota Foundation,
chairing the Ophthalmology and Visual Neurosciences Division. Dr. Lindstrom holds a B.A. degree in Pre-Medical Studies, a B.S.
degree in Medicine and an M.D. degree from the University of Minnesota. Dr. Lindstrom brings to the Board over 30 years of ophthalmology
industry experience, as well extensive experience serving as a director of other companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stephen
G. Austin, CPA</B> has served as a director since July 2012. He has been a Partner in Swenson Advisors, LLP, a regional accounting
firm (registered with the Public Company Accounting Oversight Board), since May 1998 and has served as Managing Partner since
October 2006. At Swenson Advisors, Mr. Austin manages assurance, Sarbanes-Oxley and other business consulting for public and private
companies with a focus on technology, manufacturing, service, real estate, social media and non-profit organizations. Prior to
joining Swenson Advisors, Mr. Austin accumulated over 22 years of experience as an audit partner with Price Waterhouse LLP, where
he worked from 1976 to 1996, and with McGladrey &amp; Pullen, LLP, where he worked from 1996 to 1998, serving both public and
private companies. He serves as a board member or advisory board member for various not-for-profit foundations, associations and
public service organizations in the United States, is on the global board of directors of Integra International, an international
association of accounting firms, and served as a director on the board of Avanir Pharmaceuticals, Inc. from March 2003 to December
2012, where he also served on the audit committee and compensation committee. In 2004, Mr. Austin published a book on business
ethics entitled &ldquo;Rise of the New Ethics Class,&rdquo; and in 2005 and 2006 he published articles in Asia discussing The
Sarbanes-Oxley Act of 2002. Mr. Austin has also authored articles for the American Institute of CPAs, including the Journal of
Accountancy. Mr. Austin holds a B.S. degree in accounting from Bob Jones University and an MBA degree from the University of Georgia
and has been licensed as a Certified Public Accountant since 1978. Mr. Austin brings to our Board financial and accounting expertise
and extensive experience serving as a director of other companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Anthony
G. Principi, J.D., </B>has been a director since September 2015. Mr. Principi has served as the Chairman of the Principi Group,
LLC since 2016. He was Chairman of the Spectrum Group (2012-2016) and previously served as the CEO and president of the Principi
Group until its merger with the Spectrum Group in 2012. From 2005 through 2010, he was the Senior Vice President of Government
Relations of Pfizer, Inc. Prior to joining Pfizer, Inc., Mr. Principi served as Secretary of the U.S. Department of Veterans Affairs
from 2001 through 2005. In 2005, he served as the Chairman of the Defense 2005 Base Realignment and Closure Commission. Prior
to becoming Secretary of the U.S. Department of Veterans Affairs, Mr. Principi was President of QTC Medical Services Inc. from
1999 through 2001 and Senior Vice President of Lockheed Martin IMS from 1995 through 1996. Prior to joining Lockheed Martin IMS,
Mr. Principi was Chief Counsel and Staff Director of the U.S. Senate Armed Services Committee from 1993 through 1994, and was
Chief Counsel and Staff Director of the U.S. Senate Committee on Veterans&rsquo; Affairs from 1984 through 1988. Mr. Principi
serves as a director and member of the corporate governance and compensation and evaluation committees of Mutual of Omaha. He
is also a member of the board of directors of Engility Holdings, Inc. and GetWellNetwork&reg;, Inc. Mr. Principi previously served
as Executive Chairman of QTC Management, the largest provider of medical and disability evaluations to the federal government,
and also served on the board of directors of Perot Systems, Inc. Mr. Principi received a Bachelor of Science from the U.S. Naval
Academy and a Juris Doctor from Seton Hall University School of Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Vote
Required and Board of Directors&rsquo; Recommendation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
director is elected by a plurality of the votes cast on the election of directors at a meeting at which a quorum is present. As
a result, the nominees who receive the highest number of votes, up to the number of directors to be elected at the Annual Meeting,
will be elected. Because directors are elected by a plurality of the votes cast, abstentions and broker non-votes will not be
counted in determining which nominees receive the largest number of votes cast and therefore will have no effect on the outcome
of the vote on this proposal. The persons named in the enclosed proxy will vote the proxies they receive FOR the election of the
nominees named above, unless a particular proxy card withholds authorization to do so or provides contrary instructions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
BOARD OF DIRECTORS RECOMMENDS THAT STOCKHOLDERS VOTE <U>FOR</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
ELECTION OF EACH OF THE NOMINEES FOR DIRECTOR.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>PROPOSAL
NO. 2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RATIFICATION
OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the recommendation of our Audit Committee, our Board has selected KMJ Corbin &amp; Company LLP (&ldquo;KMJ&rdquo;) to serve as
our independent registered public accounting firm for the fiscal year ending December 31, 2017, and has further directed that
the selection of our independent registered public accounting firm be submitted for ratification by our stockholders at our Annual
Meeting. KMJ has served as our independent registered public accounting firm since September 17, 2007. Representatives of KMJ
are expected to be present at the Annual Meeting, will have an opportunity to make a statement if they so desire and will be available
to respond to appropriate questions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholder
ratification of the selection of KMJ as our independent registered public accounting firm is not required by our Bylaws or otherwise.
However, the Board is submitting the selection of KMJ to the stockholders for ratification as a matter of good corporate practice.
If the stockholders do not ratify the selection, the Board and our Audit Committee will reconsider whether or not to retain KMJ.
Even if the selection is ratified, the Board and the Audit Committee may, in their discretion, direct the appointment of a different
independent registered public accounting firm at any time during the year if they determine that such a change would be in our
and our stockholders&rsquo; best interests.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Audit
and All Other Fees</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate
fees for professional services billed to the company by KMJ for the years ended December 31, 2016 and 2015, were as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 60%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2016</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2015</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: left">Audit Fees</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">151,999</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">125,400</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Audit-Related Fees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">12,575</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">60,550</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Other Fees</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt">Total</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">$</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">164,574</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">$</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">185,950</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Audit
Fees&rdquo; represent fees for professional services provided in connection with the audit of our annual consolidated financial
statements, and the review of our consolidated financial statements included in our quarterly reports. &ldquo;Audit-Related Fees&rdquo;
represent fees for professional services provided in connection with the review of our registration statements on Forms S-8 and
S-3, and the acquisition audits of our wholly owned subsidiaries. There were no fees billed by or paid to our principal accountant
during the years ended December 31, 2016 and 2015 for tax compliance, tax advice or tax planning services or for financial information
systems design and implementation services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pre-Approval
Policy</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Audit Committee pre-approves all services to be provided by KMJ. All fees paid to KMJ for services performed in 2016 and 2015
were pre-approved by our Audit Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Vote
Required and Board of Directors&rsquo; Recommendation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approval
of this proposal requires the affirmative vote of a majority of the votes cast on the proposal at a meeting at which a quorum
is present. Abstentions will be counted as present for purposes of determining the presence of a quorum, and will have the same
effect as an AGAINST vote on this proposal. Broker non-votes are not expected to result from the vote on this proposal. The persons
named in the enclosed proxy will vote the proxies they receive FOR the ratification of the selection of KMJ as our independent
registered public accounting firm, unless a particular proxy card withholds authorization to do so or provides contrary instructions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
BOARD OF DIRECTORS RECOMMENDS THAT STOCKHOLDERS VOTE <U>FOR</U> THE RATIFICATION OF THE SELECTION OF KMJ CORBIN &amp; COMPANY
LLP AS THE COMPANY&rsquo;S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2017.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>PROPOSAL
NO. 3</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APPROVAL
OF 2017 INCENTIVE PLAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the Annual Meeting, the stockholders of the Company will be asked to approve the adoption of the 2017 Incentive Plan (the &ldquo;<B><I>2017
Plan</I></B>&rdquo;), including the material terms of performance goals for performance awards granted under the 2017 Plan. The
2017 Plan will become effective only after approval of stockholders at the Annual Meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board has recommended approval of the 2017 Plan, which allows for the issuance of equity based rewards because it believes that
equity awards are important to incentivize our employees, including our executive officers, and our directors to remain with the
Company, to motivate them to help achieve our corporate objectives, and to align their interests with those of our stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board believes that the 2017 Plan will promote the interests of stockholders and is consistent with principles of good corporate
governance, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Independent
    Committee</I>. The 2017 Plan will be administered by our Compensation Committee, which is composed entirely of independent
    directors who meet the NASDAQ standards for independence.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">&#9679;</TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>No
    Discounted Stock Options or SARs</I>. All stock option and stock appreciation rights (&ldquo;<B><I>SAR</I></B>&rdquo;) awards
    under the 2017 Plan must have an exercise or base price that is not less than the fair market value of the underlying common
    stock on the date of grant.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">&#9679;</TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>No
    Repricing</I>. Other than in connection with a corporate transaction affecting the Company, the 2017 Plan prohibits any repricing
    of stock options or SARs without stockholder approval.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">&#9679;</TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Performance
    Awards</I>. Under the 2017 Plan, the Compensation Committee may grant performance-based awards intended to qualify as exempt
    performance-based compensation under Section 162(m) (&ldquo;<B><I>Section 162(m)</I></B>&rdquo;) of the Internal Revenue Code
    of 1986, as amended (the &ldquo;<B><I>Code</I></B>&rdquo;) as well as other performance-based awards.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Existing
Equity Plan Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
September 2017, the Company will no longer able to issue grants from its 2007 Equity Incentive Plan (the &ldquo;<B><I>2007 Plan</I></B>&rdquo;),
which will expire by its terms. At present, the Company has one existing equity incentive plan (the 2007 Plan), which was previously
approved by our stockholders. As of April 24, 2017, our 2007 Plan has 456,334 shares available for grant as equity awards. If
the 2017 Plan is approved by our stockholders, the Company does not intend to make amendments to the 2007 Plan&rsquo;s share pool,
and it will expire by its terms in September 2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table includes aggregated information regarding awards outstanding under our 2007 Plan, the number of shares available
for future awards under our 2007 Plan as of April 24, 2017, and the proposed number of shares issuable under the 2017 Plan:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Number of shares</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">As a percentage of stock outstanding</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 68%; text-align: left">Outstanding stock options</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">2,286,938</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">11.5</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Outstanding restricted stock units</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,292,876</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.5</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Other outstanding equity awards</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.0</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Total shares subject to outstanding awards as April 24, 2017</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,579,814</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17.9</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Total shares available for future awards as of April 24, 2017 under 2007 Plan</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">541,534</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.7</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Proposed shares available for future awards under 2017 Plan</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10.0</TD><TD STYLE="text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
information with respect to all of our equity compensation plans in effect as of December 31, 2016 is provided under the heading
&ldquo;Equity Compensation Plan Information.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Reasons
for Seeking Stockholder Approval</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board believes that equity-based compensation is a critical part of the Company&rsquo;s compensation program. Stockholder approval
of the 2017 Plan would allow us to continue to attract and retain directors, executives, and other employees with equity incentives.
In 2015 and 2016, the Company made equity awards under its existing equity incentive plans totaling approximately 1,077,612 shares
and 1,820,300 shares, respectively. The Company estimates, based on the advice of Radford to our Compensation Committee, that
the availability of 2,000,000 shares would provide a sufficient additional number of shares to enable the Company to continue
to make awards expected under its current compensation program.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, stockholder approval of the 2017 Plan would preserve our ability to grant a range of tax-efficient stock-based incentive
awards under the 2017 Plan. Section 162(m) generally provides that compensation provided to a publicly held corporation&rsquo;s
CEO or any of its three most highly paid named executive officers (other than its CEO or CFO) is not deductible by the corporation
for U.S. income tax purposes for any taxable year to the extent it exceeds $1 million. This limitation does not apply to compensation
that qualifies as exempt performance-based compensation by meeting certain requirements under Section 162(m), including the requirement
that the material terms, including those of the related performance goals, be disclosed to and approved by stockholders every
five years. For the 2017 Plan, these terms are described below under &ldquo;Eligibility,&rdquo; &ldquo;Individual Limits&rdquo;
and &ldquo;Performance Criteria.&rdquo; Stockholders are being asked to approve, among other material terms, a set of business
criteria on which performance goals may be based for future performance awards under the 2017 Plan. Although stockholder approval
is one of the requirements for exemption under Section 162(m), even with stockholder approval there can be no guarantee that compensation
will be treated as exempt performance-based compensation under Section 162(m). Furthermore, our Compensation Committee will continue
to have authority to provide compensation that is not exempt from the limits on deductibility under Section 162(m).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
stockholders approved the 2007 Plan at our annual meeting held in September 2007 and approved amendments to the 2007 Plan in August
2012 and September 2013. If stockholders do not approve this Proposal No. 3, the Company can continue to make awards under the
2007 Plan, but the Company will have limited shares available for future equity grants, the 2007 Plan will expire in September
2017, and its ability to make tax deductible performance awards to executive officers will be limited under Section 162(m).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Summary
of the 2017 Plan</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2017 Plan will only become effective subject to approval by our stockholders. This summary is not a complete description of all
provisions of the 2017 Plan and is qualified in its entirety by reference to the 2017 Plan, which is attached as Annex A to this
Proxy Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Purpose</I>.
The purpose of the 2017 Plan is to advance the Company&rsquo;s interests by providing for the grant to participants of stock-based
and other incentive awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Plan
Administration</I>. The 2017 Plan is administered by our Compensation Committee, who has the authority to, among other things,
interpret the 2017 Plan, determine eligibility for, grant and determine the terms of awards under the 2017 Plan, and to do all
things necessary or appropriate to carry out the purposes of the 2017 Plan. Our Compensation Committee&rsquo;s determinations
under the 2017 Plan are conclusive and binding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Term</I>.
No awards will be made after the tenth anniversary of the plan&rsquo;s adoption, but previously granted awards may continue beyond
that date in accordance with their terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Authorized
Shares</I>. Subject to adjustment, the maximum number of shares of our common stock that may be delivered in satisfaction of awards
under the 2017 Plan is 2,000,000. Any shares of common stock underlying awards that are settled in cash or that otherwise expire,
terminate or are forfeited prior to the issuance of stock, would again be available for issuance under the 2017 Plan. Shares of
common stock that are withheld by the Company from an award in payment of the exercise price of any award requiring exercise or
in satisfaction of the tax withholding requirements with respect to any award will not again be available for issuance under the
2017 Plan. Each share of common stock underlying an option, RSU or SAR award will count against the share pool as 1.0 share. Any
shares that again become available under the 2017 Plan will be returned to the share pool at the rates described in the preceding
sentence. On April 24, 2017, the closing price of our common stock as reflected on NASDAQ was $4.12.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Individual
Limits</I>. The maximum number of shares for which options may be granted and the maximum number of shares of stock subject to
SARs which may be granted to any person in any calendar year for purposes of Section 162(m) is, in each case, 700,000 shares.
The maximum number of shares subject to other awards that may be granted to any person in any calendar year for purposes of Section
162(m) 500,000 shares. The maximum amount that may be paid to any person in any calendar year for purposes of Section 162(m) with
respect to cash awards is $2,000,000. Any awards granted in excess of the foregoing limits will not be eligible to be excluded
from the applicable Section 162(m) limits and such excess amount may not be deductible by the Company as performance-based compensation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Eligibility</I>.
Our Compensation Committee selects participants from among the key employees, directors, consultants and advisors of the Company
and its affiliates. Eligibility for options intended to be incentive stock options (&ldquo;<B><I>ISOs</I></B>&rdquo;) is limited
to employees of the Company or certain affiliates. As of April 24, 2017, approximately 142 employees and 6 directors would be
eligible to participate in the 2017 Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Types
of Awards</I>. The 2017 Plan provides for grants of options, SARs, restricted and unrestricted stock and stock units, performance
awards, cash awards and other awards convertible into or otherwise based on shares of our stock. Dividend equivalents may also
be provided in connection with awards under the 2017 Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Restricted
    and Unrestricted Stock</I>: A restricted stock award is an award of common stock subject to forfeiture restrictions, while
    an unrestricted stock award is not subject to restrictions.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">&#9679;</TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Stock
    Options and SARs</I>: The 2017 Plan provides for the grant of ISOs, non-qualified stock options (&ldquo;<B><I>NSOs</I></B>&rdquo;),
    and SARs. The exercise price of an option, and the base price against which a SAR is to be measured, may not be less than
    the fair market value (or, in the case of an ISO granted to a ten percent stockholder, 110% of the fair market value) of a
    share of common stock on the date of grant. Our Compensation Committee determines when stock options or SARs become exercisable
    and the terms on which
    such awards remain exercisable. Stock options and SARs will generally have a maximum term of ten years. SARs are payable in
    cash, in shares of our common stock or in a combination of cash and shares.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Stock
    Units</I>: A stock unit award is denominated in shares of common stock and entitles the participant to receive stock or cash
    measured by the value of the shares in the future. The delivery of stock or cash under a stock unit may be subject to the
    satisfaction of performance or other vesting conditions.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">&#9679;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Performance
    Awards</I>: A performance award is an award the vesting, settlement or exercisability of which is subject to specified performance
    criteria.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">&#9679;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Cash
    Awards</I>: A cash award is an award denominated in cash.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Vesting</I>.
Our Compensation Committee has the authority to determine the vesting schedule applicable to each award, and to accelerate the
vesting or exercisability of any award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Termination
of Employment</I>. Our Compensation Committee determines the effect of termination of employment or service on an award. Unless
otherwise provided by our Compensation Committee or in an award agreement, upon a termination of employment or service all unvested
options and other awards requiring exercise will terminate and all other unvested awards will be forfeited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Performance
Criteria</I>. The 2017 Plan provides that grants of performance awards may be made based upon, and subject to achieving, &ldquo;performance
objectives&rdquo; over a specified performance period. Performance objectives with respect to those awards that are intended to
qualify as &ldquo;performance-based compensation&rdquo; for purposes of Section 162(m) are limited to an objectively determinable
measure of performance relating to any, or any combination of, the following (measured either absolutely or by reference to an
index or indices and determined either on a consolidated basis or, as the context permits, on a divisional, subsidiary, line of
business, project or geographical basis or in combinations thereof): sales; revenues; assets; expenses; earnings before or after
deduction for all or any portion of interest, taxes, depreciation, or amortization, whether or not on a continuing operations
or an aggregate or per share basis; return on equity, investment, capital or assets; one or more operating ratios; borrowing levels,
leverage ratios or credit rating; market share; capital expenditures; cash flow; stock price; stockholder return; sales of particular
products or services; customer acquisition or retention; acquisitions and divestitures (in whole or in part); joint ventures and
strategic alliances; spin-offs, split-ups and the like; reorganizations; recapitalizations, restructurings, financings (issuance
of debt or equity) or refinancings; or regulatory and/or clinical development; intellectual property protection; and any other
performance metric approved by the Compensation Committee designed to increase stockholder value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent consistent with the requirements for satisfying the performance-based compensation exception under Section 162(m),
our Compensation Committee may provide in the case of any award intended to qualify for such exception that one or more of the
performance objectives applicable to an award will be adjusted in an objectively determinable manner to reflect events (for example,
acquisitions and divestitures) occurring during the performance period of such award that affect the applicable performance objectives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Transferability</I>.
Awards under the 2017 Plan may not be transferred except by will or by the laws of descent and distribution, unless (for awards
other than ISOs) otherwise provided by our Compensation Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Corporate
Transactions.</I> In the event of a consolidation, merger or similar transaction, a sale or transfer of all or substantially all
of the Company&rsquo;s assets or a dissolution or liquidation of the Company (each, a &ldquo;<B><I>Covered Transaction</I></B>&rdquo;),
our Compensation Committee may, among other things, provide for the continuation or assumption of outstanding awards, for new
grants in substitution of outstanding awards, for the accelerated vesting or delivery of shares under awards or for a cash-out
of outstanding awards, in each case on such terms and with such restrictions as it deems appropriate. Except as our Compensation
Committee may otherwise determine, awards not assumed will terminate upon the consummation of such Covered Transaction. In the
event of a Covered Transaction other than a liquidation or dissolution of the Company, all outstanding awards held by our non-employee
directors will accelerate and vest in full.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Adjustment</I>.
In the event of certain corporate transactions (including, but not limited to, a stock dividend, stock split or combination of
shares, recapitalization or other change in the Company&rsquo;s capital structure that constitutes an equity restructuring within
the meaning of ASC 718), our Compensation Committee will make appropriate adjustments to the maximum number of shares that may
be delivered under and the individual limits included in the 2017 Plan, and will also make appropriate adjustments to the number
and kind of shares of stock or securities subject to awards, the exercise prices of such awards or any other terms of awards affected
by such change. Our Compensation Committee may also make the types of adjustments described above to take into account distributions
to stockholders and events other than those listed above if it determines that such adjustments are appropriate to avoid distortion
in the operation of the plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Amendment
and Termination</I>. Our Compensation Committee can amend the 2017 Plan or outstanding awards, or terminate the 2017 Plan as to
future grants of awards, except that our Compensation Committee will not be able alter the terms of an award if it would affect
materially and adversely a participant&rsquo;s rights under the award without the participant&rsquo;s consent (unless expressly
provided in the 2017 Plan or reserved by our Compensation Committee at the time of grant). Stockholder approval will be required
for any amendment to the extent such approval is required by law, including the Code or applicable stock exchange requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Federal
Income Tax Consequences Under 2017 Plan</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of some of the material federal income tax consequences associated with the grant and exercise of awards
under the 2017 Plan under current federal tax laws and certain other tax considerations associated with awards under the 2017
Plan. The summary does not address tax rates or non-U.S., state or local tax consequences, nor does it address employment-tax
or other federal tax consequences except as noted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Restricted
Stock</I>. A participant who is awarded or purchases shares subject to a substantial risk of forfeiture generally does not have
income until the risk of forfeiture lapses. When the risk of forfeiture lapses, the participant has ordinary income equal to the
excess of the fair market value of the shares at that time over the purchase price, if any, and a corresponding deduction is generally
available to the Company. However, a participant may make an election under Section 83(b) of the Code to be taxed on restricted
stock when it is acquired rather than later, when the substantial risk of forfeiture lapses. An 83(b) election must be made not
later than thirty (30) days after the transfer of the shares to the participant and must satisfy certain other requirements. A
participant who makes an effective 83(b) election will realize ordinary income equal to the fair market value of the shares as
of the time of acquisition less any price paid for the shares. A corresponding deduction will generally be available to the Company.
Fair market value for this purpose is determined without regard to the forfeiture restrictions. If a participant makes an effective
83(b) election, no additional income results by reason of the lapsing of the restrictions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of determining capital gain or loss on a sale of shares awarded under the 2017 Plan, the holding period in the shares
begins when the participant realizes taxable income with respect to the transfer. The participant&rsquo;s tax basis in the shares
equals the amount paid for the shares plus any income realized with respect to the transfer. However, if a participant makes an
effective 83(b) election and later forfeits the shares, the tax loss realized as a result of the forfeiture is limited to the
excess of what the participant paid for the shares (if anything) over the amount (if any) realized in connection with the forfeiture.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>ISOs</I>.
In general, a participant realizes no taxable income upon the grant or exercise of an ISO. However, the exercise of an ISO may
result in an alternative minimum tax liability to the participant. With some exceptions, a disposition of shares purchased under
an ISO within two years from the date of grant or within one year after exercise produces ordinary income to the participant (and
generally a deduction to the Company) equal to the value of the shares at the time of exercise less the exercise price. Any additional
gain recognized in the disposition is treated as a capital gain for which the Company is not entitled to a deduction. If the participant
does not dispose of the shares until after the expiration of these one and two-year holding periods, any gain or loss recognized
upon a subsequent sale is treated as a long-term capital gain or loss for which the Company is not entitled to a deduction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>NSOs</I>.
In general, a participant has no taxable income upon the grant of an NSO but realizes income in connection with exercise of the
option in an amount equal to the excess (at time of exercise) of the fair market value of the shares acquired upon exercise over
the exercise price. A corresponding deduction is generally available to the Company. Upon a subsequent sale or exchange of the
shares, any recognized gain or loss is treated as a capital gain or loss for which the Company is not entitled to a deduction.
An ISO that is exercised more than three months after termination of employment (other than termination by reason of death) is
generally treated as an NSO. ISOs are also treated as NSOs to the extent they first become exercisable by an individual in any
calendar year for shares having a fair market value (determined as of the date of grant) in excess of $100,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>SARs</I>.
The grant of a SAR does not itself result in taxable income, nor does taxable income result merely because a SAR becomes exercisable.
In general, a participant who exercises a SAR for shares of stock or receives payment in cancellation of a SAR will have ordinary
income equal to the amount of any cash and the fair market value of any stock received. A corresponding deduction is generally
available to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Restricted
Stock Units</I>. The grant of a restricted stock unit does not itself generally result in taxable income. Instead, the participant
is taxed upon vesting (and a corresponding deduction is generally available to the Company), unless he or she has made a proper
election to defer receipt of the shares (or cash if the award is cash settled) under Section 409A of the Code (&ldquo;<B><I>Section
409A</I></B>&rdquo;). If the shares delivered are restricted for tax purposes, the participant will instead be subject to the
rules described above for restricted stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Section
162(m)</I>. Stock options, SARs and certain performance awards under the 2017 Plan are generally intended to be exempt or eligible
for exemption from the deductibility limits of Section 162(m). However, as discussed above in &ldquo;Reasons for Seeking Stockholder
Approval,&rdquo; the Compensation Committee will have discretionary authority to provide compensation that is not exempt from
the limits on deductibility under Section 162(m).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Section
409A</I>. Section 409A imposes an additional 20% income tax, plus, in some cases, a further income tax in the nature of interest,
on nonqualified deferred compensation that does not comply with deferral, payment-timing and other formal and operational requirements
specified in Section 409A and related regulations and that is not exempt from those requirements. Stock options and SARs granted
under the 2017 Plan are intended to be exempt from Section 409A. The 2017 Plan gives the Compensation Committee the flexibility
to prescribe terms for other awards that are consistent with the requirements of, or an exemption from, Section 409A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Certain
Change of Control Payments</I>. Under Section 280G of the Code, the vesting or accelerated exercisability of options or the vesting
and payments of other awards in connection with a change of control of a corporation may be required to be valued and taken into
account in determining whether participants have received compensatory payments, contingent on the change in control, in excess
of certain limits. If these limits are exceeded, a substantial portion of amounts payable to the participant, including income
recognized by reason of the grant, vesting or exercise of awards, may be subject to an additional 20% federal tax and may be non-deductible
to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>New
Plan Benefits</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee will have full discretion to determine the number and amount of awards to be granted to employees under
the 2017 Plan, subject to the terms of the plan. Therefore, the future benefits or amounts that would be received by the executive
officers, employees and other groups under the 2017 Plan are not determinable at this time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Required
Vote</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approval
of the 2017 Plan requires the affirmative vote of a majority of the shares present in person or by proxy and entitled to vote
on the matter. Abstentions will have the same effect as voting against the proposal and broker non-votes will have no effect on
the vote outcome.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
BOARD OF DIRECTORS RECOMMENDS A VOTE &ldquo;FOR&rdquo; PROPOSAL NO. 3.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CORPORATE
GOVERNANCE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Corporate
Governance Guidelines</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors has adopted corporate governance guidelines to assist it in the exercise of its responsibilities and to serve
the interests of the Company and our stockholders. The corporate governance guidelines are available for review on our website
at http://imprimispharma.investorroom.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Director
Independence</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors currently consists of the following five members: Dr. Robert J. Kammer (Chairman); Stephen G. Austin; Dr. Richard
L. Lindstrom; Anthony G. Principi, and Mark L. Baum. The Board has determined that (i) Mr. Austin, Dr. Lindstrom, Mr. Principi
and Dr. Kammer, comprising a majority of our current Board, are &ldquo;independent&rdquo; directors, as that term is defined by
Nasdaq Marketplace Rule 5605(a)(2). Mr. Baum is not independent because he currently serves as our Chief Executive Officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Lindstrom recently entered into a license agreement with the Company related to certain ophthalmology products and patents. Our
Board of Directors has reviewed the license agreement and financials terms, and have determined that it does not expect total
payments (non-board compensation) to Dr. Lindstrom will be in excess of $120,000 for the first twelve months of the license agreements
term. The Board of Directors believe that by entering into the license agreement Dr. Lindstrom&rsquo;s independence (and ability
to provide independent oversight) is not compromised.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nominations
for Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Nomination and Corporate Governance Committee evaluates and recommends to the Board of Directors nominees for each election of
directors. There are no stated minimum criteria for director nominees; rather, in considering potential new directors, the Nomination
and Corporate Governance Committee considers a variety of factors and may identify and evaluate individuals from various disciplines
and backgrounds. Among the qualifications to be considered in the selection of candidates are the following: broad experience
in business, finance or administration; familiarity with the Company&rsquo;s industry; prominence and reputation in a particular
profession or field of endeavor; and whether the individual has the time available to devote to the work of the Board and one
or more of its committees. The Nomination and Corporate Governance Committee also reviews the activities and associations of each
candidate to determine the independence of the candidate under applicable Nasdaq and Securities and Exchange Commission (&ldquo;SEC&rdquo;)
rules and to ensure that there is no legal impediment, conflict of interest or other consideration that might hinder or prevent
service on the Board. In addition to these factors, the Nomination and Corporate Governance Committee may also consider such other
factors as it may deem relevant or in the best interests of the Company and its stockholders. The Nomination and Corporate Governance
Committee recognizes that under applicable regulatory requirements at least one member of the Board must, and believes that it
is preferable that more than one member of the Board should, meet the criteria for an &ldquo;audit committee financial expert&rdquo;
as defined by SEC rules. Further, although the Company does not have a formal diversity policy, the Nomination and Corporate Governance
Committee seeks to nominate directors that bring to the Company a variety of perspectives, skills, expertise, and sound business
understanding and judgment, derived from business, professional, governmental, finance, community and industry experience.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Nomination and Corporate Governance Committee identifies nominees by first evaluating the current members of the Board of Directors
willing to continue in service. Current members of the Board of Directors with skills and experience that are relevant and considered
valuable to the Company&rsquo;s business and who are willing to continue in service are considered for re-nomination, balancing
the value of continuity of service by existing members of the Board of Directors with that of obtaining new perspectives. If any
member of the Board of Directors up for re-election at an upcoming annual meeting of stockholders does not wish to continue in
service, the Nomination and Corporate Governance Committee would identify a new nominee to replace such director in light of the
criteria and factors described above. If the Nomination and Corporate Governance Committee believes that the Board of Directors
requires additional candidates for nomination, it may explore alternative sources for identifying additional candidates. This
may include engaging, as appropriate, a third party search firm to assist in identifying qualified candidates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Nomination and Corporate Governance Committee reviews all director nominees, including those recommended by stockholders, in accordance
with the factors and qualifications described above to determine whether they possess attributes the committee believes would
be beneficial and valuable to the Company. The Nomination and Corporate Governance Committee will select qualified candidates
and make its recommendations to the Board, which will formally decide whether to nominate the recommended candidates for election
to the Board. Stockholders may recommend nominees for consideration by the Nomination and Corporate Governance Committee by complying
with certain notification requirements set forth in our Bylaws. These requirements provide that a stockholder who desires to recommend
a candidate for nomination to our Board of Directors must do so in writing to our Corporate Secretary at our principal executive
offices, which written notice must be received no later than 90 days before the date of the annual meeting of stockholders at
which directors are to be elected. The stockholder&rsquo;s written notice must include, among other things as specified in our
Bylaws, certain personal identification information about the stockholder and its recommended director nominee(s); the principal
occupation or employment of the recommended director nominee(s); the class and number of shares of the Company that are beneficially
owned by the stockholder and its recommended director nominee(s); and any other information relating to the recommended director
nominee(s) that is required to be disclosed in solicitations for proxies for the election of directors pursuant to Regulation
14A under the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;). Stockholders may obtain a copy of
our Bylaws by writing to our Corporate Secretary at Imprimis Pharmaceuticals, Inc., c/o Corporate Secretary, 12264 El Camino Real,
Suite 350, San Diego, California 92130, or by accessing our Bylaws on the Investor Relations section of our website at http://imprimispharma.investorroom.com.
A stockholder who complies in full with all of the notice provisions set forth in our Bylaws will be permitted to present the
director nominee at the applicable annual meeting of stockholders, but will not be entitled to have the nominee included in our
proxy statement for the annual meeting unless an applicable SEC rule requires that we include the director nominee in our proxy
statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stockholder
Communications with Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders
may communicate with the Board of Directors by sending a letter to the Corporate Secretary, Imprimis Pharmaceuticals, Inc., 12264
El Camino Real, Suite 350, San Diego, California 92130. Each communication must set forth the name and address of the stockholder
on whose behalf the communication is sent and should indicate in the address whether the communication is intended for the entire
Board, the non-employee directors as a group or an individual director. Each communication will be screened by the Corporate Secretary
or his or her designee to determine whether it is appropriate for presentation to the Board or any specified director(s). Examples
of inappropriate communications include junk mail, spam, mass mailings, resumes, job inquiries, surveys, business solicitations
and advertisements, as well as unduly hostile, threatening, illegal, unsuitable, frivolous, patently offensive or otherwise inappropriate
material. Communications determined to be appropriate for presentation to the Board or the director(s) to whom they are addressed
will be submitted to the Board or such director(s) on a periodic basis. Any communications that concern accounting, internal control
or auditing matters will be handled in accordance with procedures adopted by the Audit Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Code
of Business Conduct and Ethics </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board has adopted a Code of Business Conduct and Ethics, which is available for review on our website at http://imprimispharma.investorroom.com,
and is also available in print, without charge, to any stockholder who requests a copy by writing to us at Imprimis Pharmaceuticals,
Inc., 12264 El Camino Real, Suite 350, San Diego, California 92130, Attention: Investor Relations. Each of our directors, employees
and officers, including our Chief Executive Officer, Chief Financial Officer, and all of our other principal executive officers,
are required to comply with the Code of Business Conduct and Ethics. There have not been any waivers of the Code of Business Conduct
and Ethics relating to any of our executive officers or directors in the past year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Meetings
and Committees of the Board</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board is responsible for overseeing the management of our business. We keep our directors informed of our business at meetings
and through reports and analyses presented to the Board and the committees of the Board. Regular communications between our directors
and management also occur outside of formal meetings of the Board and committees of the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Meeting
Attendance</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board generally holds meetings on a quarterly basis, but may hold additional meetings as required. In 2016, the Board held four
meetings. Each of our directors attended 100% of the Board meetings that were held during the periods when he was a director and
100% of the meetings of each committee of the Board on which he served that were held during the periods that he served on such
committee. We do not have a policy requiring that directors attend our annual meetings of stockholders. All of our directors attended
our 2016 annual meeting of stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Committees
of the Board of Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board currently has three standing committees to facilitate and assist the Board in the execution of its responsibilities: the
Audit Committee, the Compensation Committee and the Nomination and Corporate Governance Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Audit
Committee</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Audit Committee is currently composed of Messrs. Stephen Austin (Chairman), Anthony Principi and Robert Kammer. Our Board has
affirmatively determined that each member of the Audit Committee in 2016 was independent under Nasdaq Marketplace Rule 5605(a)(2)
and satisfied all other qualifications under Nasdaq Marketplace Rule 5065(c) and the applicable rules of the SEC, and that each
current member of the Audit Committee is independent under Nasdaq Marketplace Rule 5605(a)(2) and satisfies all other qualifications
under Nasdaq Marketplace Rule 5605(c) and the applicable rules of the SEC. Our Board has also affirmatively determined that Stephen
Austin qualifies as an &ldquo;audit committee financial expert&rdquo; as such term is defined in Regulation S-K under the Securities
Act of 1933. The Audit Committee held five meetings in 2016.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee acts pursuant to a written charter that has been adopted by the Board, which is available for review on our website
at http://imprimispharma.investorroom.com. The responsibilities of the Audit Committee include overseeing, reviewing and evaluating
our financial statements, accounting and financial reporting processes, internal control functions and the audits of our financial
statements. The Audit Committee is also responsible for the appointment, compensation, retention, and as necessary, the termination
of our independent registered public accounting firm.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Compensation
Committee</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Compensation Committee is currently composed of Messrs. Richard Lindstrom (Chairman), Anthony Principi and Stephen Austin. Our
Board has affirmatively determined that each member of the Compensation Committee during 2016 was independent under Nasdaq Marketplace
Rule 5605(a)(2) and satisfied all other qualifications under Nasdaq Marketplace Rule 5065(d) and the applicable rules of the SEC,
and that each current member of the Compensation Committee is independent under Nasdaq Marketplace Rule 5605(a)(2) and satisfies
all other qualifications under Nasdaq Marketplace Rule 5065(d) and the applicable rules of the SEC. The Compensation Committee
held five meetings in 2016.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee acts pursuant to a written charter that has been adopted by the Board, which is available for review on
our website at http://imprimispharma.investorroom.com. The responsibilities of the Compensation Committee include reviewing and
making recommendations to our Board concerning the compensation and benefits of our executive officers, including our Chief Executive
Officer, and directors, overseeing the administration of our stock option and employee benefits plans, and reviewing general policies
relating to compensation and benefits.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Nomination
and Corporate Governance Committee</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Nomination and Corporate Governance Committee is currently composed of Messrs. Anthony Principi (Chairman), Stephen Austin and
Richard Lindstrom. Our Board has affirmatively determined that each member of the Nomination and Corporate Governance Committee
during 2016 was independent under Nasdaq Marketplace Rule 5605(a)(2), and that each current member of the Nomination and Corporate
Governance Committee is independent under Nasdaq Marketplace Rule 5605(a)(2). The Nomination and Corporate Governance Committee
held four meetings in 2016.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Nomination and Corporate Governance Committee acts pursuant to a written charter that has been adopted by the Board, which is
available for review on our website at http://imprimispharma.investorroom.com. The responsibilities of the Nomination and Corporate
Governance Committee include evaluating and making recommendations to the Board with respect to director nominees and providing
oversight of our corporate governance policies and practices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Board
Leadership Structure</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board may, but is not required to, select a Chairman of the Board on an annual basis. The positions of Chairman of the Board and
Chief Executive Officer may be filled by one individual or two different individuals. Currently the positions of Chairman of the
Board and Chief Executive Officer are separated. Our Board believes that this structure has allowed Mark L. Baum, Chief Executive
Officer, to focus on our day-to-day business, while allowing Robert Kammer, our Chairman of the Board, to lead the Board in its
fundamental role of providing advice to and independent oversight (including risk oversight) of management.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
separated Chairman of the Board and Chief Executive Officer positions are augmented by our independent directors, who comprise
all of our Board committees and meet regularly in executive session without Dr. Kammer, Mr. Baum or other members of our management
present to ensure that our Board maintains an appropriate level of independent oversight of management.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Board
Role in Risk Management</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board as a whole has responsibility for risk oversight, and each Board committee has responsibility for reviewing certain risk
areas and reporting to the full Board. The oversight responsibility of the Board and its committees is enabled by management reporting
processes that are designed to provide visibility to the Board about the identification, assessment, and management of critical
risks and management&rsquo;s risk mitigation strategies in certain focus areas. These areas of focus include strategic, operational,
financial and reporting, succession and compensation, and other areas. The Board and its committees oversee risks associated with
their respective areas of responsibility, as summarized below. Each committee meets with key management personnel and representatives
of outside advisors as required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 28%; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Board/Committee</B></FONT></TD>
    <TD STYLE="width: 2%; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 70%; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Primary
    Areas of Risk Oversight </B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Full
    Board </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
    and exposures associated with our business strategy and other current matters that may present material risk to our financial
    performance, operations, prospects or reputation. </FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit
    Committee </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Overall
    policies with respect to risk assessment and risk management, material pending legal proceedings involving the Company and
    other contingent liabilities, any potential related party or conflict of interest transactions, as well as other risks and
    exposures that may have a material impact on our financial statements. </FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation
    Committee </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
    and exposures associated with management succession planning and executive compensation programs and arrangements, including
    incentive plans. </FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nomination
    and Corporate Governance Committee </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
    and exposures associated with director succession planning, corporate governance, and overall board effectiveness. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transactions
with Related Persons</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
the beginning of 2016, there have been no transactions in which the Company was or is a participant, and there are no currently
proposed transactions in which the Company is to be a participant, in which the amount involved exceeds the lesser of $120,000
or 1% of the Company&rsquo;s average assets at year end for the last two completed fiscal years, and in which any director, officer
or beneficial holder of more than 5% of any class of our voting securities or member of such person&rsquo;s immediate family had
or will have a direct or indirect material interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Company
Policy Regarding Related Party Transactions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
charter of the Audit Committee of our Board tasks the Audit Committee with reviewing all related party transactions for potential
conflict of interest situations on an ongoing basis (if such transactions are not reviewed and overseen by another independent
body of the Board). In accordance with that policy, the Audit Committee&rsquo;s general practice is to review and oversee any
transactions that are reportable as related party transactions under the Financial Accounting Standards Board (&ldquo;FASB&rdquo;)
and SEC rules and regulations. Management advises the Audit Committee and the full Board of Directors on a regular basis of any
such transaction that is proposed to be entered into or continued and seeks approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
16(a) Beneficial Ownership Reporting Compliance</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
16(a) of the Exchange Act requires our executive officers, directors and persons who beneficially own more than 10% of our common
stock to file initial reports of ownership and reports of changes in ownership with the SEC. Such persons are required by SEC
regulations to furnish us with copies of all Section 16(a) reports filed by such persons.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
solely on our review of the copies of such reports furnished to us, we believe that during the fiscal year ended December 31,
2016, all executive officers, directors and greater than 10% beneficial owners of our common stock complied with the reporting
requirements of Section 16(a) of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Executive
Officers</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
officers are appointed by our Board and serve at its discretion. Set forth below is information regarding our executive officers
as of April 27, 2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; width: 25%; text-align: justify; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; width: 63%; text-align: justify; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Position</B></FONT></TD>
    <TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; width: 8%; text-align: center; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Age</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark
    L. Baum</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer and Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Andrew
    R. Boll</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer and Corporate Secretary</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">John
    P. Saharek</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Commercial Officer</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clayton
    D. Edwards</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Operating Officer</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Baum&rsquo;s biographical information is included with such information for the other members of our Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Andrew
R. Boll, CFA, CMA </B>started with Imprimis in December 2011, and has served as Imprimis&rsquo; Chief Financial Officer since
his promotion to that role in February 2015. He oversees the Company&rsquo;s accounting and financial reporting, investor relations,
human resources and other operational departments. In December 2011, Mr. Boll worked as a consultant for Imprimis and was hired
as its Vice President of Accounting and Public Reporting (<I>Principal Financial and Accounting Officer</I>) in February 2012.
Prior to his start at Imprimis, from November 2007 to November 2011, Mr. Boll worked for BCGU, LLC, a privately held fund manager
specializing in micro-cap, small-cap and venture type investment opportunities. There he provided financial and accounting consulting
services to public and private company clients. From 2004 to 2007, Mr. Boll held various accounting roles at Welsh Companies,
LLC, a privately held commercial real estate company, its fund and its other subsidiaries. Mr. Boll is a CFA charterholder, Certified
Management Accountant and earned his Bachelor of Science degree in Corporate and Public Finance. He is a member of the Institute
of Management Accountants, the CFA Institute, and the CFA Society of San Diego.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>John
P. Saharek</B> started with Imprimis as our Vice President of Commercialization, Ophthalmology in November 2013 until his promotion
to Chief Commercial Officer in February 2015. Mr. Saharek oversees all of the Company&rsquo;s commercial activities, including
marketing, sales and customer care departments. He is a senior healthcare industry executive with over 30 years of experience
developing and commercializing pharmaceutical, biotech, surgical device and diagnostic product portfolios. Before joining the
Company, he was the Head of U.S. Marketing and Strategy (April 2013 to October 2013) and National Director, Sales and Reimbursement
(July 2011 to April 2013) for ThromboGenics Inc., a biotherapeutics company, where he worked on developing the commercial strategy
and building a team to launch a new biologic into the U.S. market. Prior to that he was Vice President, Business Development at
SurModics Inc., a provider of medical device coatings and in vitro diagnostic products, from March 2006 to July 2011, where he
worked with large and small pharmaceutical companies on multi-platform drug delivery initiatives in the U.S. and internationally.
Earlier in his career, he held positions in marketing and sales at a number of companies, including his tenure with Bausch &amp;
Lomb. Mr. Saharek has a Master&rsquo;s degree in Business Administration from the University of Hartford and a Bachelor&rsquo;s
degree from Central Connecticut State University.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Clayton
D. Edwards, R.Ph</B> joined Imprimis in August 2016 as Senior Vice President of Operations until his promotion to Chief Operating
Officer in April 2017 where he oversees the company&rsquo;s operations, including pharmacy, production, dispensing, customer service,
information technology and quality. Mr. Edwards is a healthcare executive with over 30 years&rsquo; experience developing and
operationalizing complex healthcare products and services. Prior to joining Imprimis, he was the Senior Vice President of Home
Delivery Pharmacy and Prior Authorization (June 2011 to June 2016) for OptumRx, a UnitedHealthcare company. Earlier in his career,
he held various executive level positions at Doctor Diabetic Pharmacy/Sanare August 2010 to May 2011, Liberty Medical February
2005 to July 2009 and Medco Health Solutions May 1991 to February 2005. He actively serves on the Albany College of Pharmacy &amp;
Health Sciences Dean&rsquo;s Advisory Counsel, where he graduated with his Pharmacy degree. He also has a Master&rsquo;s degree
in Business Administration from St. Joseph&rsquo;s University.</FONT></P>



<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><B>DIRECTOR COMPENSATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Director Compensation Program for Year Ending
December 31, 2016</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">A summary of the non-employee
director compensation arrangements for 2016 is set forth below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Cash Compensation</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>&nbsp;</I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Retainer and</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; vertical-align: bottom; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Meeting Fees</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual Board Retainer Fee:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 79%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All non-employee directors</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 18%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35,000</FONT></TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual Chairman Retainer Fees*:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman of the Board</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,000</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit Committee Chairman</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,000</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation Committee Chairman</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate Governance Committee Chairman</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,000</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual Committee Member Retainer Fees*:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit Committee</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,500</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation Committee</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,000</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate Governance Committee</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,000</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.2in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These fees are in addition to the Annual Board Retainer Fee, as applicable. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Non-employee directors
are also reimbursed for their reasonable out-of-pocket expenses incurred in connection with attending Board and committee meetings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Equity Compensation</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We do not have a formal
equity compensation program for our non-employee directors. Rather, our Compensation Committee and our Board determine, in their
discretion, if and when to grant equity awards to any of our directors and the amount and other terms of any such award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In June 2016, the Company
granted an aggregate of 63,450 restricted stock unit awards (&ldquo;RSUs&rdquo;) (12,690 RSUs per director) to its non-employee
directors, with an aggregate value of approximately $250,000. These RSUs vest in equal quarterly installments over a one-year period
subject to the director&rsquo;s continued service, but the issuance and delivery of the shares subject to the RSUs are deferred
until the director resigns or otherwise terminates his service as a director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Director Compensation Table</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following table shows
the compensation earned by or awarded or paid in 2016 to the individuals who served as our non-employee directors during such period.
All compensation received by Mr. Baum, is disclosed in the Summary Compensation Table below. Mr. Baum did not receive any additional
compensation for his services as a director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name</FONT></TD>
    <TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fees Earned or Paid in</FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash ($)</FONT></TD>
    <TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock Awards ($)(1)(2)</FONT></TD>
    <TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total ($)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 43%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert J. Kammer</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55,000</FONT></TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49,999</FONT></TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">104,999</FONT></TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stephen Austin</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">54,000</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49,999</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">103,999</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">William H. Nelson(3)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">51,625</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49,999</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101,624</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Richard L. Lindstrom</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">53,500</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49,999</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">103,499</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anthony J. Principi</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">46,875</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49,999</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">96,874</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.35in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reflects the dollar amount of the grant date fair value of awards granted in 2016, measured in accordance with FASB Accounting Standards Codification (&ldquo;ASC&rdquo;) Topic 718 (&ldquo;Topic 718&rdquo;) and without adjustment for estimated forfeitures. For a discussion of the assumptions used to calculate the value of equity awards, refer to Note 12 to our consolidated financial statements for the fiscal year ended December 31, 2016 included in the Annual Report.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The aggregate number of stock and option awards held as of December 31, 2016 by each non-employee director are as follows:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares Underlying Stock Options</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares Underlying Restricted Stock Unit Awards</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 49%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert J. Kammer</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,459</FONT></TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,459</FONT></TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stephen G. Austin</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,123</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,459</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49,582</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Richard L. Lindstrom</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,440</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,440</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anthony J. Principi</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,263</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,263</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Nelson resigned from the Board on September 20, 2016.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>EXECUTIVE COMPENSATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><I>Compensation Philosophy and Objectives</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">Our philosophy in setting
compensation policies for executive officers has two fundamental objectives: (1) to attract, motivate and retain a highly skilled
team of executives and (2) to align our executives&rsquo; interests with those of our stockholders by rewarding short-term and
long-term performance and tying compensation to increases in stockholder value. The Compensation Committee believes that executive
compensation should be directly linked both to continuous improvements in corporate performance (&ldquo;pay for performance&rdquo;)
and the achievement of objectives that are expected to increase stockholder value. In furtherance of this goal, the Compensation
Committee has established the following guidelines as a foundation for compensation decisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">provide a competitive total compensation package that enables the Company to attract and retain highly qualified executives with the skills and experience required for the achievement of business goals;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">align compensation elements with the Company&rsquo;s annual goals and long-term business strategies and objectives;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">promote the achievement of key strategic and financial performance measures by linking short-term and long-term cash and equity incentives to the achievement of measurable corporate and individual performance goals; and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">align executives&rsquo; incentives with the creation of stockholder value.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">The Compensation Committee
considers, with respect to each of the Company&rsquo;s executive officers, the total compensation that may be awarded, including
base salary, annual incentive compensation, long-term incentive compensation, and other benefits, such as discretionary cash bonuses,
perquisites and other personal benefits available to each executive officer or that may be received by such executive officer under
certain circumstances, including compensation payable upon termination of the executive officer under an employment agreement or
severance agreement (if applicable). The Compensation Committee recognizes that its overall goal is to award compensation that
is reasonable when all elements of potential compensation are considered. The Compensation Committee believes that cash compensation
in the form of base salary and an annual incentive bonus provides our executives with short-term rewards for success in operations,
and that long-term compensation through the award of stock options, restricted stock units and other equity awards aligns the objectives
of management with those of our stockholders with respect to long-term performance and success.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">The Compensation Committee
also has historically focused on the Company&rsquo;s financial and working capital condition when making compensation decisions
and approving performance objectives. Because the Company has historically sought to preserve cash and currently does not operate
at a profit, overall compensation traditionally has been weighted more heavily toward equity-based compensation, as well as cash
payments that are earned only upon the Company&rsquo;s achievement of specified performance goals. The Compensation Committee will
continue to periodically reassess the appropriate weighting of cash and equity compensation in light of the Company&rsquo;s expenditures
in connection with commercial operations and its working capital needs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Roles in Determining Executive Officer Compensation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Compensation Committee</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In accordance with its
charter, the Compensation Committee is responsible for, among other things, reviewing and evaluating our executive officer compensation
program, including, among other things: (i) determining the objectives of the executive officer compensation program and reviewing
and recommending to the Board the program as a whole and the elements of compensation that comprise the program to be consistent
with such objectives; (ii) evaluating the performance of the Chief Executive Officer, and in consultation with the Chief Executive
Officer, the performance of our other executive officers, in light of the level of achievement of individual and corporate goals
and objectives; and (iii) approving and/or recommending to the Board the compensation package for all executive officers of the
Company. In accordance with its charter, the Compensation Committee, from time to time, solicits information and, as appropriate,
recommendations from management of the Company with respect to executive officer compensation, although the ultimate determination
and any recommendations to the Board remain with the Compensation Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Chief Executive Officer</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Compensation for the Chief
Executive Officer is reviewed, evaluated and approved by the Compensation Committee without the presence or participation of the
Chief Executive Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Chief Executive Officer
reviews and makes recommendations to the Compensation Committee with respect to the compensation of our other executive officers
and other members of senior management. While the Compensation Committee may review and consider recommendations of the Chief Executive
Officer, the Compensation Committee takes such action regarding compensation as it deems appropriate, which may include concurring
with the Chief Executive Officer&rsquo;s recommendations, or proposing adjustments to such recommendations, prior to the Compensation
Committee approving any compensation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Compensation Consultants</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In September 2015, the
Compensation Committee retained the services of an external compensation consultant, Radford, an Aon Hewitt Company (&ldquo;Radford&rdquo;).
The mandate of the consultant is to assist the Compensation Committee in its review of executive and director compensation practices,
including the competitiveness of pay levels, executive compensation design, benchmarking with the Company&rsquo;s peers in the
industry and other technical considerations including tax- and accounting-related matters. The Compensation Committee regularly
evaluates Radford&rsquo;s performance, considers alternative compensation consultants and has the final authority to engage and
terminate Radford&rsquo;s services. The decision to engage Radford was not made or recommended by the Company&rsquo;s management.
The Compensation Committee, after a review of the factors set forth in Section 10C-1of the Securities Exchange Act of 1934 and
NASDAQ requirements, has determined that the work performed by Radford in 2015 and continuing to be performed in 2016 does not
present any conflicts of interest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><I>Competitive Market
Benchmarking</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Compensation Committee draws on a number of resources to assist in the evaluation of the various components of the Company&rsquo;s
executive compensation program including, but not limited to, industry data compiled yearly by Radford in its Global Life Sciences
Survey, which represents a nationally-based assessment of executive compensation widely used within the pharmaceutical and biotechnology
industry sectors. While we do not establish compensation levels based solely on benchmarking, pay practices at other companies
are an important factor that the Compensation Committee considers in assessing the reasonableness of compensation and ensuring
that our compensation practices are competitive in the marketplace. The Compensation Committee adopted a group of peer companies
in the fourth quarter of 2015, and the Compensation Committee, with the assistance of Radford, may revise the group of peer companies
to take into account changes in market capitalization and similarities to the Company along the dimensions of competition for talent,
phase of development or stage of commercialization, current and potential market capitalization, and number of employees in the
future. More specifically, when establishing the 2015 peer group, the Compensation Committee and Radford focused on biotechnology
and pharmaceutical companies with commercial products NDA&rsquo;s filed, lead products in late phase 3 development, or in the beginning
stages of revenue recognition, with market capitalizations ranging from $40 million to $200 million and employee headcounts ranging
from 30 to 300 employees. Our current list of peer companies is comprised of the following companies:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 85%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: justify; width: 33%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AcelRx Pharmaceuticals, Inc.</FONT></TD>
    <TD NOWRAP STYLE="text-align: justify; width: 33%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Biodel</FONT></TD>
    <TD NOWRAP STYLE="text-align: justify; width: 34%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Omeros</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ADMA Biologics</FONT></TD>
    <TD NOWRAP STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Biota Pharmaceuticals, Inc. </FONT></TD>
    <TD NOWRAP STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OncoGenex Pharmaceuticals</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alderyra Therapeutics</FONT></TD>
    <TD NOWRAP STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Caladrius Biosciences</FONT></TD>
    <TD NOWRAP STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peregrine Pharmaceuticals</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alimera Sciences</FONT></TD>
    <TD NOWRAP STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cytori Therapeutics</FONT></TD>
    <TD NOWRAP STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repros Therapeutics</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Apricus Biosciences</FONT></TD>
    <TD NOWRAP STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Histogenics</FONT></TD>
    <TD NOWRAP STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vital Therapies</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aradigm</FONT></TD>
    <TD NOWRAP STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">InSite Vision</FONT></TD>
    <TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AVEO Pharmaceuticals, Inc.</FONT></TD>
    <TD NOWRAP STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ocular Therapeutix</FONT></TD>
    <TD NOWRAP>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">In
addition to adopting the above group of peer companies in 2015 (the &ldquo;2015 peer group&rdquo;), the Compensation Committee
engaged Radford to conduct a comprehensive benchmarking study reporting on compensation levels and practices, including equity,
relative to the 2015 peer group. An Executive Compensation Assessment report was prepared by Radford in December 2015 that provided
a competitive assessment of the Company&rsquo;s executive compensation program as compared to the market data for base salaries,
target total cash compensation and equity compensation of the 2015 peer group. In consideration of the benchmarking data in Radford&rsquo;s
competitive assessment of the Company&rsquo;s executive compensation programs and the Company&rsquo;s performance in 2015, adjustments
to compensation were made in the second quarter of 2016, as described below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><I>Compensation Program Overview</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In 2016, our executive
compensation program consisted of the following forms of compensation, each of which are described in greater detail:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Base Salary</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual Bonus</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity Compensation</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee Benefit Program</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Base Salary</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Compensation Committee
believes it is important to provide adequate fixed compensation to our executive officers working in a highly volatile and competitive
industry. Our Compensation Committee believes the base salaries are generally the appropriate cash compensation level that will
allow us to attract and retain highly skilled executives. The Compensation Committee&rsquo;s choice of this target percentile reflects
consideration of our stockholders&rsquo; interests in paying what is necessary to achieve our corporate goals, while conserving
cash as much as practicable. We believe that, given the industry in which we operate, our current working capital needs and our
compensation philosophy and objectives, base salaries at this level are generally sufficient to retain our current executives and
to hire new executives when and as required. In determining appropriate base salary levels for a given executive officer, the Compensation
Committee considers the following factors:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 0.25in; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">individual performance of the executive, as well as our overall performance, during the prior year; </FONT></TD></TR>
<TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">level of responsibility, including breadth, scope and complexity of the position; </FONT></TD></TR>
<TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">level of experience and expertise of the executive; </FONT></TD></TR>
<TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">internal review of the executive&rsquo;s compensation relative to other executives to ensure internal equity; and </FONT></TD></TR>
<TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">executive officer compensation levels at other similar companies to ensure competitiveness. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Salaries for executive
officers are determined on an individual basis at the time of hire. Adjustments to base salary are considered annually in light
of each executive officer&rsquo;s individual performance, the Company&rsquo;s performance and compensation levels at peer companies
in our industry, as well as changes in job responsibilities or promotion. The Chief Executive Officer assists the Compensation
Committee in its annual review of the base salaries of other executive officers based on the foregoing criteria.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Annual Bonus</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company provides executive
officers with annual performance-based cash bonuses, which are specifically designed to reward executives for overall corporate
performance as well as individual performance in a given year. Corporate goals are established at the beginning of each year by
the Compensation Committee with input from senior management. The target annual incentive bonus amounts relative to base salary
vary depending on each executive&rsquo;s accountability, scope of responsibilities and potential impact on the Company&rsquo;s
performance. Accordingly, the higher the level of control and accountability that is exercisable by an executive officer over our
overall performance, the greater the percentage of the executive officer&rsquo;s target total cash compensation that is dependent
on the annual performance-based cash bonus award. 2015 target annual incentive bonus levels ranged from 45% to 50% of base salary
for our named executive officers. We believe these target bonus levels for our executive officers are appropriate and consistent
with our pay-for-performance compensation philosophy. At the end of each fiscal year, individual and corporate performance are
measured versus plan and a percentage of target is fixed, which then determines the size of the total bonus pool from which annual
bonus incentives are to be paid to executive officers. All cash bonuses are awarded retrospectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Under this plan, corporate
and individual goals are established at the beginning of each fiscal year by the Compensation Committee with input from senior
management. For 2016, executive officers, except for the Chief Executive Officer, are assigned annual incentive bonus targets with
50%-60% of the bonus attributed to corporate performance and 40%-50% based on individual performance. For 2017, executive officers,
except for the Chief Executive Officer, are assigned annual incentive bonus targets with 80% of the bonus attributed to corporate
performance and 20% based on individual performance. For 2016 and 2017, the annual incentive bonus for our Chief Executive Officer
is based 100% on overall corporate performance. An executive officer&rsquo;s target annual incentive bonus amount relative to his
annual base salary is established depending on the executive officer&rsquo;s accountability, scope of responsibility and potential
impact on the Company&rsquo;s performance. Target annual incentive bonus levels for 2016 and 2017 were 65% of annual base salary
for our Chief Executive Officer and 50% for all other executive officers. At the end of each year, the Compensation Committee,
with input from senior management, evaluates individual and corporate performance compared against the goals established under
the plan, which determines the size of the total bonus pool from which cash bonuses are to be paid to executive officers. Based
on this evaluation, the Compensation Committee determined to award, for service performed in 2016, our Chief Executive Officer
a cash incentive bonus equal to 41% of his annual base salary, our Chief Financial Officer a cash incentive bonus equal to 36%
of his annual base salary and our Chief Commercial Officer a cash incentive bonus equal to 41% of his annual base salary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Equity Compensation</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As an additional component
of our compensation program, executive officers are eligible to receive equity compensation in the form of stock options or restricted
stock awards, which may also be granted as awards of RSUs. The Compensation Committee does not have a stated policy regarding the
issuance of equity grants, however, historically our executive officers have been granted service/time based vesting equity awards
and certain executive officers have also been granted options and RSUs that contain performance/market based vesting conditions.
The Compensation Committee grants stock options to executive officers to aid in their retention, to motivate them to assist with
the achievement of corporate objectives and to align their interests with those of our stockholders by creating a return tied to
the performance of our stock price. In determining the form, date of issuance and value of a grant, the Compensation Committee
considers the contributions and responsibilities of each executive officer, appropriate incentives for the achievement of our long-term
growth, the size and value of grants made to other executives at peer companies holding comparable positions, individual achievement
of designated performance goals, and the Company&rsquo;s overall performance relative to corporate objectives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Employee Benefit Program</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Executive officers are
eligible to participate in all of our employee benefit plans, including medical, dental, vision, group life, disability and accidental
death and dismemberment insurance, in each case on the same basis as other employees, subject to applicable law. We also provide
vacation and other paid holidays to all employees, including executive officers, all of which we believe to be comparable to those
provided at peer companies. These benefit programs are designed to enable us to attract and retain our workforce in a competitive
marketplace. Health, welfare and vacation benefits ensure that we have a productive and focused workforce through reliable and
competitive health and other benefits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Our retirement savings
plan (401(k)) plan is a tax-qualified retirement savings plan, pursuant to which all employees, including the named executive officers,
are able to contribute certain amounts of their annual compensation, subject to limits prescribed by the Internal Revenue Service.
We have historically made matching contributions of up to 4% of cash compensation contributed to the plan. The value of the 401(k)
benefit for each of our named executive officers is reflected in the &ldquo;All Other Compensation&rdquo; column of the Summary
Compensation Table.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><I>Change of Control
Arrangements</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">We
have entered into change of control arrangements with each of our named executive officers. Our Board approved these change of
control arrangements in order to mitigate some of the risk that exists for executives working in a biopharmaceutical company at
our current stage and where the possibility exists that we may be acquired if our efforts succeed. These arrangements are intended
to retain highly skilled executives who have, or who may seek, alternatives that may appear to them to be less risky in terms of
the potential loss of their position following a merger or sale, particularly where the services of these executive officers may
not be required by the acquirer. These arrangements provide change of control benefits either upon the termination of the employee&rsquo;s
service, a significant change in job responsibilities or the need to relocate within 12 months following a change of control. By
using a so-called &ldquo;double trigger&rdquo; change of control benefit, and thereby tying the severance benefit both to a change
in control and change in job status, rather than the mere consummation of a change of control transaction, the Compensation Committee
believes that it is better able to balance the employee&rsquo;s need for certainty with the interests of our stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">Information
regarding the change of control arrangements and the potential value of payments upon termination related to a change of control
is provided for the named executive officers under the headings &ldquo;Change of Control Arrangements&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><I>Changes in Compensation
for 2016</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Executive Compensation Assessment report prepared by Radford in December 2015 provided a competitive assessment of the Company&rsquo;s
compensation practices as compared to that of the 2015 peer group. The Compensation Committee has determined to aim and set its
executives&rsquo; base salaries and total target based cash compensation amounts (base salary plus target bonus) for 2016, in aggregate,
at levels near the 25<SUP>th</SUP> percentile (the bottom quartile) of salaries of executives with similar roles as compared to
the 2015 peer group and set its executives equity compensation levels near the 75<SUP>th</SUP> percentile (the upper quartile)
of level of the Company&rsquo;s equity guidelines. The Compensation Committee focused on the Company&rsquo;s financial and working
capital condition when making these compensation decisions. The current pay structure allows the Company to preserve cash, while,
we believe, providing competitive compensation packages to its executives, and more closely align them near the 50<SUP>th </SUP>percentile
in total direct compensation (cash and equity in aggregate) of their counterparts within the 2015 peer group. The Company also
entered into new employment agreements in April 2016 with its executive officers as further described below which provides for
uniform employment agreements with its executives and, we believe, are representative of market based terms and conditions. The
April 2016 employment agreements also eliminated provisions described in prior employment agreements related to <FONT STYLE="background-color: white">gross-up
payments equal to the amount of any excise tax owed by an executive as a result of any severance payments related to a change of
control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Summary Compensation Table</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following table summarizes
compensation earned by or awarded or paid to our named executive officers for 2016, which consist of all individuals serving as
our principal executive officer in 2016 and our next most highly compensated executive officer who was serving as an executive
officer at the end of 2016. Mr. Saharek&rsquo;s compensation information for up until his appointment as our Chief Commercial Officer
effective February 1, 2015, is not included in the table below, as he was not an executive officer of the Company prior to then.
Mr. Edward&rsquo;s compensation information is not included in the table below, as he was not an executive officer of the Company
prior to his appointment as our Chief Operating Officer on April 13, 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name and principal position</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salary</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock Awards(1)</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option Awards(1)</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Equity Plan Compensation (2)</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All Other Compensation(3)</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 30%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark L. Baum</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="width: 7%; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2016</FONT></TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">372,386</FONT></TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,072,933</FONT></TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">544,860</FONT></TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">153,043</FONT></TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,600</FONT></TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,153,822</FONT></TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2015</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">338,870</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,783,577</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">114,369</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,600</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,247,416</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Andrew R. Boll</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2016</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">234,110</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">531,654</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">192,420</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">84,700</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,396</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,050,280</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer(4)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2015</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">196,178</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">449,570</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">80,000</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,600</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">736,348</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">John P. Saharek</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2016</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">247,288</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">192,420</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">102,596</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,576</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">550,880</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Commercial Officer(5)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2015</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">201,315</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">221,100</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">534,600</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">66,000</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,142</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,031,157</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR>
    <TD STYLE="vertical-align: top; width: 0.35in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reflects the dollar amount of the grant date fair value of awards granted during the respective fiscal years, measured in accordance with Topic 718 and without adjustment for estimated forfeitures. For a discussion of the assumptions used to calculate the value of equity awards, refer to Note 12 to our consolidated financial statements for the year ended December 31, 2016 included in the Annual Report. For information about the material terms of each equity award, see the table entitled &ldquo;Outstanding Equity Awards at Fiscal Year End&rdquo; below.</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts represent payouts under the Company&rsquo;s annual cash bonus incentive plan based on the Company&rsquo;s performance measured against the corporate objectives established for the named executive officer and the named executive officer&rsquo;s individual performance measured against his individual goals. Such amounts are determined and paid after the end of each year, but reflect individual and Company performance for the respective years reflected above. </FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts represent matching contributions made by us for the named executive officer under our 401(k) retirement savings plan.</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation information for Mr. Boll is related to compensation for his service as our Vice President of Accounting and Public Reporting up until he was appointed as the Company&rsquo;s Chief Financial Officer in February 2015. </FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Saharek was appointed as the Company&rsquo;s Chief Commercial Officer in February 2015. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Outstanding Equity Awards at Fiscal Year-End</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following table sets
forth certain information regarding outstanding equity awards held by our named executive officers as of December 31, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="17" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option
    Awards</FONT></TD>
    <TD STYLE="font-weight: bold; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="14" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
    Awards</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incentive
    </FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incentive
    Plan</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plan
    Awards:</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Awards:</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Market</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of<BR>
 Shares</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Market
    Value</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number<BR>

    of</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Value
    of Unearned</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">or Units
    of</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of Shares
    or</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
    or Units</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
    or Units</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Units
    of</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of Stock</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of Stock</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underlying
    Unexercised</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underlying
    Unexercised</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">that<BR>
    Have</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
    <BR>
    that</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">that<BR>
    Have</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
    <BR>
    Have</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expiration</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Have
    Not</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unexercisable</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested(1)</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested(1)</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 20%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark
    L. Baum</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;125,000
    </FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.40</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/25/2022</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;60,000 </FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.50</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/31/2017</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;25,000 </FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.50</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/31/2017</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;180,000 </FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.99</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/2/2023</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;10,266 </FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,134</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.71</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/10/2024</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;30,000 </FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">150,000</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.95</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/1/2026</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">600,000</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.87</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/31/2020</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,050,000</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,625,000</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Andrew R. Boll</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">90,000</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.00</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/1/2023</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;2,467</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,933</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.71</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/10/2024</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;10,000</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.95</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/1/2026</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,000</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">75,000</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">157,500</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">393,750</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">John P. Saharek</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,000</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(15)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.16</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/12/2023</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;3,434</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(16)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,566</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.75</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/3/2024</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;52,500</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(17)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,500</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.37</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/1/2025</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;10,000</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(18)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.95</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/1/2026</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;30,000</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(19)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">75,000</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR>
    <TD STYLE="vertical-align: top; width: 0.35in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;(1) </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Calculated by multiplying the number of unvested shares by $2.50, the closing price per share of our common stock on The NASDAQ Capital Market on December 31, 2016 (which was the last business day of our 2016 fiscal year).</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2) </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents an option granted to Mr. Baum on April 1, 2012 under the 2007 Incentive Stock and Awards Plan (the &ldquo;Plan&rdquo;) as compensation for his services, including his service as Chairman of the Board. The option vested in 12 equal monthly installments of 10,417 shares commencing on January 25, 2012.</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3) </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents an option granted to Mr. Baum on April 1, 2012 under the Plan in connection with his appointment as our Chief Executive Officer. The option vested over a two-year period, with 15,000 shares vesting immediately upon issuance and an additional 1,875 shares vesting monthly for the 24 months thereafter.</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4) </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents an option granted to Mr. Baum on April 1, 2012 under the Plan in connection with his services as a director. The option vested in four equal quarterly installments of 6,250 shares commencing on June 30, 2012.</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5) </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents an option granted to Mr. Baum on May 2, 2013 under the Plan in connection with his services as our Chief Executive Officer and pursuant to the terms of his employment agreement with us. The option vests in 12 equal quarterly installments of 15,000 shares over three years commencing on the three-month anniversary of the date of grant.</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6) </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents an option granted to Mr. Baum on February 10, 2014 under the Plan in connection with his services as our Chief Executive Officer. The option vests in three equal annual installments of 5,133 shares over three years commencing on the one-year anniversary of the date of grant.</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents an option granted to Mr. Baum on April 1, 2016 under the Plan in connection with his services as our Chief Executive Officer. The option vests in 12 equal quarterly installments of 15,000 shares over three years commencing on the three-month anniversary of the date of grant.</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8) </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents an option granted to Mr. Baum on July 30, 2015 under the Plan in connection with his services as our Chief Executive Officer. The option vests upon achieving certain stock price targets as described further below over a five-year period: </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 75%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 78%; text-align: justify; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of Shares</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 21%; text-align: justify; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Target Share Price</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,000 shares</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$9.00 or greater</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,000 shares</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$10.00 or greater</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,000 shares</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$12.00 or greater</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,000 shares</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$14.00 or greater</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,000 shares</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$15.00 or greater</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR>
    <TD STYLE="vertical-align: top; text-align: justify; width: 0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents an award of RSUs granted to Mr. Baum on April 25, 2016 under the Plan in connection with his services as our Chief Executive Officer and pursuant to the terms of his employment agreement with us. The RSUs vest upon achieving and maintaining certain stock price targets ranging from $9 to $15 a share over a three-year period. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR>
    <TD STYLE="vertical-align: top; text-align: justify; width: 0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10) </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents an option granted to Mr. Boll on April 1, 2013 under the Plan in connection with his service as our Vice President, Accounting and Public Reporting (and currently as our Chief Financial Officer). The option vests in 12 equal quarterly installments of 7,500 shares over three years commencing on the three-month anniversary of the date of grant.</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11) </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents an option granted to Mr. Boll on February 10, 2014 under the Plan in connection with his services as our Vice President, Accounting and Public Reporting (and currently as our Chief Financial Officer). The option vests in three equal annual installments of 2,467 shares over three years commencing on the one-year anniversary of the date of grant.</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12) </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents an option granted to Mr. Boll on April 1, 2016 under the Plan in connection with his services as our Chief Executive Officer. The option vests in 12 equal quarterly installments of 5,000 shares over three years commencing on the three-month anniversary of the date of grant.</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13) </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents an award of RSUs granted to Mr. Boll on February 1, 2015 under the Plan in connection with his services as our Chief Financial Officer and pursuant to the terms of his employment agreement with us. The RSUs vest in full on February 1, 2018 contingent upon continuous service to the Company through such date.</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents an award of RSUs granted to Mr. Boll on April 25, 2016 under the Plan in connection with his services as our Chief Financial Officer and pursuant to the terms of his employment agreement with us. The RSUs vest upon achieving and maintaining certain stock price targets ranging from $9 to $15 a share over a three-year period.</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(15) </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents an option granted to Mr. Saharek on November 12, 2013 under the Plan in connection with his appointment as our Vice President of Commercialization, Ophthalmology (and currently as our Chief Commercial Officer). The option vests according to the following schedule 25% of the shares subject to the option vest and become exercisable on the first anniversary of the grant date and the remaining 75% of the shares subject to the option vest and become exercisable quarterly in equal installments thereafter over two years.</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(16) </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents an option granted to Mr. Saharek on March 3, 2014 under the Plan in connection with his appointment as our Vice President of Commercialization, Ophthalmology (and currently as our Chief Commercial Officer).. The option vests according to the following schedule 25% of the shares subject to the option vest and become exercisable on the first anniversary of the grant date and the remaining 75% of the shares subject to the option vest and become exercisable quarterly in equal installments thereafter over three years.</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(17) </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents an option granted to Mr. Saharek on February 1, 2015 under the Plan in connection with his service as our Chief Commercial Officer. The option vests in 12 equal quarterly installments of 7,500 shares over three years commencing on the three-month anniversary of the date of grant.</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(18) </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents an option granted to Mr. Saharek on April 1, 2016 under the Plan in connection with his services as our Chief Commercial Officer. The option vests in 12 equal quarterly installments of 5,000 shares over three years commencing on the three-month anniversary of the date of grant.</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(19) </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents an award of RSUs granted to Mr. Saharek on February 1, 2015 under the Plan in connection with his services as our Chief Commercial Officer and pursuant to the terms of his employment agreement with us. The RSUs vest in full on February 1, 2018 contingent upon continuous service to the Company through such date.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Compensation Arrangements with Mark L. Baum</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Employment Agreements</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">On
May 2, 2013, we entered into an amended and restated employment agreement with Mark L. Baum, our Chief Executive Officer, which
amended the employment agreement Mr. Baum entered into with us effective April 1, 2012. The employment agreement had an initial
term of three years and was renewable thereafter for consecutive one-year terms unless earlier terminated by either party. The
agreement provided for an initial annual base salary of $329,000 and a target annual incentive bonus of 45% of his annual base
salary. In addition, pursuant to the employment agreement, Mr. Baum received the following equity incentive awards: (i) 180,000
options to purchase our common stock; (ii) 200,000 restricted stock units subject to time-based vesting; and (iii) 1,050,000 restricted
stock units subject to performance-based vesting if the Company achieves and maintains certain stock price targets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On April 25, 2016, we entered
into a new employment agreement (the &ldquo;Baum Agreement&rdquo;) with Mr. Baum with respect to his employment as Chief Executive
Officer. This new agreement replaces his 2012 employment agreement, as amended, with us. Mr. Baum&rsquo;s employment with the Company
is at-will and may be terminated either by Mr. Baum or the Company at any time for any reason or for no reason. The Baum Agreement
provides for an initial annual base salary of $388,000 and a target annual bonus incentive under the Company&rsquo;s Management
Incentive Plan of 60% of his base salary. In addition, as described more fully below, pursuant to the employment agreement, Mr.
Baum received the following equity incentive awards: (i) 180,000 options to purchase our common stock (the &ldquo;Baum Options&rdquo;);
and (ii) 1,050,000 restricted stock units subject to performance-based accelerated vesting (the &ldquo;Baum Performance Equity
Award&rdquo;). Concurrent with the issuance of the Baum Performance Equity Award, Mr. Baum agreed to forfeit 1,050,000 restricted
stock units subject to performance-based vesting granted to him in May 2013. As a result, the issuance of the Baum Performance
Equity Award has been treated as a modification of the RSU granted to Mr. Baum in May 2013 for accounting purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>&nbsp;</I></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>CEO Involuntary Termination</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Should Mr. Baum&rsquo;s
employment be terminated by the Company without Cause (as defined in the Baum Agreement) or should Mr. Baum terminate his employment
with the Company for Good Reason (as defined in the Baum Agreement) (each an &ldquo;Involuntary Termination&rdquo;), any unvested
Baum Options shall be accelerated as if Mr. Baum had completed an additional 18 months of employment with the Company as of the
date of such Involuntary Termination. In addition, Mr. Baum will receive an extension to exercise his vested options until the
earlier of the original expiration date and 18 months following the date of his Involuntary Termination. In the event of an Involuntary
Termination of Mr. Baum&rsquo;s employment with the Company, Mr. Baum will be entitled to (i) a severance payment equal to the
sum of 12 months of his then base salary plus the greater of his (x) annual bonus for the preceding calendar year or (y) target
annual bonus for the year in which the termination occurs; (ii) his annual bonus for the year in which the termination occurs,
determined based on actual results for such year, pro-rated up until the date of his termination; and (iii) continued group health
plan coverage through COBRA for a period of up to 12 months. In the event of an Involuntary Termination of Mr. Baum&rsquo;s employment
occurring more than 30 days prior to the fifth anniversary of the grant date, the Baum Performance Equity Awards will remain eligible
to vest pursuant to their terms for a period of 18 months following Mr. Baum&rsquo;s Involuntary Termination, provided that such
18 month period will not extend beyond the day before the fifth anniversary of the grant date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>2016 Performance Equity Award</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In connection with the
Baum Agreement, Mr. Baum was granted a performance-based restricted stock unit award of up to 1,050,000 performance stock units.
The 1,050,000 performance stock units comprising the Baum Performance Equity Award will vest on the fifth anniversary of the grant
date, subject to Mr. Baum&rsquo;s continued employment with the Company, and may vest earlier if the Company achieves and maintains
certain stock price targets during the five year period following the grant date or upon a Change in Control if the Baum Performance
Equity Award is not assumed, continued or substituted for by the acquiring entity. The performance-based vesting criteria are broken
into five equal tranches and require that the Company achieve and maintain certain stock price targets ranging from $9 per share
to $15 per share during the five-year period following the grant date. These market-based accelerated vesting conditions are set
forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 96%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tranche</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of Shares</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Target Share Price</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock Price Appreciation as of Date of Grant(1)</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tranche 1</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 39%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">200,000 shares</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 35%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$9.00 or greater</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">125</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tranche 2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">200,000 shares</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$10.00 or greater</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">150</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tranche 3</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">200,000 shares</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$12.00 or greater</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">200</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tranche 4</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">200,000 shares</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$14.00 or greater</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">250</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tranche 5</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">250,000 shares</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$15.00 or greater</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">275</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 96%">
<TR>
    <TD STYLE="width: 0.35in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The closing sale
    price of our Common Stock on April 25, 2016, the date the Baum Performance Equity grant was made, was $3.98.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">For each respective tranche
to vest the following conditions must be met: (i) the Company&rsquo;s common stock must have an official closing price at or above
the Target Share Price for the respective tranche (each such date, a &ldquo;Trigger Date&rdquo;); (ii) during the period that includes
the Trigger Date and the immediately following 19 trading days (the &ldquo;Measurement Period&rdquo;), the arithmetic mean of the
20 closing prices of the Company&rsquo;s common stock during the Measurement Period must be at or above the Target Share Price
for such tranche; and (iii) with certain limited exceptions, Mr. Baum must be in service with the Company through at the date of
vesting. In addition, the Baum Performance Equity Award contains an incentive recoupment (or &ldquo;clawback&rdquo;) provision
that provides for Mr. Baum&rsquo;s forfeiture or repayment of the benefits granted under the Baum Performance Equity Award under
certain circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Change in Control Arrangements</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In the event of an Involuntary
Termination of Mr. Baum&rsquo;s employment within one month prior to, or 12 months following, a Change in Control (as defined in
the Plan), any unvested Baum Options shall be deemed fully vested as of the date of such Involuntary Termination. Should an Involuntary
Termination of Mr. Baum&rsquo;s employment occur within one month prior to, or 12 months following, a Change in Control, Mr. Baum
shall be entitled to (i) a severance payment equal to the sum of 18 months of his then base salary plus the greater of his (x)
annual bonus for the preceding calendar year or (y) target annual bonus for the year in which the termination occurs; (ii) his
annual bonus for the year in which the termination occurs, determined based on actual results for such year, pro-rated up until
the date of his termination; and (iii) continued group health plan coverage through COBRA for a period of up to 18 months. Furthermore,
in the event of an Involuntary Termination of Mr. Baum&rsquo;s employment within one month prior, to or 12 months following, a
Change in Control, any unvested portion of the Baum Performance Equity Award will accelerate in full based on the performance standards
at the time of such Involuntary Termination as set forth in the award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Also in connection with
the Baum Agreement, Mr. Baum and the Company entered into a retention letter agreement (the &ldquo;Baum Retention Letter Agreement&rdquo;)
that provides upon the closing of an event of a Change of Control within five years of the date of the Baum Agreement, Mr. Baum
will be entitled to receive a retention bonus ranging from 1.5% of the Change in Control Consideration (as defined in the Baum
Retention Letter Agreement) to 0.7% of the Change in Control Consideration depending on when the closing of a Change of Control
occurs (e.g., the sooner the Change of Control, the higher the retention bonus percentage). Payment of the retention bonus is subject
to Mr. Baum&rsquo;s continuous employment through the closing of the Change in Control or an Involuntary Termination of his employment
on or before the closing of the Change in Control. Mr. Baum and the Company agreed that the Baum Retention Letter Agreement supersedes
the previous retention letter agreement, dated July 31, 2015, between the parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Other Equity Incentive Grants</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Mr. Baum has received other
equity awards, as detailed in the table entitled &ldquo;Outstanding Equity Awards at Fiscal Year End&rdquo; above, and is eligible
to receive additional equity awards at the time awards are granted to other senior executives and otherwise at the discretion of
the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Compensation Arrangements with Andrew R.
Boll</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Employment Agreements</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">Effective
as of February 1, 2015, we entered into an amended and restated employment agreement with Mr. Boll in connection with his appointment
as our Chief Financial Officer, which restates and supersedes his prior employment agreement with us entered into on February 1,
2012. The amended and restated employment agreement provided for the following, among other things: (i) a term of three years,
(ii) an annual base salary of $200,000; (iii) eligibility to receive an annual cash bonus in an amount equal to at least 20% of
his then-current annual base salary and a target of 50% of his then-current annual base salary, with the precise amount to be determined
at the discretion of the Board; and (iv) certain initial equity awards in connection with his appointment as our Chief Financial
Officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On April 25, 2016, the
Company entered into a new employment agreement (the &ldquo;Boll Agreement&rdquo;) with Mr. Boll with respect to his employment
as Chief Financial Officer and Corporate Secretary. This new agreement replaces his 2012 employment agreement, as amended, with
the Company. Mr. Boll&rsquo;s employment with the Company is at-will and may be terminated either by Mr. Boll or the Company at
any time for any reason or for no reason. The Boll Agreement provides for an initial annual base salary of $250,000 and a target
annual incentive bonus of 50% of his annual base salary. In addition, as described more fully below, pursuant to the employment
agreement, Mr. Boll received the following equity incentive awards: (i) 60,000 options to purchase our common stock (the &ldquo;Boll
Options&rdquo;); and (ii) 157,500 restricted stock units subject to performance-based accelerated vesting (the &ldquo;Boll Performance
Equity Award&rdquo;). Concurrent with the issuance of the Boll Performance Equity Award, Mr. Boll agreed to forfeit 157,500 restricted
stock units subject to performance-based vesting granted to him in February 2015. As a result, the issuance of the 2016 Performance
Equity Award has been treated as a modification of the RSU granted to Mr. Boll in February 2015 for accounting purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>CFO Involuntary Termination</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Should Mr. Boll&rsquo;s
employment be terminated by the Company without Cause (as defined in the Boll Agreement) or should Mr. Boll terminate his employment
with the Company for Good Reason (as defined in the Boll Agreement) (each an &ldquo;Involuntary Termination&rdquo;), any unvested
Boll Options shall be accelerated as if Mr. Boll had completed an additional 12 months of employment with the Company as of the
date of such Involuntary Termination. In addition, Mr. Boll will receive an extension to exercise his vested options until the
earlier of the original expiration date and 12 months following the date of his Involuntary Termination. In the event of an Involuntary
Termination of Mr. Boll&rsquo;s employment with the Company, Mr. Boll will be entitled to (i) a severance payment equal to the
sum of six months of his then base salary plus the greater of his (x) annual bonus for the preceding calendar year or (y) target
annual bonus for the year in which the termination occurs; (ii) his annual bonus for the year in which the termination occurs,
determined based on actual results for such year, pro-rated up until the date of his termination; and (iii) continued group health
plan coverage through COBRA for a period of up to six months.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>2016 Performance Equity Award</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The 157,500 performance
stock units comprising the Boll Performance Equity Award will vest on the fifth anniversary of the grant date, subject to Mr. Boll&rsquo;s
continued employment with the Company, and may vest earlier if the Company achieves and maintains certain stock price targets during
the five year period following the grant date or upon a Change in Control if the Boll Performance Equity Award is not assumed,
continued or substituted for by the acquiring entity. The performance-based vesting criteria are broken into five equal tranches
and require that the Company achieve and maintain certain stock price targets ranging from $9 per share to $15 per share during
the five-year period following the grant date. These market-based accelerated vesting conditions are set forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 96%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tranche</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of Shares</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Target Share Price</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock Price Appreciation as of Date of Grant(1)</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tranche 1</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 39%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,000 shares</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 35%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$9.00 or greater</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">125</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tranche 2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,000 shares</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$10.00 or greater</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">150</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tranche 3</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,000 shares</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$12.00 or greater</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">200</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tranche 4</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,000 shares</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$14.00 or greater</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">250</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tranche 5</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,500 shares</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$15.00 or greater</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">275</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 96%">
<TR>
    <TD STYLE="width: 0.35in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The closing sale price of our Common Stock on April 25, 2016, the date the Boll Performance Equity grant was made, was $3.98.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.65pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">For each respective tranche
to vest the following conditions must be met: (i) the Company&rsquo;s common stock must have an official closing price at or above
the Target Share Price for the respective tranche (each such date, a &ldquo;Trigger Date&rdquo;); (ii) during the period that includes
the Trigger Date and the immediately following 19 trading days (the &ldquo;Measurement Period&rdquo;), the arithmetic mean of the
20 closing prices of the Company&rsquo;s common stock during the Measurement Period must be at or above the Target Share Price
for such tranche; and (iii) with certain limited exceptions, Mr. Boll must be in service with the Company through at the date of
vesting. In addition, the Boll Performance Equity Award contains an incentive recoupment (or &ldquo;clawback&rdquo;) provision
that provides for Mr. Boll&rsquo;s forfeiture or repayment of the benefits granted under the Boll Performance Equity Award under
certain circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Change in Control Arrangements</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Should an Involuntary Termination
of Mr. Boll&rsquo;s employment occur within one month prior to, or 12 months following, a Change in Control, Mr. Boll shall be
entitled to (i) a severance payment equal to the sum of 12 months of his then base salary plus the greater of his (x) annual bonus
for the preceding calendar year or (y) target annual bonus for the year in which the termination occurs; (ii) his annual bonus
for the year in which the termination occurs, determined based on actual results for such year, pro-rated up until the date of
his termination; and (iii) continued group health plan coverage through COBRA for a period of up to 12 months. Furthermore, in
the event of an Involuntary Termination of Mr. Boll&rsquo;s employment within one month prior to, or 12 months following, a Change
in Control, any unvested Boll Options shall be deemed fully vested as of the date of such Involuntary Termination. In the event
of an Involuntary Termination of Mr. Boll&rsquo;s employment occurring more than 30 days prior to the fifth anniversary of the
grant date, the Boll Performance Equity Awards will remain eligible to vest pursuant to their terms for a period of 12 months following
Mr. Boll&rsquo;s Involuntary Termination, provided that such 12 month period will not extend beyond the day before the fifth anniversary
of the grant date. Furthermore, in the event of an Involuntary Termination of Mr. Boll&rsquo;s employment within one month prior,
to or 12 months following, a Change in Control, any unvested portion of the Boll Performance Equity Award will accelerate in full
based on the performance standards at the time of such Involuntary Termination as set forth in the award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Also, in connection with
the Boll Agreement, Mr. Boll and the Company entered into a retention letter agreement (the &ldquo;Boll Retention Letter Agreement&rdquo;)
that provides upon the closing of an event of a Change of Control within five years of the date of the Boll Agreement, Mr. Boll
will be entitled to receive a retention bonus ranging from 1.0% of the Change in Control Consideration (as defined in the Boll
Retention Letter Agreement) to 0.2% of the Change in Control Consideration depending on when the closing of a Change of Control
occurs (e.g., the sooner the Change of Control, the higher the retention bonus percentage). Payment of the retention bonus is subject
to Mr. Boll&rsquo;s continuous employment through the closing of the Change in Control or an Involuntary Termination of his employment
on or before the closing of the Change in Control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Equity Incentive Grants</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Mr. Boll has received other
equity awards, as detailed in the table entitled &ldquo;Outstanding Equity Awards at Fiscal Year End&rdquo; above, and is eligible
to receive additional equity awards at the time awards are granted to other senior executives and otherwise at the discretion of
the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Compensation Arrangements with John P. Saharek</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Employment Agreements</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">Effective
as of February 1, 2015, we entered into an employment agreement with John P. Saharek in connection with his appointment as our
Chief Commercial Officer. The employment agreement provided for the following, among other things: (i) a term of three years, (ii)
an annual base salary of $220,000; (iii) bonus target of 50% of his then-current annual base salary, with the precise amount to
be determined at the discretion of the Board; and (iv) certain initial equity awards in connection with his appointment as our
Chief Commercial Officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On April 25, 2016, the
Company entered into a new employment agreement (the &ldquo;Saharek Agreement&rdquo;) with Mr. Saharek with respect to his employment
as Chief Commercial Officer. This new agreement replaces his 2015 employment agreement, with the Company. Mr. Saharek&rsquo;s employment
with the Company is at-will and may be terminated either by Mr. Saharek or the Company at any time for any reason or for no reason.
The Saharek Agreement provides for an initial annual base salary of $260,000 and a target annual incentive bonus of 50% of his
annual base salary. In addition, pursuant to the employment agreement, Mr. Saharek received 60,000 options to purchase our common
stock (the &ldquo;Saharek Options&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>CCO Involuntary Termination</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Should Mr. Saharek&rsquo;s
employment be terminated by the Company without Cause (as defined in the Saharek Agreement) or should Mr. Saharek terminate his
employment with the Company for Good Reason (as defined in the Saharek Agreement) (each an &ldquo;Involuntary Termination&rdquo;),
any unvested Saharek Options shall be accelerated as if Mr. Saharek had completed an additional 12 months of employment with the
Company as of the date of such Involuntary Termination. In addition, Mr. Saharek will receive an extension to exercise his vested
options until the earlier of the original expiration date and 12 months following the date of his Involuntary Termination. In the
event of an Involuntary Termination of Mr. Saharek&rsquo;s employment with the Company, Mr. Saharek will be entitled to (i) a severance
payment equal to the sum of six months of his then Base Salary plus the greater of his (x) Annual Bonus for the preceding calendar
year or (y) target Annual Bonus for the year in which the termination occurs; (ii) his Annual Bonus for the year in which the termination
occurs, determined based on actual results for such year, pro-rated up until the date of his termination; and (iii) continued group
health plan coverage through COBRA for a period of up to six months.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Change of Control Provisions</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Should an Involuntary Termination
of Mr. Saharek&rsquo;s employment occur within one month prior to, or 12 months following, a Change in Control, Mr. Saharek shall
be entitled to (i) a severance payment equal to the sum of 12 months of his then base salary plus the greater of his (x) annual
bonus for the preceding calendar year or (y) target annual bonus for the year in which the termination occurs; (ii) his annual
bonus for the year in which the termination occurs, determined based on actual results for such year, pro-rated up until the date
of his termination; and (iii) continued group health plan coverage through COBRA for a period of up to 12 months. Furthermore,
in the event of an Involuntary Termination of Mr. Saharek&rsquo;s employment within one month prior to, or 12 months following
a Change in Control, any unvested Saharek Options shall be deemed fully vested as of the date of such Involuntary Termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Also, in connection with
the Saharek Agreement, Mr. Saharek and the Company entered into a retention letter agreement (the &ldquo;Saharek Retention Letter
Agreement&rdquo;) that provides upon the closing of an event of a Change of Control within two years of the date of the Saharek
Agreement, Mr. Saharek will be entitled to receive a retention bonus ranging from 0.5% of the Change in Control Consideration (as
defined in the Saharek Retention Letter Agreement) to 0.25% of the Change in Control Consideration depending on when the closing
of a Change of Control occurs (e.g., the sooner the Change of Control, the higher the retention bonus percentage). Payment of the
retention bonus is subject to Mr. Saharek&rsquo;s continuous employment through the closing of the Change in Control or an Involuntary
Termination of his employment on or before the closing of the Change in Control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Equity Incentive Grants</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Mr. Saharek has received
other equity awards, as detailed in the table entitled &ldquo;Outstanding Equity Awards at Fiscal Year End&rdquo; above, and is
eligible to receive additional equity awards at the time awards are granted to other senior executives and otherwise at the discretion
of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Securities Authorized for Issuance Under
Equity Compensation Plans</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following table summarizes
our compensation plans under which our equity securities are authorized for issuance as of December 31, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><B>EQUITY COMPENSATION
PLAN INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="font-weight: bold; padding-bottom: 1.5pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of Shares to be Issued Upon Exercise of Outstanding Options, Warrants and Rights</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD>
    <TD STYLE="font-weight: bold; padding-bottom: 1.5pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted- Average Exercise Price of Outstanding Options, Warrants and Rights</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD>
    <TD STYLE="font-weight: bold; padding-bottom: 1.5pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of Shares &nbsp;Remaining Available &nbsp;for Future Issuance &nbsp;Under Equity &nbsp;Compensation Plans</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 49%; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity compensation plans approved by security holders(1)</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,386,434</FONT></TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.20</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">815,159</FONT></TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity compensation plans not approved by security holders</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,748,829</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.91</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,135,263</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.02</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">815,159</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.35in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents shares reserved under the Plan. See Note 12 to our consolidated financial statements included in the Annual Report. The Plan was initially adopted on September 17, 2007, and was subsequently amended on November 5, 2008, February 26, 2012, July 18, 2012, May 2, 2013 and September 27, 2013. As of December 31, 2016, the Plan provided for the issuance of a maximum of an aggregate of 5,000,000 shares of the Company&rsquo;s common stock.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excludes outstanding RSUs, which have no associated exercise price.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><B>SECURITY OWNERSHIP
OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><B>STOCKHOLDER MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following table sets
forth the shares of our common stock beneficially owned by (i) each of our directors, (ii) each of our named executive officers,
(iii) all of our directors and executive officers as a group, and (iv) all persons known by us to beneficially own more than 5%
of our outstanding common stock. We have determined the beneficial ownership shown on this table in accordance with the rules of
the Securities and Exchange Commission. Under these rules, shares are considered beneficially owned if held by the person indicated,
or if such person, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, has or
shares the power to vote, to direct the voting of and/or to dispose of or to direct the disposition of such shares. Except as otherwise
indicated in the accompanying footnotes, the information in the table below is based on information as of April 24, 2017. Unless
otherwise indicated in the footnotes to the following table, each person named in the table has sole voting and investment power
with respect to shares of common stock and the address for such person is c/o Imprimis Pharmaceuticals, Inc. 12264 El Camino Real,
Suite 350, San Diego, CA 92130.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial Owner</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount and Nature of Beneficial Ownership</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of Shares</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Percentage (1)</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; text-align: justify; padding-bottom: 1.5pt; text-decoration: underline"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>5% + Stockholders</U></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 62%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Longboard Capital Advisors, LLC (2)</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,416,000</FONT></TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.02</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-style: italic; text-decoration: underline; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors and Officers</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark L. Baum (3)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,031,409</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.03</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Andrew R. Boll (4)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">210,400</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.05</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">John P. Saharek (5)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">111,246</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clayton D. Edwards (6)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert J. Kammer (7)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">997,999</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.99</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stephen G. Austin (8)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,064</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anthony J. Principi (9)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,854</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Richard L. Lindstrom (10)</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">217,094</FONT></TD>
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.08</FONT></TD>
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All executives and directors as a group (8 persons)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,612,785</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.55</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.35in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents less than 1%.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial ownership percentages are based on 19,965,415 shares of our common stock outstanding as of April 24, 2017. Shares of common stock subject to options or warrants that are currently exercisable or exercisable within 60 days after April 24, 2017 are deemed outstanding for the purpose of computing the percentage ownership of the person holding such options or warrants, but are not deemed outstanding for the purpose of computing the percentage ownership of any other person.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This information is as of March 21, 2017 and based on a Schedule 13G/A April 19, 2017 by Longboard Capital Advisors, LLC and Brett Conrad. Includes 208,000 shares of our common stock issuable upon exercise of warrants. The address for Longboard Capital Advisors, LLC is 1312 Cedar St. Santa Monica, California 90405.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes 393,733 shares of common stock issuable upon the exercise of stock options exercisable within 60 days after April 24, 2017 and 156,000 shares of common stock issuable upon the exercise of warrants exercisable within 60 days after April 24, 2017.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes 117,400 shares of common stock issuable upon the exercise of stock options exercisable within 60 days after April 24, 2017 and 39,000 shares of common stock issuable upon the exercise of warrants exercisable within 60 days after April 24, 2017.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes 111,246 shares of common stock issuable upon the exercise of stock options exercisable within 60 days after April 24, 2017.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Edwards currently does not hold any shares of common stock issuable upon the exercise of stock options exercisable within 60 days after April 24, 2017.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes 22,941 shares of common stock issuable upon Mr. Kammer&rsquo;s discontinuation of service as a director. &nbsp; &nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes 17,123 shares of common stock issuable upon the exercise of stock options exercisable within 60 days after April 24, 2017 and 22,941 shares of common stock issuable upon Mr. Austin&rsquo;s discontinuation of service as a director. &nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes 10,854 shares of common stock issuable upon Mr. Principi&rsquo;s discontinuation of service as a director. &nbsp; &nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes 17,094 shares of common stock issuable upon Mr. Lindstrom&rsquo;s discontinuation of service as a director and 100,000 shares of common stock issuable upon the exercise of warrant exercisable within 60 days after April 24, 2017.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>REPORT OF THE AUDIT COMMITTEE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Audit Committee manages
relations with and evaluates the performance of the Company&rsquo;s independent registered public accounting firm, and evaluates
policies and procedures relating to internal control systems. The Audit Committee operates under a written Audit Committee charter
that has been adopted by the Board, a copy of which is available on the Company&rsquo;s website at http://imprimispharma.investorroom.com.
All members of the Audit Committee currently meet the independence and qualification standards for Audit Committee membership set
forth in the rules and listing standards of Nasdaq and the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Other than Mr. Austin,
the Audit Committee members are not professional accountants or auditors. The members&rsquo; functions are not intended to duplicate
or to certify the activities of management and the independent registered public accounting firm. The Audit Committee serves a
Board-level oversight role in which it provides advice, counsel and direction to management and the auditors on the basis of the
information it receives, discussions with management and the auditors, and the experience of the Audit Committee&rsquo;s members
in business, financial and accounting matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Audit Committee oversees
the Company&rsquo;s financial reporting process on behalf of the Board. The Company&rsquo;s management has the primary responsibility
for the financial statements and reporting process, including the Company&rsquo;s system of internal controls. In fulfilling its
oversight responsibilities, the Audit Committee reviewed with management the audited financial statements included in the Annual
Report. This review included a discussion of the quality and the acceptability of the Company&rsquo;s financial reporting, including
the nature and extent of disclosures in the financial statements and the accompanying notes. The Audit Committee also reviewed
the progress and results of the testing of the design and effectiveness of the Company&rsquo;s internal control over financial
reporting pursuant to Section 404 of the Sarbanes-Oxley Act of 2002.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Audit Committee also
reviewed and discussed with the Company&rsquo;s independent registered public accounting firm, which is responsible for expressing
an opinion on the conformity of the audited financial statements with accounting principles generally accepted in the United States
of America, its judgments as to the quality and the acceptability of the Company&rsquo;s financial reporting and such other matters
as are required to be discussed with such firm by Public Company Accounting Oversight Board (United States) Auditing Standard No.
16 (as amended), Communication with Audit Committees and Rule 2-07 of SEC Regulation S-X. The Audit Committee has received the
written disclosures and the letter from the independent registered public accounting firm required by the Public Company Accounting
Oversight Board. The Audit Committee discussed with the independent registered public accounting firm its independence from management
and the Company, including the matters required by the applicable rules of the Public Company Accounting Oversight Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In addition to the matters
specified above, the Audit Committee discussed with the Company&rsquo;s independent registered public accounting firm the overall
scope, plans and estimated costs of their audit. The Audit Committee met with the independent registered public accounting firm
periodically, with and without management present, to discuss the results of the independent registered public accounting firm&rsquo;s
examinations, the overall quality of the Company&rsquo;s financial reporting and the independent registered public accounting firm&rsquo;s
reviews of the quarterly financial statements and drafts of the quarterly and annual reports.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In reliance on the reviews
and discussions referred to above, the Audit Committee recommended to the Board of Directors that the Company&rsquo;s audited financial
statements for the fiscal year ended December 31, 2016 should be included in the Annual Report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 318.25pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 318.25pt; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Submitted by the Audit Committee of the Board of Directors</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stephen Austin, Chairman</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anthony Principi</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert Kammer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 318.25pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">This report of the Audit
Committee shall not be deemed incorporated by reference by any general statement incorporating by reference this Proxy Statement
into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that we specifically incorporate
this information by reference, and shall not otherwise be deemed filed under such acts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt">&nbsp;</P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>HOUSEHOLDING OF PROXY MATERIALS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The SEC has adopted rules
that permit companies and intermediaries (e.g., brokers) to satisfy the delivery requirements for proxy statements and annual reports
with respect to two or more stockholders sharing the same address by delivering a single proxy statement addressed to those stockholders.
This process, which is commonly referred to as &ldquo;householding,&rdquo; can provide added convenience for stockholders and cost
savings for companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">This year, a number of
brokers with account holders who are the Company&rsquo;s stockholders will be &ldquo;householding&rdquo; our proxy materials. A
single copy of this Proxy Statement will be delivered to multiple stockholders sharing an address unless contrary instructions
have been received from the affected stockholders. Once you have received notice from your broker that it will be &ldquo;householding&rdquo;
communications to your address, &ldquo;householding&rdquo; will continue until you are notified otherwise or until you revoke your
consent. If, at any time, you no longer wish to participate in &ldquo;householding&rdquo; and would prefer to receive a separate
proxy statement and annual report from us, please notify your broker, direct your written request to Imprimis Pharmaceuticals,
Inc., c/o Corporate Secretary, 12264 El Camino Real, Suite 350, San Diego, California 92130 or call Investor Relations at (858)
704-4587 and we will promptly thereafter deliver separate copies to you. Stockholders who currently receive multiple copies of
our proxy materials at their address and would like to request &ldquo;householding&rdquo; of these materials should contact their
brokers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>STOCKHOLDER PROPOSALS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Stockholder Proposals for 2018 Annual Meeting</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Pursuant to Rule 14a-8
under the Exchange Act, stockholders may present proper proposals for inclusion in our proxy statement and for consideration at
our next annual meeting of stockholders. To be eligible for inclusion in our proxy statement for our 2018 annual meeting of stockholders,
a stockholder&rsquo;s proposal must be received by us no later than December 28, 2017, unless the date of our 2018 annual meeting
of stockholders is more than 30 days before or after the one-year anniversary date of the Annual Meeting, in which case such proposals
must be received by the Company a reasonable time before the Company begins to print and send applicable proxy materials. In addition,
stockholder proposals must otherwise comply with Rule 14a-8 under the Exchange Act, including delivery of proof of ownership of
our common stock in accordance with Rule 14a-8(b)(2). The submission of a stockholder proposal does not guarantee that it will
be included in our proxy statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Advance Notice for Proposals for Business
to be Discussed at the 2018 Annual Meeting of Stockholders</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Our Bylaws require advance
notice of business to be brought before a stockholders&rsquo; meeting, including nominations of persons for election as directors.
To be timely, notice of stockholder proposals must be received by our Corporate Secretary at our principal executive offices not
less than 120 days nor more than 180 days prior to the anniversary date of the mailing of the proxy materials for the preceding
year&rsquo;s annual meeting, or between October 29, 2017 and December 28, 2017 for our 2018 annual meeting of stockholders, and
must contain specified information concerning the matters to be brought before such meeting and concerning the stockholder proposing
such matters, except if we did not hold an annual meeting the previous year, or if the date of the applicable annual meeting of
stockholders has been changed by more than 30 days from the date of the previous year&rsquo;s meeting, then the deadline is a reasonable
time before we begin to print and mail our proxy materials, and not later than the close of business on the later of (i) the 90th
day prior to the scheduled annual meeting or (ii) the 15th day following the day on which public announcement of the date of annual
meeting was first made. A copy of our Bylaws may be obtained by written request to the Corporate Secretary at Imprimis Pharmaceuticals,
Inc., c/o Corporate Secretary, 12264 El Camino Real, Suite 350, San Diego, California 92130. Our Bylaws are also available on the
Investor Relations section of our website at http://imprimispharma.investorroom.com. If we comply and the stockholder does not
comply with the requirements of Rule 14a-4(c)(2) under the Exchange Act, we may exercise discretionary voting authority under proxies
that we solicit to vote in accordance with our best judgment on any such stockholder proposal or nomination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>ANNUAL REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Annual Report accompanies
the proxy materials being provided to all stockholders. We will provide, without charge, additional copies of the Annual Report
upon the receipt of a written or oral request by any stockholder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>OTHER MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Board of Directors
knows of no other matters that will be presented for consideration at the Annual Meeting. If any other matters are properly brought
before the Annual Meeting, it is the intention of the persons named in the accompanying proxy to vote on such matters in accordance
with their best judgment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-left: 10pt; text-align: justify; text-indent: -10pt">&nbsp;</TD>
    <TD STYLE="width: 50%; padding-left: 10pt; text-align: justify; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By Order of the Board of Directors</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 10pt; text-align: justify; text-indent: -10pt">&nbsp;</TD>
    <TD STYLE="padding-left: 10pt; text-align: justify; text-indent: -10pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 10pt; text-align: justify; text-indent: -10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-left: 10pt; text-align: justify; text-indent: -10pt; padding-bottom: 1.5pt">Mark L. Baum</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 10pt; text-align: justify; text-indent: -10pt">&nbsp;</TD>
    <TD STYLE="padding-left: 10pt; text-align: justify; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Chief Executive Officer and Director</I></FONT></TD></TR>
</TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: right">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: right">Annex A</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center">IMPRIMIS PHARMACEUTICALS,
INC.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center">2017 INCENTIVE
STOCK AND AWARDS PLAN</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">1. Purpose of the
Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The purpose of this 2017
Incentive Stock and Awards Plan (the &ldquo;<U>Plan</U>&rdquo;) of Imprimis Pharmaceuticals, Inc. (the &ldquo;<U>Company</U>&rdquo;)
is to enable the Company to offer to its employees, officers, directors, advisors and consultants whose past, present and/or potential
contributions to the Company and/or any Subsidiary of the Company, within the meaning of Section 424(f) of the United States Internal
Revenue Code of 1986, as amended (the &ldquo;<U>Code</U>&rdquo;), have been, are or will be important to the success of the Company,
an opportunity to acquire an equity interest in the Company. It is further intended that certain options granted pursuant to the
Plan shall constitute incentive stock options within the meaning of Section 422 of the Code (the &ldquo;<U>Incentive Options</U>&rdquo;)
while certain other options granted pursuant to the Plan shall be nonqualified stock options (the &ldquo;<U>Nonqualified Options</U>&rdquo;).
Incentive Options and Nonqualified Options are hereinafter referred to collectively as &ldquo;<U>Options.</U>&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company intends that
the Plan meet the requirements of Rule 16b-3 (&ldquo;<U>Rule 16b-3</U>&rdquo;) promulgated under the Securities Exchange Act of
1934, as amended (the &ldquo;<U>Exchange Act</U>&rdquo;), and that transactions of the type specified in subparagraphs (c) to (f)
inclusive of Rule 16b-3 by officers and directors of the Company pursuant to the Plan will be exempt from the operation of Section
16(b) of the Exchange Act. Further, the Plan is intended to satisfy the performance-based compensation exception to the limitation
on the Company&rsquo;s tax deductions imposed by Section 162(m) of the Code with respect to those Options, awards of Restricted
Stock (as defined below), and awards of Restricted Stock Units (as defined below) for which qualification for such exception is
intended. In all cases, the terms, provisions, conditions and limitations of the Plan shall be construed and interpreted consistent
with the Company&rsquo;s intent as stated in this Section 1.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2. Administration
of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Board of Directors
of the Company (the &ldquo;<U>Board</U>&rdquo;) shall appoint and maintain as administrator of the Plan a Committee (the &ldquo;<U>Committee</U>&rdquo;)
consisting of two or more directors who are (i) &ldquo;Independent Directors&rdquo; (as such term is defined under the rules of
the NASDAQ Stock Market), (ii) &ldquo;Non-Employee Directors&rdquo; (as such term is defined in Rule 16b&not;3) and (iii) &ldquo;Outside
Directors&rdquo; (as such term is defined in Section 162(m) of the Code), which shall serve at the pleasure of the Board. The Committee,
subject to Sections 3, 5, 6 and 7 hereof, shall have full power and authority to designate recipients of Options, restricted stock
(&ldquo;<U>Restricted Stock</U>&rdquo;) and restricted stock units (&ldquo;<U>Restricted Stock Units</U>&rdquo;) and to determine
the terms and conditions of the respective Option, Restricted Stock and Restricted Stock Unit agreements (which need not be identical)
and to interpret the provisions and supervise the administration of the Plan. The Committee shall have the authority, without limitation,
to designate which Options granted under the Plan shall be Incentive Options and which shall be Nonqualified Options. To the extent
any Option does not qualify as an Incentive Option, it shall constitute a separate Nonqualified Option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Subject to the provisions
of the Plan, the Committee shall interpret the Plan and all Options, Restricted Stock and Restricted Stock Units granted under
the Plan, shall make such rules as it deems necessary for the proper administration of the Plan, shall make all other determinations
necessary or advisable for the administration of the Plan and shall correct any defects or supply any omission or reconcile any
inconsistency in the Plan or in any Options, Restricted Stock or Restricted Stock Units granted under the Plan in the manner and
to the extent that the Committee deems desirable to carry into effect the Plan or any Options, Restricted Stock or Restricted Stock
Units. The act or determination of a majority of the Committee shall be the act or determination of the Committee and any decision
reduced to writing and signed by all of the members of the Committee shall be fully effective as if it had been made by a majority
of the Committee at a meeting duly held for such purpose. Subject to the provisions of the Plan, any action taken or determination
made by the Committee pursuant to this and the other Sections of the Plan shall be conclusive on all parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In the event that for any
reason the Committee is unable to act or if the Committee at the time of any grant, award or other acquisition under the Plan does
not consist of two or more Non-Employee Directors, or if there shall be no such Committee, or if the Board otherwise determines
to administer the Plan, then the Plan shall be administered by the Board, and references herein to the Committee (except in the
proviso to this sentence) shall be deemed to be references to the Board, and any such grant, award or other acquisition may be
approved or ratified in any other manner contemplated by subparagraph (d) of Rule 16b-3; <U>provided</U>, <U>however</U>, that
grants to the Company&rsquo;s Chief Executive Officer or to any of the Company&rsquo;s other four most highly compensated officers
that are intended to qualify as performance-based compensation under Section 162(m) of the Code may only be granted by the Committee.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 34; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">3. Designation of
Optionees and Grantees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The persons eligible for
participation in the Plan as recipients of Options (the &ldquo;<U>Optionees</U>&rdquo;) or Restricted Stock or Restricted Stock
Units (the &ldquo;<U>Grantees</U>&rdquo; and together with Optionees, the &ldquo;<U>Participants</U>&rdquo;) shall include directors,
officers and employees of, and consultants and advisors to, the Company or any Subsidiary; provided that Incentive Options may
only be granted to employees of the Company and any Subsidiary. In selecting Participants, and in determining the number of shares
to be covered by each Option or award of Restricted Stock or Restricted Stock Units granted to Participants, the Committee may
consider any factors it deems relevant, including, without limitation, the office or position held by the Participant or the Participant&rsquo;s
relationship to the Company, the Participant&rsquo;s degree of responsibility for and contribution to the growth and success of
the Company or any Subsidiary, the Participant&rsquo;s length of service, promotions and potential. A Participant who has been
granted an Option, Restricted Stock or Restricted Stock Units hereunder may be granted an additional Option or Options, Restricted
Stock or Restricted Stock Units if the Committee shall so determine.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4. Stock Reserved
for the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(a) Subject to adjustment
as provided in Section 9 hereof, a total of 2,000,000 shares of the Company&rsquo;s common stock, par value $0.001 per share (the
&ldquo;Stock&rdquo;), shall be subject to the Plan. The shares of Stock subject to the Plan shall consist of unissued shares, treasury
shares or previously issued shares held by any Subsidiary of the Company, and such number of shares of Stock shall be and is hereby
reserved for such purpose. Any of such shares of Stock that may remain unissued and that are not subject to outstanding Options
or Restricted Stock Units at the termination of the Plan shall cease to be reserved for the purposes of the Plan, but until termination
of the Plan the Company shall at all times reserve a sufficient number of shares of Stock to meet the requirements of the Plan.
Should any Option or award of Restricted Stock or Restricted Stock Units expire or be canceled prior to its exercise or vesting
in full or should the number of shares of Stock to be delivered upon the exercise or vesting in full of an Option or award of Restricted
Stock or Restricted Stock Units be reduced for any reason, the shares of Stock theretofore subject to such Option, Restricted Stock
or Restricted Stock Units may be subject to future Options, Restricted Stock or Restricted Stock Units under the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(b) The maximum number
of shares of Stock with respect to which Options may be granted to any Optionee in any calendar year shall be five hundred thousand
(500,000) shares. In connection with an Optionee&rsquo;s commencement of employment or service with the Company or any Subsidiary,
an Optionee may be granted Options for up to an additional two hundred thousand (200,000) shares which shall not count against
the limit set forth in the previous sentence. The foregoing limitations shall be adjusted proportionately in connection with any
change in the Company&rsquo;s capitalization pursuant to Section 9, below. To the extent required by Section 162(m) of the Code
or the regulations thereunder, in applying the foregoing limitations with respect to an Optionee, if any Option is canceled, the
canceled Option shall continue to count against the maximum number of Shares with respect to which Options may be granted to the
Optionee. For this purpose, the repricing of an Option shall be treated as the cancellation of the existing Option and the grant
of a new Option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(c) For awards of Restricted
Stock or Restricted Stock Units that are intended to qualify as &ldquo;performance-based compensation&rdquo; under Section 162(m)
of the Code, the maximum number of shares of Stock with respect to which such awards may be granted to any Grantee in any calendar
year shall be five hundred thousand (500,000) shares. The foregoing limitation shall be adjusted proportionately in connection
with any change in the Company&rsquo;s capitalization pursuant to Section 9, below. Subject to the terms of the Plan, awards of
Restricted Stock or Restricted Stock Units that are intended to qualify as performance-based compensation under Section 162(m)
of the Code shall be subject to satisfaction of performance criteria. The performance criteria established by the Committee may
be based on any one of, or combination of, the following: (i) increase in share price, (ii) earnings per share, (iii) total stockholder
return, (iv) operating margin, (v) gross margin, (vi) return on equity, (vii) return on assets, (viii) return on investment (ix)
operating income, (x) net operating income, (xi) pre-tax profit (xii) cash flow, (xiii) revenue, (xiv) expenses, (xv) earnings
before interest, taxes and depreciation, (xvi) economic value added and (xvii) market share. The performance criteria may be applicable
to the Company, Subsidiaries and/or any individual business units of the Company or any Subsidiary. Partial achievement of the
specified criteria may result in a payment or vesting corresponding to the degree of achievement as specified in the Restricted
Stock or Restricted Stock Unit agreement. In addition, the performance criteria shall be calculated in accordance with generally
accepted accounting principles, but excluding the effect (whether positive or negative) of any change in accounting standards and
any extraordinary, unusual or nonrecurring item, as determined by the Committee, occurring after the establishment of the performance
criteria applicable to the award intended to be performance-based compensation. Each such adjustment, if any, shall be made solely
for the purpose of providing a consistent basis from period to period for the calculation of performance criteria in order to prevent
the dilution or enlargement of the Grantee&rsquo;s rights with respect to an award intended to be performance-based compensation.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5. Terms and Conditions
of Options.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Options granted under the
Plan shall be subject to the following conditions and shall contain such additional terms and conditions, not inconsistent with
the terms of the Plan, as the Committee shall deem desirable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(a) <U>Option Price</U>.
The purchase price of each share of Stock purchasable, under an Incentive Option shall be determined by the Committee at the time
of grant, but shall not be less than 100% of the Fair Market Value (as defined below) of such share of Stock on the date the Option
is granted; provided, however, that with respect to an Optionee who, at the time such Incentive Option is granted, owns (within
the meaning of Section 424(d) of the Code) more than 10% of the total combined voting power of all classes of stock of the Company
or of any Subsidiary, the purchase price per share of Stock shall be at least 110% of the Fair Market Value per share of Stock
on the date of grant. The purchase price of each share of Stock purchasable under a Nonqualified Option shall not be less than
100% of the Fair Market Value, of such share of Stock on the date the Option is granted. The exercise price for each Option shall
be subject to adjustment as provided in Section 9 below. &ldquo;Fair Market Value&rdquo; means: (i) if the Stock is listed on one
or more established stock exchanges or national market systems, including without limitation The NASDAQ Global Select Market, The
NASDAQ Global Market or The NASDAQ Capital Market of The NASDAQ Stock Market LLC, the closing sales price for such Stock (or the
closing bid, if no sales were reported) as quoted on the principal exchange or system on which the Stock is listed (as determined
by the Committee) on the date of grant of the Option or Stock (or, if no closing sales price or closing bid was reported on that
date, as applicable, on the last trading date such closing sales price or closing bid was reported), as reported in The Wall Street
Journal or such other source as the Committee deems reliable; (ii) if the Stock is regularly quoted on an automated quotation system
(including but not limited to the OTC Bulletin Board) or by a recognized securities dealer, the closing sales price for such Stock
as quoted on such system or by such securities dealer on the date of grant of the Option or Stock, but if selling prices are not
reported, the Fair Market Value of a share of Stock shall be the mean between the high bid and low asked prices for the Stock on
the date of grant of the Option or Stock (or, if no such prices were reported on that date, on the last date such prices were reported),
as reported in The Wall Street Journal or, such other source as the Committee deems reliable; or (iii) in the absence of an established
market for the Stock of the type described in (i) and (ii), above, the Fair Market Value thereof shall be determined by the Committee
in good faith. Anything in this Section 5(a) to the contrary notwithstanding, in no event shall the purchase price of a share of
Stock be less than the minimum price permitted under the rules and policies of any national securities exchange on which the shares
of Stock are listed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(b) <U>Option Term</U>. The
term of each Option shall be fixed by the Committee, but no Option shall be exercisable more than ten years after the date such
Option is granted and in the case of an Incentive Option granted to an Optionee who, at the time such Incentive Option is granted,
owns (within the meaning of Section 424(d) of the Code) more than 10% of the total combined voting power of all classes of stock
of the Company or of any Subsidiary, no such Incentive Option shall be exercisable more than five years after the date such Incentive
Option is granted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(c) <U>Exercisability</U>.
Subject to Section 5(j) hereof, Options shall be exercisable at such time or times and subject to such terms and conditions as
shall be determined by the Committee at the time of grant; <U>provided</U>, <U>however</U>, that in the absence of any Option vesting
periods designated by the Committee at the time of grant, Options shall vest and become exercisable as to one-third of the total
number of shares subject to the Option on each of the first, second and third anniversaries of the date of grant; and provided
further that no Options shall be exercisable until such time as any vesting limitation required by Section 16 of the Exchange Act,
and related rules, shall be satisfied if such limitation shall be required for continued validity of the exemption provided under
Rule 16b-3(d)(3).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Upon the occurrence of
a &ldquo;Change in Control&rdquo; (as hereinafter defined), the Committee may accelerate the vesting and exercisability of outstanding
Options, in whole or in part, as determined by the Committee in its sole discretion. In its sole discretion, the Committee may
also determine that, upon the occurrence of a Change in Control, each outstanding Option shall terminate within a specified number
of days after notice to the Optionee thereunder, and each such Optionee shall receive, with respect to each share of Company Stock
subject to such Option, an amount equal to the excess of the Fair Market Value of such shares immediately prior to such Change
in Control over the exercise price per share of such Option; such amount shall be payable in cash, in one or more kinds of property
(including the property, if any, payable in the transaction) or a combination thereof, as the Committee shall determine in its
sole discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">For purposes of the Plan,
unless otherwise defined in an employment agreement between the Company and the relevant Optionee, a Change in Control shall be
deemed to have occurred if:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(i) a tender offer
(or series of related offers) shall be made and consummated for the ownership of 50% or more of the outstanding voting securities
of the Company, unless as a result of such tender offer more than 50% of the outstanding voting securities of the surviving or
resulting corporation shall be owned in the aggregate by the stockholders of the Company (as of the time immediately prior to the
commencement of such offer), any employee benefit plan of the Company or its Subsidiaries, and their affiliates;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(ii) the Company
shall be merged or consolidated with another corporation, unless as a result of such merger or consolidation more than 50% of the
outstanding voting securities of the surviving or resulting corporation shall be owned in the aggregate by the stockholders of
the Company (as of the time immediately prior to such transaction), any employee benefit plan of the Company or its Subsidiaries,
and their affiliates;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(iii) the Company
shall sell substantially all of its assets to another corporation that is not wholly owned by the Company, unless as a result of
such sale more than 50% of such assets shall be owned in the aggregate by the stockholders of the Company (as of the time immediately
prior to such transaction), any employee benefit plan of the Company or its Subsidiaries and their affiliates; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(iv) a Person (as
defined below) shall acquire 50% or more of the outstanding voting securities of the Company (whether directly, indirectly, beneficially
or of record), unless as a result of such acquisition more than 50% of the outstanding voting securities of the surviving or resulting
corporation shall be owned in the aggregate by the stockholders of the Company (as of the time immediately prior to the first acquisition
of such securities by such Person), any employee benefit plan of the Company or its Subsidiaries, and their affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Notwithstanding the foregoing, if Change of
Control is defined in an employment agreement between the Company and the relevant Optionee, then, with respect to such Optionee,
Change of Control shall have the meaning ascribed to it in such employment agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">For purposes of this Section
5(c), ownership of voting securities shall take into account and shall include ownership as determined by applying the provisions
of Rule 13d-3(d)(I)(i) (as in effect on the date hereof) under the Exchange Act. In addition, for such purposes, &ldquo;Person&rdquo;
shall have the meaning given in Section 3(a)(9) of the Exchange Act, as modified and used in Sections 13(d) and 14(d) thereof;
<U>provided</U>, <U>however</U>, that a Person shall not include (A) the Company or any of its Subsidiaries; (B) a trustee or other
fiduciary holding securities under an employee benefit plan of the Company or any of its Subsidiaries; (C) an underwriter temporarily
holding securities pursuant to an offering of such securities; or (D) a corporation owned, directly or indirectly, by the stockholders
of the Company in substantially the same proportion as their ownership of stock of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(d) <U>Method of Exercise</U>.
Options to the extent then exercisable may be exercised in whole or in part at any time during the option period, by giving written
notice to the Company specifying the number of shares of Stock to be purchased, accompanied by payment in full of the purchase
price, in cash, or by check or such other instrument as may be acceptable to the Committee. As determined by the Committee, in
its sole discretion, at or after grant, payment in full or in part may be made at the election of the Optionee (i) in the form
of Stock owned by the Optionee (based on the Fair Market Value of the Stock which is not the subject of any pledge or security
interest, (ii) in the form of shares of Stock withheld by the Company from the shares of Stock otherwise to be received with such
withheld shares of Stock having a Fair Market Value equal to the exercise price of the Option, or (iii) by a combination of the
foregoing, such Fair Market Value determined by applying the principles set forth in Section 5(a), provided that the combined value
of all cash and cash equivalents and the Fair Market Value of any shares surrendered to the Company is at least equal to such exercise
price and except with respect to (ii) above, such method of payment will not cause a disqualifying disposition of all or a portion
of the Stock received upon exercise of an Incentive Option. An Optionee shall have the right to dividends and other rights of a
stockholder with respect to shares of Stock purchased upon exercise of an Option at such time as the Optionee (i) has given written
notice of exercise and has paid in full for such shares, and (ii) has satisfied such conditions that may be imposed by the Company
with respect to the withholding of taxes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(e) <U>Non-transferability
of Options</U>. Options are not transferable and may be exercised solely by the Optionee during his lifetime or after his death
by the person or persons entitled thereto under his will or the laws of descent and distribution. The Committee, in its sole discretion,
may permit a transfer of a Nonqualified Option to (i) a trust for the benefit of the Optionee, (ii) a member of the Optionee&rsquo;s
immediate family (or a trust for his or her benefit) or (iii) pursuant to a domestic relations order. Any attempt to transfer,
assign, pledge or otherwise dispose of, or to subject to execution, attachment or similar process, any Option contrary to the provisions
hereof shall be void and ineffective and shall give no right to the purported transferee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(f) <U>Termination by Death</U>.
Unless otherwise determined by the Committee, if any Optionee&rsquo;s employment with or service to the Company or any Subsidiary
terminates by reason of death, the Option may thereafter be exercised, to the extent then exercisable (or on such accelerated basis
as the Committee shall determine at or after grant), by the legal representative of the estate or by the legatee of the Optionee
under the will of the Optionee, for a period of one (1) year after the date of such death (or, if later, such time as the Option
may be exercised pursuant to Section 15(d) hereof) or until the expiration of the stated term of such Option as provided under
the Plan, whichever period is shorter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(g) <U>Termination by Reason
of Disability</U>. Unless otherwise determined by the Committee, if any Optionee&rsquo;s employment with or service to the Company
or any Subsidiary terminates by reason of Disability (as defined below), then any Option held by such Optionee may thereafter be
exercised, to the extent it was exercisable at the time of termination due to Disability (or on such accelerated basis as the Committee
shall determine at or after grant), but may not be exercised after ninety (90) days after the date of such termination of employment
or service (or, if later, such time as the Option may be exercised pursuant to Section 15(d) hereof) or the expiration of the stated
term of such Option, whichever period is shorter; <U>provided</U>, <U>however</U>, that, if the Optionee dies within such ninety
(90) day period, any unexercised Option held by such Optionee shall thereafter be exercisable to the extent to which it was exercisable
at the time of death for a period of one (1) year after the date of such death (or, if later, such time as the Option may be exercised
pursuant to Section 15(d) hereof) or for the stated term of such Option, whichever period is shorter. &ldquo;Disability&rdquo;
shall mean an Optionee&rsquo;s total and permanent disability; <I>provided</I>, that if Disability is defined in an employment
agreement between the Company and the relevant Optionee, then, with respect to such Optionee, Disability shall have the meaning
ascribed to it in such employment agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(h) <U>Termination by Reason
of Retirement</U>. Unless otherwise determined by the Committee, if any Optionee&rsquo;s employment with or service to the Company
or any Subsidiary terminates by reason of Normal or Early Retirement (as such terms are defined below), any Option held by such
Optionee may thereafter be exercised to the extent it was exercisable at the time of such Retirement (or on such accelerated basis
as the Committee shall determine at or after grant), but may not be exercised after ninety (90) days after the date of such termination
of employment or service (or, if later, such time as the Option may be exercised pursuant to Section 15(d) hereof) or the expiration
of the stated term of such Option, whichever date is earlier; <U>provided</U>, <U>however</U>, that, if the Optionee dies within
such ninety (90) day period, any unexercised Option held by such Optionee shall thereafter be exercisable, to the extent to which
it was exercisable at the time of death, for a period of one (1) year after the date of such death (or, if later, such time as
the Option may be exercised pursuant to Section 15(d) hereof) or for the stated term of such Option, whichever period is shorter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">For purposes of this paragraph
(h), &ldquo;<U>Normal Retirement</U>&rdquo; shall mean retirement from active employment with the Company or any Subsidiary on
or after the normal retirement date specified in the applicable Company or Subsidiary pension plan or if no such pension plan,
age 65, and &ldquo;<U>Early Retirement</U>&rdquo; shall mean retirement from active employment with the Company or any Subsidiary
pursuant to the early retirement provisions of the applicable Company or Subsidiary pension plan or if no such pension plan, age
55.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(i) <U>Other Terminations</U>.
Unless otherwise determined by the Committee upon grant, if any Optionee&rsquo;s employment with or service to the Company or any
Subsidiary is terminated by such Optionee for any reason other than death, Disability, Normal or Early Retirement or Good Reason
(as defined below), the Option shall thereupon terminate, except that the portion of any Option that was exercisable on the date
of such termination of employment or service may be exercised for the lesser of ninety (90) days after the date of termination
(or, if later, such time as the Option may be exercised pursuant to Section 15(d) hereof) or the balance of such Option&rsquo;s
term, which ever period is shorter. The transfer of an Optionee from the employ of or service to the Company to the employ of or
service to a Subsidiary, or vice versa, or from one Subsidiary to another, shall not be deemed to constitute a termination of employment
or service for purposes of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(i) In the event
that the Optionee&rsquo;s employment or service with the Company or any Subsidiary is terminated by the Company or such Subsidiary
for &ldquo;cause&rdquo; any unexercised portion of any Option shall immediately terminate in its entirety. For purposes hereof,
unless otherwise defined in an employment agreement between the Company and the relevant Optionee, &ldquo;Cause&rdquo; shall exist
upon a good-faith determination by the Board, following a hearing before the Board at which an Optionee was represented by counsel
and given an opportunity to be heard, that such Optionee has been accused of fraud, dishonesty or act detrimental to the interests
of the Company or any Subsidiary of Company or that such Optionee has been accused of or convicted of an act of willful and material
embezzlement or fraud against the Company or of a felony under any state or federal statute; <U>provided</U>, <U>however</U>, that
it is specifically understood that &ldquo;Cause&rdquo; shall not include any act of commission or omission in the good-faith exercise
of such Optionee&rsquo;s business judgment as a director, officer or employee of the Company, as the case may be, or upon the advice
of counsel to the Company. Notwithstanding the foregoing, if Cause is defined in an employment agreement between the Company and
the relevant Optionee, then, with respect to such Optionee, Cause shall have the meaning ascribed to it in such employment agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(ii) In the event
that an Optionee is removed as a director, officer or employee by the Company at any time other than for &ldquo;Cause&rdquo; or
resigns as a director, officer or employee for &ldquo;Good Reason&rdquo; the Option granted to such Optionee may be exercised by
the Optionee, to the extent the Option was exercisable on the date such Optionee ceases to be a director, officer or employee.
Such Option may be exercised at any time within one (1) year after the date the Optionee ceases to be a director, officer or employee
(or, if later, such time as the Option may be exercised pursuant to Section 15(d) hereof), or the date on which the Option otherwise
expires by its terms; whichever period is shorter, at which time the Option shall terminate; <U>provided</U>, <U>however</U>, if
the Optionee dies before the Options terminate and are no longer exercisable, the terms and provisions of Section 5(1) shall control.
For purposes of this Section 5(i), and unless otherwise defined in an employment agreement between the Company and the relevant
Optionee, Good Reason shall exist upon the occurrence of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1.25in; text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="width: 0.65in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD>
    <TD STYLE="text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the assignment to Optionee of any duties inconsistent with the position in the Company that Optionee held immediately prior to the assignment;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify; text-indent: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD>
    <TD STYLE="text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a Change of Control resulting in a significant adverse alteration in the status or conditions of Optionee&rsquo;s participation with the Company or other nature of Optionee&rsquo;s responsibilities from those in effect prior to such Change of Control, including any significant alteration in Optionee&rsquo;s responsibilities immediately prior to such Change in Control; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; text-indent: 0in; width: 1.25in">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 0.65in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(C)</FONT></TD>
    <TD STYLE="text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the failure by the Company to continue to provide Optionee with benefits substantially similar to those enjoyed by Optionee prior to such failure.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">Notwithstanding the foregoing, if
Good Reason is defined in an employment agreement between the Company and the relevant Optionee, then, with respect to such Optionee,
Good Reason shall have the meaning ascribed to it in such employment agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(j) <U>Limit on Value of
Incentive Option</U>. The aggregate Fair Market Value, determined as of the date the Incentive Option is granted, of Stock for
which Incentive Options are exercisable for the first time by any Optionee during any calendar year under the Plan (and/or any
other stock option plans of the Company or any Subsidiary) shall not exceed $100,000.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">6. Terms and Conditions
of Restricted Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Restricted Stock may be
granted under this Plan aside from, or in association with, any other award and shall be subject to the following conditions and
shall contain such additional terms and conditions (including provisions relating to the acceleration of vesting of Restricted
Stock upon a Change of Control), not inconsistent with the terms of the Plan, as the Committee shall deem desirable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(a) <U>Grantee rights</U>.
A Grantee shall have no rights to an award of Restricted Stock unless and until Grantee accepts the award within the period prescribed
by the Committee and, if the Committee shall deem desirable, makes payment to the Company in cash, or by check or such other instrument
as may be acceptable to the Committee. After acceptance and issuance of a certificate or certificates, as provided for below, the
Grantee shall have the rights of a stockholder with respect to Restricted Stock subject to the non-transferability and forfeiture
restrictions described in Section 6(d) below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(b) <U>Issuance of Certificates</U>.
The Company shall issue in the Grantee&rsquo;s name a certificate or certificates for the shares of Common Stock associated with
the award promptly after the Grantee accepts such award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(c) <U>Delivery of Certificates</U>.
Unless otherwise provided, any certificate or certificates issued evidencing shares of Restricted Stock shall not be delivered
to the Grantee until such shares are free of any restrictions specified by the Committee at the time of grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(d) <U>Forfeitability, Non-transferability
of Restricted Stock</U>. Shares of Restricted Stock are forfeitable until the terms of the Restricted Stock grant have been satisfied.
Shares of Restricted Stock are not transferable until the date on which the Committee has specified such restrictions have lapsed.
Unless otherwise provided by the Committee at or after grant, distributions in the form of dividends or otherwise of additional
shares or property in respect of shares of Restricted Stock shall be subject to the same restrictions as such shares of Restricted
Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(e) <U>Change of Control</U>.
Upon the occurrence of a Change in Control as defined in Section 5(c), the Committee may accelerate the vesting of outstanding
Restricted Stock, in whole or in part, as determined by the Committee, in its sole discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(f) <U>Termination of Employment</U>.
Unless otherwise determined by the Committee at or after grant, in the event the Grantee ceases to be an employee or otherwise
associated with the Company for any other reason, all shares of Restricted Stock theretofore awarded to him which are still subject
to restrictions shall be forfeited and the Company shall have the right to complete the blank stock power. The Committee may provide
(on or after grant) that restrictions or forfeiture conditions relating to shares of Restricted Stock will be waived in whole or
in part in the event of termination resulting from specified causes, and the Committee may in other cases waive in whole or in
part restrictions or forfeiture conditions relating to Restricted Stock.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">7. Terms and Conditions
of Restricted Stock Units.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Restricted Stock Units
may be granted under this Plan aside from, or in association with, any other award and shall be subject to the following conditions
and shall contain such additional terms and conditions (including provisions relating to the acceleration of vesting of Restricted
Stock Units upon a Change of Control), not inconsistent with the terms of the Plan, as the Committee shall deem desirable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(a) <U>Grantee rights</U>.
A Grantee shall have no rights to an award of Restricted Stock Units unless and until Grantee accepts the award within the period
prescribed by the Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(b) <U>Form and Timing of
Payment</U>. Payment of earned Restricted Stock Units will be made as soon as practicable after the date(s) determined by the Committee
and set forth in the Restricted Stock Unit agreement. The Committee, in its sole discretion, may only settle earned Restricted
Stock Units in cash, shares of Common Stock, or a combination of both.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(c) <U>Forfeitability, Non-transferability
of Restricted Stock Units</U>. Restricted Stock Units are forfeitable until the terms of the Restricted Stock Unit grant have been
satisfied. Restricted Stock Units are not transferable until the date on which the Committee has specified such restrictions have
lapsed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(d) <U>Change of Control</U>.
Upon the occurrence of a Change in Control as defined in Section 5(c), the Committee may accelerate the vesting of outstanding
Restricted Stock Units, in whole or in part, as determined by the Committee, in its sole discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(e) <U>Termination of Employment</U>.
Unless otherwise determined by the Committee at or after grant, in the event the Grantee ceases to be an employee or otherwise
associated with the Company for any other reason, all unvested Restricted Stock Units theretofore awarded to him shall be forfeited.
The Committee may provide (on or after grant) that forfeiture conditions relating to Restricted Stock Units will be waived in whole
or in part in the event of termination resulting from specified causes, and the Committee may in other cases waive in whole or
in part forfeiture conditions relating to Restricted Stock Units.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">8. Term of Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">No Option or award of Restricted
Stock or Restricted Stock Units shall be granted pursuant to the Plan on or after the date which is ten years from the effective
date of the Plan, but Options and awards of Restricted Stock and Restricted Stock Units theretofore granted may extend beyond that
date.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">9. Capital Change
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In the event of any merger,
reorganization, consolidation, recapitalization, stock dividend, or other change in corporate structure affecting the Stock, the
Committee shall make an appropriate and equitable adjustment in the number and kind of shares reserved for issuance under the Plan
and in the number and option price of shares subject to outstanding Options granted under the Plan, to the end that after such
event each Optionee&rsquo;s proportionate interest shall be maintained (to the extent possible) as immediately before the occurrence
of such event. The Committee shall, to the extent feasible, make such other adjustments as may be required under the tax laws so
that any Incentive Options previously granted shall not be deemed modified within the meaning of Section 424(h) of the Code. Appropriate
adjustments shall also be made in the case of outstanding Restricted Stock and Restricted Stock Units granted under the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The adjustments described
above will be made only to the extent consistent with continued qualification of the Option under Section 422 of the Code (in the
case of an Incentive Option) and Section 409A of the Code.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">10. Purchase for Investment/Conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Unless the Options and
shares covered by the Plan have been registered under the Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;),
or the Company has determined that such registration is unnecessary, each person exercising or receiving Options, Restricted Stock
or Restricted Stock Units under the Plan may be required by the Company to give a representation in writing that he is acquiring
the securities for his own account for investment and not with a view to, or for sale in connection with, the distribution of any
part thereof. The Committee may impose any additional or further restrictions on awards of Options, Restricted Stock or Restricted
Stock Units as shall be determined by the Committee at the time of award.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">11. Taxes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(a) The Company may make
such provisions as it may deem appropriate, consistent with applicable law, in connection with any Options, Restricted Stock or
Restricted Stock Units granted under the Plan with respect to the withholding of any taxes (including income or employment taxes)
or any other tax matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(b) If any Grantee, in connection
with the acquisition of Restricted Stock, makes the election permitted under Section 83(b) of the Code (that is, an election to
include in gross income in the year of transfer the amounts specified in Section 83(b)), such Grantee shall notify the Company
of the election with the Internal Revenue Service pursuant to regulations issued under the authority of Code Section 83(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(c) If any Grantee shall
make any disposition of shares of Stock issued pursuant to the exercise of an Incentive Option under the circumstances described
in Section 421(b) of the Code (relating to certain disqualifying dispositions), such Grantee shall notify the Company of such disposition
within ten (10) days hereof.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">12. Effective Date
of Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Plan shall be effective
upon the earlier to occur of its adoption by the Board or its approval by the stockholders of the Company; provided, however, that
if, and only if, certain options are intended to qualify as Incentive Stock Options, the Plan must be approved by the Company&rsquo;s
stockholders no later than one-year after approval by the Board, and further, that in the event certain Option, Restricted Stock
or Restricted Stock Unit grants hereunder are intended to qualify as performance-based compensation within the meaning of Section
162(m) of the Code, the requirements as to stockholder approval set forth in Section 162(m) of the Code are satisfied.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">13. Amendment and
Termination.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Board may amend, suspend,
or terminate the Plan, except that no amendment shall be made that would impair the rights of any Participant under any Option,
Restricted Stock or Restricted Stock Units theretofore granted without the Participant&rsquo;s consent, and except that no amendment
shall be made which, without the approval of the stockholders of the Company would:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(a) materially increase the
number of shares that may be issued under the Plan, except as is provided in Section 8;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(b) materially increase the
benefits accruing to the Participants under the Plan;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(c) materially modify the
requirements as to eligibility for participation in the Plan;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(d) decrease the exercise
price of an Incentive Option to less than 100% of the Fair Market Value per share of Stock on the date of grant thereof or the
exercise price of a Nonqualified Option to less than 100% of the Fair Market Value per share of Stock on the date of grant thereof;
or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(e) extend the term of any
Option beyond that provided for in Section 5(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(f) except as otherwise provided
in Sections 5(d) and 8 hereof, reduce the exercise price of outstanding Options or effect repricing through cancellations and re-grants
of new Options.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Subject to the forgoing,
the Committee may amend the terms of any Option, Restricted Stock or Restricted Stock Units theretofore granted, prospectively
or retrospectively, but no such amendment shall impair the rights of any Participant without the Participant&rsquo;s consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">It is the intention of
the Board that the Plan comply strictly with the provisions of Section 409A of the Code and Treasury Regulations and other Internal
Revenue Service guidance promulgated thereunder (the &ldquo;<U>Section 409A Rules</U>&rdquo;) and the Committee shall exercise
its discretion in granting awards hereunder (and the terms of such awards), accordingly. The Plan and any grant of an award hereunder
may be amended from time to time (without, in the case of an award, the consent of the Participant) as may be necessary or appropriate
to comply with the Section 409A Rules.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">14. Government Regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Plan, and the grant
and exercise of Options, Restricted Stock or Restricted Stock Units hereunder, and the obligation of the Company to sell and deliver
shares under such Options, Restricted Stock and Restricted Stock Units shall be subject to all applicable laws, rules and regulations,
and to such approvals by any governmental agencies, national securities exchanges and interdealer quotation systems as may be required.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">15. General Provisions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(a) <U>Certificates</U>.
All certificates for shares of Stock delivered under the Plan shall be subject to such stop transfer orders and other restrictions
as the Committee may deem advisable under the rules, regulations and other requirements of the Securities and Exchange Commission,
or other securities commission having jurisdiction, any applicable Federal or state securities law, any stock exchange or interdealer
quotation system upon which the Stock is then listed or traded and the Committee may cause a legend or legends to be placed on
any such certificates to make appropriate reference to such restrictions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(b) <U>Employment Matters</U>.
Neither the adoption of the Plan nor any grant or award under the Plan shall confer upon any Participant who is an employee of
the Company or any Subsidiary any right to continued employment or, in the case of a Participant who is a director, continued service
as a director, with the Company or a Subsidiary, as the case may be, nor shall it interfere in any way with the right of the Company
or any Subsidiary to terminate the employment of any of its employees, the service of any of its directors or the retention of
any of its consultants or advisors at any time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(c) <U>Limitation of Liability</U>.
No member of the Committee, or any officer or employee of the Company acting on behalf of the Committee, shall be personally liable
for any action, determination or interpretation taken or made in good faith with respect to the Plan, and all members of the Committee
and each and any officer or employee of the Company acting on their behalf shall, to the extent permitted by law, be fully indemnified
and protected by the Company in respect of any such action, determination or interpretation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(d) <U>Registration of Stock</U>.
Notwithstanding any other provision in the Plan, no Option may be exercised unless and until the Stock to be issued upon the exercise
thereof has been registered under the Securities Act and applicable state securities laws, or are, in the opinion of counsel to
the Company, exempt from such registration in the United States. The Company shall not be under any obligation to register under
applicable federal or state securities laws any Stock to be issued upon the exercise of an Option or vesting of Restricted Stock
Units granted hereunder in order to permit the exercise of an Option or vesting of Restricted Stock Units and the issuance and
sale of the Stock subject to such Option or Restricted Stock Units, although the Company may in its sole discretion register such
Stock at such time as the Company shall determine. If the Company chooses to comply with such an exemption from registration, the
Stock issued under the Plan may, at the direction of the Committee, bear an appropriate restrictive legend restricting the transfer
or pledge of the Stock represented thereby, and the Committee may also give appropriate stop transfer instructions with respect
to such Stock to the Company&rsquo;s transfer agent.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">16. Non-Uniform Determinations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Committee&rsquo;s determinations
under the Plan, including, without limitation, (i) the determination of the Participants to receive awards, (ii) the form, amount
and timing of such awards, (iii) the terms and provisions of such awards and (iii) the agreements evidencing the same, need not
be uniform and may be made by it selectively among Participants who receive, or who are eligible to receive, awards under the Plan,
whether or not such Participants are similarly situated.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">17. Governing Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The validity, construction,
and effect of the Plan and any rules and regulations relating to the Plan shall be determined in accordance with the internal laws
of the State of Delaware, without giving effect to principles of conflicts of laws, and applicable federal law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;<IMG SRC="image_010.jpg" ALT="" STYLE="height: 900; width: 695">&nbsp;</P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 43 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><IMG SRC="image_011.jpg" ALT="" STYLE="height: 900; width: 695">&nbsp;&nbsp;</P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 44 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" != ,<# 2(  A$! Q$!_\0
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MQ-8U2WTC3;[4KF"XNH;%))GMK*W-Y>R;<_ZF!6!)/\(...Z\"MI0%554850
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MU/;VL"EC)/<W LXT';,A'/Y\]<FJ]CJ5EJ, FL+J&_MRH87$,BS1A2N5:.4
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MH]%;[23HC-??N3Y!7/Z^_P#!IEP/VZCZ']F3_P!'_&ZORJ^,/_*P=>?]I(O
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MGL<=FV)^MUJB::=*<VE#I_R];G:V[>FEQSPO[W#O^2;>NCMRH^H6'+^PC/\
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M6D7\GBB7P=I.O^)I[OQ#)XA6X\0O<6LM_J]G;-X<-Q8/KDS/-OWZ';DM"OZ
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7Q3Y8Q5U)2DW:\G/5*VKJ***]X\P__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_002.jpg
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !; ,@# 2(  A$! Q$!_\0
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M,K 8W))&C(WXIMJ88NC*O]7A*\^64O*T$F_S(]DX^\_1?/MHBW12 @C(HKJ
M6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH JW=K!>1/;W,44\,BX
M,<@!R>>>?PZ>A^E>=>/_ !EH/PM\,7GB?52\6E:5!;6SK:0F:2-I9I1]U<D
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MNNZ):>&?VH/V<O&NO:==Q_V+:K\2O!5UJ@NY&VB72+6^N1?27!8A%-DA@+*
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MT_Q9.]A\-OA[J%O<:M8Z7X\L/#]YH?C2/PYIMW!)H&EVC+)XS=Y!X+6/CO\
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M1[;Q;JVKZE+I.J_$WXL:O>7%S8ZA;Z"NKRQP*;!+*.]OX4#NCW<C^7L+LO\
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M_=3G3NJ<9TX1E;F<E&$[)-V3BI))ZGYQ_"'1;S3[_0VUGPY)%XA75];+O?\
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M9**2:OK96L54XFHUJ,:$\LHVA.$H2C.<9+EJ>UM)M24G[1N2?*K.37*U=/\
M._X:Z%J.@^._!S:;X<\1:U=2:W>G6-4USX1?$7P3XIL;:YBU)GO/$?Q U">3
MP3XB@C+*B6,,<#NC1M$C&48_0VSQY*X*L,1XDC8&.4>3%^\C5?D1"<@(GRY!
M8?>(IT@" A %X'0#/)]>O:G0?=/^\?Y"O3R/)'DN'JTEBIUX5:GM.644E%NZ
MON]7^N]CBS?/)9SBZ,IX>%&5*E4BI1DY-QNFEJDK)/E5HKW4KZWO-1117M'G
#'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_003.jpg
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" != ,0# 2(  A$! Q$!_\0
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M!) /3U!'X5:7I][=Z'CI^'7Z]:L0M%%% !1110 4444 %%%% !1110 4444
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MVZIMPP].ZM&DI-Z=6E>^FEVWNR>BBBMQ!143R;"!CMG]3[CTIGG^WZ?_ %Z
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MSKQ?\)='\:?#:\^&6H75]%I,_AZT\/1:BLA>\1+&"S@%Q,2!^^+6/S \8.<
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M%U:ZY-'##!K.J>%KV30K^XU>+SI+B/7X+2XG:[M;A4_);_@O9^VC^U=\./\
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CP^)S"MB*-+V-HPCR622O%7LH^ZD]'9-VVZ$M%%%>N<)__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_010.jpg
<TEXT>
begin 644 image_010.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0@ S # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MH) )P< GIQR*O:'\/=2_M;39_$G]F7UM:Z.=-= 6<N1(2K89!_ 0,YSFDF\
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MT_419ZE?PF=KEF V(D>[)S_><QK]": .VHKC+#Q)+K.J^$KB"5H[>_M+I[B
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M]%<_XQO;FPT2&:UF:*0WUI&67J5:=%8?B"11HU[<S^*_$MM+,SPVTEN(4/1
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M3G/7((!SQ5.UT75--:6[CO([C4+^^BEO9!"$C\I0%*JI8E0%7@Y8D_7CI**
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MSC/H*ZJB@!!G R<GN:6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M9)-)(IQYF_HP_ASFN@BDEN+$/);O!*Z<PNRED/H2I(_(UF#Q5IHAFDG%S;&
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MS1I"P8JS,!@9VG ZD\4 -\4:5]K\.):V=@EQY%Q:RI;($7*1S(S*H8A1\BL
M,@=JQ;G0KV2_ND&D[KF?4X;N+5"T?[F)2A*D[MX(563: 0<]<$UIZAXPM[:R
M,T4$ZS1W-M'-;SV[K((Y9 H8+C)S\V,9Y!'48JY;>*M*N99XC)+#+;Q/+-'/
M$R-&$V[LY] Z'Z,#WH VJ*CMYUN;:*= P25 ZAA@@$9Y'8U)0 4444 %%%%
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M]YK"R6LFGO81"*VV%0R[?,?+'<P&.FT=>.>,"7Q3XDC-Q&T:(+/S#*ZQ12S
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M[I286:,*R2(8U4OE5"R''S'!'IQ4#>"KA(K5;?5(T:WLK*W!>V+9DM9"Z/\
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MCC&>&)K6N7?BO3M-GN9(5@OXF;? J/(LEO<MM95=AC]UQG!Y!QP,@'HU%%%
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M2+3HM.DC?S+N.W"AE+88'C)!8#([D5J6>C:1:VPCL]-LXH6=9ML<"J"PP5;
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MX@L?E?&,@8[>U2W/GQPZ@=,M-5.ER"U0K,+A6$F]O-?!'F%=NS=M^]SS]XT
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MQS699^ 6M+.:"*]M+=_L;6D5Q:6 BEYQ\[N&R3A0"%*@Y)],2V?@<V]Q//\
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M+MWQC> N[@G@GCKTQTNNZ2^L6<4"M:$)(':*\M!<12#!&&4D'@D$$$<CN.*
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M'!I\?C?34CF^T/,[0%FG>"VD*0QB5XPS'''^K.?H2.* ,:2SN;:_E@AAU/\
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ME5AN0PN08]H+2'YY,%^549YZ]M?58+OPSJE[J5A'?265DMM*(&E=UG,AECE
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MQ9DFVC&Y@H)( XR>E 'EW@^.QUQ](T_Q-<L;&+1EFM();AHTE<R.'<D$;F
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M5JOV2.*,X+?=W,<\8'?- $'AG7=)L/&1;6O%-I?^9I:QV5Z;F&-(4R"\+[,
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MBRTZ6U-DK7=ZMLTMZQ6*-2K'<2.GW:H2>,-2BT2P>$Z1J6IZG>_9;-K*9C;
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MFUFO(7AE(>6))L!L' ?D?[U:4^KZG=7GB2SU0R)J>F>&)[:X8$A9'5\K*O\
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MT7!&0%4J?F(Z_AS0!ZKI/A75K6[M3J?B.6^LK2!H(;5(/)$@(VYE(8^80.G
MYYK.3X>7G]GPZ%/X@>7PY#*KK9&V42LBMN6-I<\J"!_#GM7G4NJZAH^LZI=V
M\DSG4+2+2T7<2$FDM86C8>^0];FE[[#PQX3A-S,1#XCFB:3)+%5,P_'ITH Z
MJ[^'MW<-?6*:[Y>AW]]]NGL_LH,FXN'95DW<*64'IQ4^M_#NVUR+7UGO"KZG
M-%/#(L7S6KI&$!'/S9 .>G!(]ZXOP@8=+\2:%,\T5]]O>5(M3L;YR]UE2?\
M2(),GC';&TU[10!S=OX4\C4?#MW]MW?V-9/:;?*QYVY%7=G/R_=SCGK534/
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M]=+JL,MO&=AVI&YVDY));;CD 'I0!TEDWA71;RQ@L(--L9]40M;"W@6/[0H
M8X*@9X(/-:MIJ=E?+<M;7"R+:S/!,>0$=?O Y],UX[;^%==U231-"O[:ZM;G
M15O(K?4$C<Q*P\IX'5R ".-OT4]ZV])@US_A5WC*2_L9K/4[F>\F,10KG*#)
M3/4'YL$4 /\ $VO6,VN0:CIGCFWT5I;2./!T43O*I)=3YC#.T@C"].,]ZAO/
M#FK:\VFVU_X_L[XWL;3V:7'AR!]Z@ LPW=."/2MW6;5[NT\#OIUO)-;0W]O*
M3$A81Q>2V&..@Y'/O2^+-'O]4\<^&FM)[VTBBANQ)>6L8/E$A, EE*C.".:
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M** "@@$$$9!ZBBB@"&TM(+"TBM+6)8H(E"1QKT51T ]JFHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *@NK.WOHUCN8EE19%D"MTW*
M0RG\" ?PJ>B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH *YSQ%K5S::UH&C6+*ESJ5RQ=RH.V")
M=\F,]R,*/K71UQOBJ$VGC3PGK;?\>T4\UE,W]TS)A#[#< /Q% &='K'B[Q5>
M:S/X=O+&QL=-NGM(8YX/,:ZD0#=N;/RJ<C&/6M>X\:IH\-C::O874FMS6_G3
M6.FQ&X,:C@OQT7/O^=9;>%_%FA7FL1^%[O2_L&J3O<_Z9O$EK*XPQ3:"&'&1
MGT'XJ?"?B72-7MM8TC4+/4+XZ>ME=G4RZ^80VX2 J">O&#V'7- &K/\ $'0H
M[;2;B%[FZ351)]D%M 79RF-R[>H.3C'KUQ61K/Q/MX=$L-0TJQNYS/J0L9XY
M+=M\# C>A4?\M,$;1GG\,4FD?#V\TF]\)2B[@F&E27DUZQRI=YUP/+&,8!]2
M./RJO=> =:_LF_2VGL&NW\3-K=NKNX0IQA&.W(;UP"/>@#5D\;V^FW_B2XU&
MXF-CIL=F_P!G%KMDA\Y1U.?F))''&*N6WC_1[B34HVBOX)+"S:^=+BV,;20
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M'0#C/?I0!L:/XTN-:^(@TF*WN;6Q&DFY>"\MC%*LOF@9Y[;2.G'XUVY( ))
M ZDUP$6B^*X/$EYXLU!M(%S'HLEI#!;^:ZK(&WJ2-NYE)SG'/. #UKL=/-U?
M^'[4ZG$(;NXM4^TQ(" CLHW 9)Q@DCJ: .'U7XF1W,NBKH4=T(KO6(;0W,]J
M1#/$6*OY;'C.<>A_6MZ;Q]I5OJZV$MMJ*(UV+(7C6K"W,QZ)O^O?&/PKE[?P
M'XICT_0=&ENM);3=%U..[CE!D$LR*Y/(VX4@,>._J,9,5[\._$=]JOVFYN-/
MN7BU5;V.[GN9C(8@V1$$P50 >GL* -C1OB5;W,?B&ZU:TN+*TTRZ,2.UNPRN
M0H4_]-2Q^[V!'UK4C^(.B?V;J-Y=B[L3IP0W%O=P&.90_P!S"]]W08_2N<OO
MAYK%]:>)M/-Q8I:ZAJ']I6DNY]XDR#L< <+@$9!)YS3&^&M_?Z/JZ7":;87U
MR(?LQMY9I@IC8-\[R')!(Z <9[]* -C1_&EQK7Q$&DQ6]S:V(TDW+P7EL8I5
ME\T#//;:1TX_&N@USQ%;Z$;9)+2_O)[DL(H;*W,KG:,D^@'U-86C>'_$;>.Q
MXEUQ],7.F&R\FS9SM/F!P<L.1][Z9 YZU+XR\.ZQK>HZ;+8RV\UC '%Q8W-Q
M)#'(2!M8F,9;'H>/SH L2>/]"C\.6&NE[@V5]<"VCVPDN)#N&"O7@J1QGVS3
M8?B#H;Z;JM[<?:[,:6RK=0W4!25"WW/E[[NU8%E\/M5MO"7A_2&GL3+IFMIJ
M$C*SA6B#NV%^7[WS=.GO4VM_#Z_U>\\73"[MHO[6:RELCEB4>!<'S!C@$^F>
M.?:@"WH_C2XUKXB#28K>YM;$:2;EX+RV,4JR^:!GGMM(Z<?C6YKOBJRT&ZM+
M.6"\N[R[#-#;6</F2,J_>.,C@9K&T;P_XC;QV/$NN/IBYTPV7DV;.=I\P.#E
MAR/O?3('/6G^.O"MUXE:Q:*RTR]B@W;HKMY(7!.,,DJ9(Z#(Q@XH FTWQ4FJ
M^+;:VM[F1+2;2C>"UFM3&X(EV%BQ.1TQMQ[YJ&#XF:%<36JQQ:CY-Y=K:6MR
M;5A#.Y;;E6/! /X^W!K,\+> M8TC6K>]U748KR)=(DL'Q([.&:8N I8<J%.
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M!Y&>E$OAC0)[6WM9M#TR2WM]WD0O:1E(MQRVT$8&3R<=: -6BJ/]BZ5_:O\
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M+<<MM!&!D\G'6I_[%TK^U?[4_LRS_M'_ )^_(7S?N[?OXS]WCKTXH O4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !117&_%6>6V^&FL2P2O%(JQ;
M71BI'[U.A% '945P=QXNU>VURP\.:5I4-[<RZ0EZ)9K@Q@')4[N#D<?F1]:S
MM.^*&I7EGHFJ3:#%#I.I7J6!D^U;I!*Q(W!=OW<@]>>#0!Z;17EUO\4M8?P[
M%XEG\.Q)HBS^3<RK=9D7Y]NY5QR 2!SU/YUM:CXSU>?7]1TOPUHL6H?V7&CW
M<LUQY8)8;@B#!R< \_Y(!V]%>>7/Q,FN++PS/HFDB[DUWSD2*6;88I(\ @G'
M(R3D^@JGHOB+Q=+\1=7MKZQC>.VL4=[**[&V(E-PV$@ EFP"2>,]<"@#T^BO
M/?#_ ,1+S4/%EGH6H6>FI)>1/(AL;X7!@906*28& < ]#5"#XI:O)HEIKTOA
M^!-)>\%I,XNLR9+$;E7;T'N>3[<T >HT5Y[I&M>(;GXP:SILZ(VFV\* )YW$
M2$95PN.68XSZ9Z\4?&%KS_A%+"*PN9+>YFU.&))$<I@L& R1VSB@#T*BO'8/
M&%QK/B#P4EY(]KJ%G<W=MJEONV@2)&O) Z@]?KGTK8'Q-U(:6OB5_#ZKX7:?
MROM'VC]^$W[/,*8QC=QC.: /2J*\\U36_$"?&#2M,M51]->T\WR_/VJZ$X>0
MC'++S@>W;-9?AKQK-;^'=%T_1M,:YU/5+FY6&*ZO"RHL9)9F<C./08]?Q /5
MZ*X/4_'NHZ)X?AGU71%M-5GO?L4,$ERHA<_\]?,[)]1^G-:/@WQC_P )+/J5
MC<16R7VGN@D:TN!-#(KC*LCCKT(([4 =717D'Q&N+9?B7IT&I/JIT_\ LLN\
M6G,^_<'?#84]/4U+X$UA]-M/$NO1S:E+X2AB$EF+Z7?*SJ/G"Y)P,\?B/>@#
MUJBO.O#WQ-;4=8L+/4K:PA34H7FMVM+T3M%M7<4E4#Y3M_7CUQ4E^)^LKX>7
MQ''X=A.C7%P(+9VNL28WE=SKMX!P>AZ^W- 'J%%>;^(_B5?^'-4F6ZTW3ULX
MKD0B)M04W4J''[Q8USA>>AY^E:;^+]9N/'E]X;TW1H)X[%H&GNI+C9MC=06.
M,<D;N![&@#M:*\H\5>--9U?PWXH;2M+4:38N]F]Y]I*3>8N,NJX^Z,COG!S[
M5-X9U[[)<Z[<>3-+/8Z%:7+&2Y9EE(MPV N/EZ<GG- 'J-%>=Z;\0]6GN?#L
MM]H4-OIVN,(H9$N=\BOCJ5QC:3TYSCGVIM[\1M6%OKNIZ;H,-SH^D3/;/,]S
MLDDD7&6"X^Z"1WS@Y]J /1J*YW4]7OG^'TVLV$2+>/IXN44MPA*;B<D<X!)'
M'.*\S@USQ'-;?#VZEC:>[GFN!&GVH@72[$PTAQQR6R,' '% 'MU%>>CXER6.
M@Z]=:QIB17^CW"VSP03;DF9ONX8C@=<\=!^%7?"GCJ36M>FT2_AL$O%MA=1R
M6%X+B)DS@J2.C D<?C]0#M:*XWXFZM+IWA3[':SB"]U2=+&"3=MV;S\S9[ +
MGGMD54^&^JW,OAW4M':X6]U#1KB6W61Y,B9<DQL6YX/(^@H [VBN&TSX@OJR
M>&XK;3U-[JDDJW,!D_X]5BSYA/'7/3.,YJOIGQ#OI_%]CHNH:?80?;FE18[>
M_6>:W* D>:%X&<=C0!Z#17CU[J;2!?LQN8-GCU;>3-PS[QSG'3"G^[TK?U+X
MAWVE>*(-/N].L$M9K];-4%^K76UC@2F-<X7V)S0!Z%17E<FO:]I7CSQU-IM@
MFH06D=I-*DUR4$2+"20@P?F;D]ON_2CQMXC@O]/T"^M4N$.H:5J,\++.4\HB
MUW?,HX8CIUX(R* /5**\RMM2FCC^&Z+%+<WMSILS1EKDHI<6RGYQ@[LGN>G6
MJ_AGQIKUE\,)/$6I6HOA%=G?(TQ+M$92KMC'&TD #I@=J /5:*Y_2_$AU;Q5
MJNEV\"-9Z?%$6N@^=\D@W!0.F O?-4M>\5ZC!XEB\.:!ID5]J1MC=S-/-Y<<
M4>=HR<$DD_S'X '6T5XYXT\8ZCK_ ( 5K.T:RE74OL&I1?:"K12*1\@8#E6S
MR>,8[UWEU:R:7\-+V 0_998=,F_=I.TOEMY;' =N3@]Z .GHKYSTVY$VC:))
MX;O?$$WBEIH_-7=*T!&3NW9^7;T]O6O59O&6KR>.-0\/V&CP2P:>8)+B[EN-
M@2)U#,<8Y(SP!Z&@#MZ*\U'Q-U(:6OB5_#ZKX7:?ROM'VC]^$W[/,*8QC=QC
M.:N>)/B%>^&M;DTR;16N9+I$.DO"Y(NG+!2C<?*1G/?CZB@#OJ*Y)O&$^G>)
MO[(UJUAMD.F&^6XCD+*2G^L3D#IACGT%11Z[>:]\*[_6I[7[#+<:?<2Q1HY)
M5=C;6SQR0 ?Q% '945\^:'KNI0^!+[PV][.VHZC<V0LYFD)?;<JI.#G.!L8?
M4UU'@_Q-JNE?#'1IX8[:X>:>=9;O4KY88H0';&XM\S$]  .U 'K=%>6:GX^U
M/6/A+JFMZ9"EI>6]P;6:2*;<$ *Y>-L<YW+CZGGBII?B)J5@NFZ2UGIRZK]@
M%U<M>Z@(H@N<(H<CYG88/MGOS@ ]-HKSJ;XFW%U8>&9]&T=;J;7//1899]GE
M21X!!..1DGGC@5/H6K73>,_$BSZ?(-2M["VEE@2\W1LYCSL0-A5YXW9P>M '
M?45Y[X?^(EYJ'BRST+4+/34DO(GD0V-\+@P,H+%),# . >AKE_#?CVZ\/>#-
M&A80RSW]U=#[7J$[+#&$;HS ,<G/% 'M5%8_AG5[C7-#BOKFW@@E<D$6]RD\
M; '[RNO&#Z=16Q0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !6)XN\/_\ "4^%[W1?M7V7[2$'G>7OV[75ONY&?NXZ]ZYKXC>-+SP]=Z3I
MFG2FWGO)<RW!M&GV1\CY5'#-GMU_.M"X^(WA[2[C[#>W\LL]N$2[N(K5S%$Y
M_OD A<GMVZ4 6[?PGY'C&U\0?;=WD:6NG>1Y6-V'W;]V>/3&/QK'MOAK]G\)
MZ%H7]K;O[*U-=0\[[-CS<,YV;=WR_?ZY/3I6QK7CW0- O8K.\N96GFMQ<Q)!
M"TGF(20"NT<]"?H,T_QKXH_X13PI<:NEN9I5VK%&RG&YNF['0=?Y=Z /._!_
M@'5]9\$6VGZEJES9:5)=-+<Z;):;9&VR9 #G!53@'H>>>]=CJ?@>_.NW^J>'
M]?;27U*-8[R,VRS*VT8#+DC:0/YUE?\ "R]GB724E$G]FWFE&Y,26CF9I@[+
MA5QNQ\I[=!G.*Z<>._#Q\-1Z^+T_89)/)3]VWF-)G&P)C.[V_'I0!GVWP\M+
M";PK]BO&C@T S$(\>YK@R@9);(V\Y/0]>U1ZQX!GU/Q'JFHPZRUM:ZK9?9+N
MW$ 9FPA52KYXP<'&.<$=ZZ'0O$FF^(X)I+"23? _ESPS1M')$WHRL,BJ_C/Q
M /#'A._U1<&:--L"D9W2MPHQWY.?H#0!S^A_#N\TO6=#U&XUN&8:3%)#'!%8
M+$KHR;<DAOO=R3G/' ZE5^&N/ </AC^UO]7>?:OM/V;K\Y;;MW>^,YIOACQ[
M(/#&JW7BO%M?Z-<>3>K%&3@,P",%&>#G'X9K<TGQQH6M:O\ V79SS?:6B\Z(
M2P/&LR?WD+ ;A[]^U $:>%;JW\?S>);;5 D%U"L5U9M &\S:N%P^?EYP>G;W
MJSXK\-_\)/9V-O\ :_LWV6^BN]WE[]VS/R]1C.>OZ5EP_%#PM.UMLNY_+GE\
M@3&V<1I)G 5FQ@$_RYZ5N#Q)IK:GJFGB5_M.F1+-=+L.%5EW#![\>E &%J/P
M[LKWQ_9>*XK@021*1<6_E;A<':5!SD8.#@\'.!68OPNN!8IH3^(YF\+I/YPT
M\VZ[R-V[89<YV[N>E=!/X]T&#2=.U'SIY4U+=]DBAMW>67;][" 9XK)U[QZC
M^'=*U7P].KI<:M%8S>;$0R@YW*5."&X% &IJWA2YO/&.E>(K'4Q:26<7D2PM
M;B02Q%LE0<C:3R,\_I6';_"^73]+TE=/UUH-5TN>:6"\^R@J5E/S(R%N1CC.
M?6M'XE^(=6\-^';6YT;R_MD]]';*)$W A@W&/J!7(^*?BEJMIX0\/:AH_D&[
MO+4W%V6CW*@4JAP.V9"1^% '37?P[N-1T.."_P#$-S=:K%??;XKV:,,D;_W!
M$3@1_P"SG_"MOPOX=N=#%W+>Z@EY<W+ACY5LL$<8 X55&?U-5M1\?Z#HUT+.
M^N)C<)$DER8;=Y%MU8#!<J"%!S5C6?&VAZ));1W%Q)-+<1>?'':PM,QB_P">
MA"@X7WH 6X\,>?X[M/$WVS;]GLFM?LWE9W98G=NSQUZ8K+MOAW;6MUK\,5\R
MZ+K49\W3UBQY4A'+H^>._&WT]!5?Q!\3+'2[SP^+)3=V>J$R/<1Q.^(NGR@#
MEL\$=1CD5-;^.;+3CJ\VLZI$UO!JIL8S';NODG!(5N.<8/S#B@!/#O@2\T>]
MMGO=9BO+6T@,,,$=BD)<$8!D8$EB!QV_GGS.?2=2N-,B\,6 \0+$FHJT&EW.
MGA4MQORS-.,AD&21TZYKV+2?&VAZP]_'!<2PR6">;<)=0M"4CQG?A@/EQ5*R
M^)7AJ_NK2WAGN0][,(;8R6LB"8DXRI(P5SW[=Z ,"]^$]S=0:K9Q>($BM+^\
M-YS8*\H<L#M9]P+*,=..?R/7:9X:.G^+]:U\W@D.II"AA$6WR_+7;G=DYSUZ
M#'O6Y++'!"\TSK'%&I9W8X"@<DD^E<QI?Q$\-ZOJ4-C:W<HDN"1;/+ \<<Y'
M78Q&#0!C7WPTO)DUJQL/$<EGI&K2M<36GV57*RMC.'R#M) R/08SWJ]9?#[[
M&VLG^T]_]I:7%IW_ ![X\O9%Y>_[W.>N./3-9_A3QI?^)_'FJ6BW)ATVT)6*
MV-DP9P!C<TA^Z<_PXY_"G^.?%^HZ1XGT[1;;4++1[>YMVF;4;R(R*6#$>6.P
M/&23ZCIW -'_ (0/_0/"EK_:7_( E63=Y'^OVC&,;OE_6O.O$EC>6TOB?1].
M7Q!;Q7]RTB:<FG"2.YD8CYTF&<(< D8' QZUV4GC;6M"\ W^L:Q;V5W<0S>5
M9W%E('@NE)^5SM)VCKG..PXS6J?B+HEOI.F75U)<&YOHB\=M%;.TIVDAFV8R
M%R#@GKVS0!L6FDLW@^#1[DE&-@MK*5YP?+VG%<QI/P[O+$^'/M>NK<KH4TK0
MA;,)NC=54(3NXP03GGKCM6\WC?P\OAI?$']H*VGNWEJZJQ8O_<VXSN]L>_2L
M'Q!\1+=O ^M:IH,K+J&G&(2074#(\9=U'S(V.H)Q0!->?#>VU"'Q+%<W[E=:
MGCN$*18-NR=.YW?IQ5_PUX6OM'U&:^U'58KV5XA$D<%DENB =6P,DL?K_3#;
MGQE:2:;K,6G2F;4=-L'N)F6,F*.01E@I;IG/\.<\'T-4/"?Q&TW5K31K2^GD
M74[Z$?/]G=(9)0/F56Q@D>QZ\=: -/7_  9;>)?$.G7VIRI/86,4BBP>+*N[
M\;RV>P P,=NM,T?P/9^'O%4^K:0Z6EE<6H@FL$B^5G#9$@;/!QQC'<TQ?B3X
M7?4Q9"^?!F^SBY\E_(,G]WS,;<_I[TECXFN&\=^)=-O988]-TRVAF1B,% R;
MF+'TH 32O %II7BK6M;2[=O[11ECA"[?L^\YD*MDY+, >@Q[UE:'\,[K2+W1
M97UR*6'2)9&@B2P6,R*X(.]@V2W(Y]NG-,OOB;;7NK>'K;0I)#%?7ZPRM<6K
MH)(CP6C+ 9&>XZ5OV/Q!\.:CJL>GV]W(6FD,,,S0NL,SCJJ2$8)_GVH SV^'
M>[=_Q-?O>(QKO_'O_P"0OO?^/?I5 _"ZY%R^S7D6U_M0:FB&Q4R%PV[:\FX%
MAU Z=<^U=%:^/-!O-?DT6WFG>]CGD@E40-MC9 2=S8P!P<'V-1Z?\0?#^IZA
M;VEO+=#[4[);3R6LB0SL.H1R,'I0!FZMX!U*[UK7=0T[Q(UBNM)'#<0_9 X$
M:Q[#@EL[NN#QC)^M2ZQ\.X-1L]%M+:_:U@TNRN;- T7F%Q-#Y6XG<,$?>]_:
MK/C[QD?!VFV<T=OYTUU<+$,HQ55_B/'4XZ#O^%.U'XB^'=,>&.>>X:62!;EX
MXK9W:&-@"&D 'R\'H>: "'P7Y-SX1F_M#/\ PCMN\./)_P"/C=$L>?O?+C;G
MO69#H"^"_ FK:;J-S<:IIDOF)#!;6?[U%D+9'!.XY;KQBNVL;ZUU*QAO;*=)
M[:90\<B'A@:\_P!-^)]K:ZAK\&O2R*MEJDMO&T%J[+%"#A6D*@@<Y&>] &G\
M+= N=!\%0"_21+^[<W$XD^^N<!0<\\*J\=CFK6O>$;N]\0P^(-$U@Z7JBVYM
M9': 3)+%G(!4D<@\Y]A3]3^(7AS2KS[-/=R2,L:32O;PO*D*-RK.R@@ @@_C
M72Q2QSPI-$ZO%(H9'4Y# \@@T <-)\-(F\)C1EU20W$FH+J-U>20AFGESD_*
M",9X[\>]=AJUC_:>CWVG^9Y7VJWDA\S;NV[E*YQQG&:X/3_B=;66H^(8->ED
M$=CJ3V\306KN(H@<!I"H('/'/6NGUGQMHFAR6\5S/++-<1>>D5K"TS>5_?(4
M'"^] %SPWHW_  CWARPTC[1]H^R1"/S=FS=[XR<?G52P\+K9^+=<UQ[H2KJL
M<,9MS%CRQ&FW[V?FS]!69;^+WU'Q_INGZ?<0SZ/>:4UXKJO+-O*]>W3IZUC^
M*OBI8P:3(WA^X:2Y6Z2%9I+9S#)\V'"N1M) ]_<9H E7X77 L4T)_$<S>%TG
M\X:>;==Y&[=L,N<[=W/2K?B#X;#Q+JE[J%_K$HG\M(],\F(H+#:=VX?-\Y)
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M02.>.]:/@+1+CP_X-L+&\C*7N&EN06#$R,Q8Y()!ZXS[5TE% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%8OB+7+O0[>*6UT6[U/>6WBV*CRP!G)S7/Z+\1W
MUG2Y]53PYJ$.FQ6TUP+IW0H_E@Y4>Y((H [JBLO0M=M==TFROHB(FNH%G$#.
M"ZJ?45H+<0/.T"S1F51EHPPW >XH DHK)\3:]%X9\.W>L3PO-';!2T:$ G+!
M>,_6N=L/B.DNJ:=8ZIH&I:6-28):SSA3&['H,@\9R/SH [BBHOM5OY@C\^+>
M25"[QDD=1CU%'VF#[1]G\Z/SL9\O<-V/7'6@"6BHOM-OY;2>?%Y:G!;>, ^F
M:59XG#%948)]XA@=OUH DHK,UO7K'0-!N=9NW+6ENFXF+YBV2  /<D@?C7/Z
M7X_>YUFQTW5/#^H:4VH*39RSE623 S@X^Z<8X]Z .SHK(TKQ+INLWVI6MG*6
M?3Y?*F9N 6QSCU Z9JW+JMC#87%\;J)K:W0O*Z,&"@#)Z?RH N45F:3KUAK&
MAP:O!*([29=P:4A2H]^>#6@9HEB\UI$$> =Y88P?>@!]%0F\M@)2;F$"(XD)
M<?)]?2EDNK>&-9)9XD1\;69P V>F#0!+13'ECC*AY%4MG )QG'6L_5O$&FZ-
MH<^L75P&LX5R7B^?=SC QU.: -.BH;.ZCOK.&ZA.8Y4#KR.A'M0UW;)<"W:X
MB$S=(RXW'\.M $U%0R7=O#N\VXB39C=N<#;GIFG2SQ01&665(XQ_&[ #\Z )
M**Q-&\2P:UK&LZ=% Z-I<J1.[$$2;@2"/RK7FGAMH_,GECB3.-SL%&?J: )*
M*8TT:*K-(BJQ 4E@ 2>F*1[B&,L'FC4J,L&8# ]Z )**9'-%-N\J1'V-M;:P
M.#Z'WKE?%WQ TSP=?Z=:7L4LC79RS1D8A3<%WM[9/Z&@#K:*:TL:!2[JH8@*
M2<9)["HUN[9D=UN(BB':[!QA3Z'TH FHJ-+B&21XXY8W=/OJK E?J.U)]I@\
ML2>='Y9. VX8S]: ):*A:[MDN!;M<1"9ND9<;C^'6LNQ\1PWWBO5- 6"19M/
MCBD>4D;7#C(Q]* -JBN+U/Q]-:>)[W0K'P[?ZE<6B(\C6[+@!E!'7ZXK5\+>
M*[3Q5:74L-O<6D]I,8+FVN5"O$X[''^>#0!OT5%'<V\T32Q3Q/&N<NK@@8Z\
MT)<P22>6D\;2;=VU7!./7'I0!+143W,$<R0O-&LK_=1F 9OH.]#W5O&^QYXE
M;<%VEP#D]!]30!+161I/B33M;O\ 4;.RD+R:?+Y,Q(P"W?;W('3-&K>)-.T6
M_P!.L;N0BXU"4QPJ!QP,DL>PH UZ*B>Y@CF2%YHUE?[J,P#-]!WJ6@ HKSUO
MBK#]GDU.'P]J<V@QS>4VI(%V_>V[@F<[<]_Z\5U-GXHTO4-?GT:VF+W4$*3.
M<87#<@ ]SCGVH V:*B^TP?:/L_G1^=C/E[ANQZXZT-<P).L#SQK*_*QEP&/T
M% $M%8=EXFM[SQ/K&B>2\;Z8D3R3.PVL)%W#'IBDU7Q/;:5K.B:<T32G57D2
M.5&&U-B@DG\Z -VBHX[B&6'SHYHWBY.]6!7CWJK>ZK;VFC7FIHRW$-M"\Q\I
M@=P522 >F>* +U%9>CZ[:ZMH5AJI(MH[V-7C25P#ST'N:K^&_$]MXCTZ[O8X
MFMX[6ZDMG\UAU3&6SZ<T ;E%1"Y@: 3K/&83_P M XV_GTIK7MHD;R/=0JB-
ML9C( %;T)[&@">BD1UD0.C!E89# Y!%1-=VR7 MVN(A,W2,N-Q_#K0!-143W
M5O&^QYXE;<%VEP#D]!]32FX@6<0&:,3,,B,L-Q'KCK0!)114$=Y:RF01W,+F
M/[X5P=OU]* )Z*C,\(C$AE01MT;<,'\::UW;)<"W:XB$S=(RXW'\.M $U%8=
MUXB-I<:TLNGSB'3+7[1YVX;9AL+%5[@C&.:GTG7[/4] L=7=EM8KR(2(LS@$
M9[9]: -6BL/5O$UOI.NZ+I<D+NVJM*$E5@%C\M0Q)^N:?XA\1VN@>&;K72OV
MJWMPIQ"P.[+!>#T[T ;-%5H[ZW:*W=Y4C:X4-&CL 3D9P/7K5F@ HJ%;NV:6
M2);B(R1C+H'&5'N.U9^A^(]-\0:4NI64W^C-(T:F3"DE6*].V<<9YH UJ***
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@""]_X\+C_KDW\C7FG@K_DWR;_KPOO_ $*6O4J* /"8-(M],TCX
M<ZCI5ND.J74H5YQ]Z0LG1CW';'8<5F^$X=^HZ!%]IM;?Q#%J3/<A;68WK?,=
MZS-G;L(/7']:^B*3:H8MM&X\$XYH XWXL?\ ),=:_P!R/_T:E4=#\!S7,NB:
MKK7B"]U);)$GM;9XUCCC?:,$XZXX_*O0:* /+? >A65UXD\7ZNULDFI6VM7*
M6LKDD1$YZ#ISNY_#TKAT733X3BM8H;D?$C^T,DE'^T"7S<[BW3;L_#-?15)M
M7=NP-V,9QSB@#P'5FTX^.;C45@N'\&1ZE$-3,;?Z.UWAOG [H&(W>N?<5L>.
M/MFA>)=3LM)0M%XQMHH860_*L^X(Q^A1R<^K"O9ZYB3PM9W'C:#6KW5+BYN+
M=6>SL9'7RX-PVLRKC)Z=?\!0!%XELK71/AO-8)H[ZK96MLD+6:/L9T& 6! )
MR/O<<\9KSSP[J=M9^+-"M/!/B'5=3L;B3%[IUVK.EM#CDY( 7'/3TZ^OM]-5
M$0G:J@MR<#K0!X&[:%H/_"?VTFE+/>+<E4ME:2,BU+IDEEYV E"0.OT-/T2U
MLKOQ!XELK8:=/:W/AYY%BTZW>*!Y%8;=H8DL0?XO7/O7O6U<D[1DC!..M'RH
MG954?0 4 ?.<#6!T#P>\/V$:1&TPU W44C6XO-BX,P7!)V[<'I^M;=U$8O@-
MXB,5T)[)[Y7M=L+QHB&>/Y8PYR4SG!]S7M*W5DT4)6>W,=P<18=<2GK\OKWZ
M59 P,#I0!Y"GA'0C\6;32SIT1L9-!%Q+"<[9)?,9=[?WFQW/?GK7G^A2$VNC
MR:X]C_98TZ>.U;4XI9( _G/N"[",28Z>V/:OIZD9588901[B@#Q)=+%U!\,]
M/U*62]@DDNAF9&C+Q8!52IYQC ]Q[&JVH:3;1^&_B3I]M:@6UE>Q36T*CY83
MW*CMQG\*]WHH P?!;Z7)X.TQM&\O[#Y6%\L$#=D[^#_M;J\/\7WMC=/KEW#:
MV6GZA;ZKDHR2RWIVL!YAD)Q&GH ,= .U?1H 4 *  .@%,\V!;CRM\8G9=VS(
MW$>N.N* /)[S1=-UOXB^.3?VR7*PZ="\0?D*QA^\/<=CVR:Q(I(&\/?#FY\1
M;I?#D:3K=%P6C$G(BW@=N ![ U[O2%0PPP!![&@#S'X4BP&O^,?[+C:.P-U"
M;=64K\A5B, \A<=/;%1>-#I<7Q+M)O&"%O#W]G,MH9$9H5N-WS;@/XMN?TKU
M2D95<88 CT(H \&=;BV^&UI>/'<KHUMXG2YL_-5BT=D"=IP>=N3^OO4/C75;
M/6;_ ,:WMA*9;5]+M!'+M(#XN(@2N>HSD9]J]_(!!!&0>QI0 !@<"@#'\,Z%
MIV@Z/%!IULL*RA992"29'*@%B3U)Q7E%Q8Z[X]UOQ/JFF:?97>GW"-I-O+<S
ME/+1"#O08.<MALU[?10!X=J&JOK_ ,+_  ]9WVY;VRUV#3[M=V&#(&7KUSMQ
MSZYJIXTTVST74?&UAIMNEK9MI5K(8(AA-WGQC./Q/YFO?** /*['2+'0OBEX
M7738%M_M6E2FX*$YF(7.6]3GG)KBAJUI%\++;P\[N-5MM8!GMS&V8AYI.6.,
M <@?4U]$T@4 D@ $]3ZT ?.7B^]L;I]<NX;6RT_4+?5<E&266].U@/,,A.(T
M] !CH!VKU#P^0?C%XN(((-K:8(_W!7>$*NYR ..6]JBM[VUNO^/>YAFX#?NY
M W!Z'CM0!Y1>:+J.M?%CQ9'I>LW6EW<=E;M&\)PKML7 ?OCZ5C1R2/\ "/Q#
M86-O<PZ_!=C^VD:0R3298;GSU*D ].P;KU/N]% 'ANC):NGBJXTB[L#9?\(_
M*D\&FVTL<!?:2K$N3^\QD$>F>^:HZ'_8LL?@6/P]%(OB9+N)KXJCA_(Q^\+D
M\%",8_V>E>ZZCI\.I:3>:=(3'%=0O"YCP" ZD$CWYJOI6GV?AW1K+3EG BMX
MUMXY)F 9L= 3QDT >*ZH-%2/QA#XEAF?Q9+>2'3B4<R,O'D>41VS^E;O@W0$
MU7XBZK+XBMQ<:C966G2'S"3MG\E"6/8L"O\ /UKU\JI8,0"1T..E+0!Y;\.+
M;1].\>^+K)(8X-22Z<PIM(86V5/';&2OZ4?%6UTB/Q)X3U#6((S8BXDBNI74
ME=F 54X]\G\Z].AE@G7S8'CD4\;T((..V127$]O!&'N98HX\X#2L ,_C0!X/
MJ?\ 8BQ>,(O$L,S^+);R0Z:2CF1D./(\HC^'/Z5[5H(U"/PQIHU$%]16TC\\
M,>3)L&<GUSUJY#<6MV=\$T,Q3O&P;'Y5)'-%,7$<J.4;:X5@=I]#Z&@#Y]NM
M1T?3[6[O= U#6?#GB43D'04+RQO)NZ;=N"".?0=,=,]-H$-K;?%Z]:_M8;76
MKO3XI[560X^T-$3*5/3KOS^->N[%WA]HW 8W8YI=H+!L#(Z'% 'SLBZ:?"<5
MK%#<CXD?VADDH_V@2^;G<6Z;=GX9K5#^&X+[Q%%XRL[NX\1OJVZV2W1_M#Q9
M7R_);@ =>XXQ[5[IM7=NP-V,9QSB@JI8,5&X=#CD4 >">+[+4KOQUXLN+=&E
MTVS2QN=1LBQ#W$2HI*Y'H-Q//;O75>+H])\0:]\.TACCETJY>8I&HPIC\M"%
MP.@XP1^%>I44 ?/^HVGV&;Q#80PRIX<MO$-L]_;VX.$MRK;^!_#P.GH/2MBR
M_LV75/%T_A)"OALZ!*LYC5EA:ZVG&T'OMZX]_6O:*1555VJ  .P% '@VF?V1
M%J'A>;Q?&'T1O#ZI9F9&>(3[OF&!_%MS_P".^U9\,<X^&T/E(RZ4GB5S>K<(
M[*L0"X\T+\Q4'J/7'>OHDA3]X XYY[4P30O*\(D1I$ WH&!(!Z9% '@MU'&/
MAUXYFL;JVETV26UV16=O)';)()$#&/>3G/&<=\=L5K^,O#>B:);^'OLTMM8?
M?D/]H6S3V<\C(H)E;G#848X/X5[,JA5 4  = *&574JP!!Z@B@#B/A3="Y\'
ML$TZ&RBBNI4C^SO(89AP3)'O)(4DGCIP?I7E/B^]L;I]<NX;6RT_4+?5<E&2
M66].U@/,,A.(T] !CH!VKZ*AFAGC#P2))'T#(P(_2G$*NYR ..6]J /,M-T/
M3=9^-'BBXOK=+@VB64L&XG"OY:D-CH2,?J?6N#O89)-4UJ#4;FUM?$+ZON@D
M:VFDO1\P\LQ%3C9@=,=/PKZ#%_9E86%W 5F_U1$@Q)_N\\_A3YYK>WVR3R11
M\[5:1@.?0$T 9OB.X-GX4U.XEMI+LQVDA>&%BC2?*<@$<CZCD5XSX/.G2^/?
M#'V1=,CM[NSGBF@L89%49B)\N5W)\Q_7\/45[XS*BEF("@9))X J$7-JD"2B
M:%8GY5MP"M]#WH \;T'3;ZY\66/@.Z1VT[P[?2W[.W(DBX: '\7.1Z?2N<\7
MWMC=/KEW#:V6GZA;ZKDHR2RWIVL!YAD)Q&GH ,= .U?145Q!/GR9HY,==C X
M_*GA5#%@!D]3CK0!Y7=D'QC\2B""#HT>"/\ K@:Y.2YT^?3_  ]87ME8QRC0
M5,5WJ"2S!\G[D,2D*9,]^OY"OH&D*J2"0"1T..E 'SY%+83>'OADVL!I[%&O
MA<#!?"*P^\!SM  R/0'M5BZ%NW@OXBS:*K+X<DFMOL0"D1EPZ^84![9Q^E>^
M4@ 4 *  .@% 'SWXA1/[?UU-=EL8FEL[<:>]Y!+(_E[./L^P@!@V,^_XU[AH
M_P!IMO"EB;II;FYCLT\QBI5Y&"#J#R&/OWK4*JQ!*@D<C(Z4M 'SYX;?3+_Q
M;X8DM[;3[:*YDNH;FU@65I%#HPV3RN?G8\X%;_@,^$K?X?+#J\2B6+4PER@5
MPRS^8WD[MOM^'K7L84+G  R<G% 4#. !DY..] "T444 %%%% !1110 4444
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M-5.FRZ;K4\5JT$$;+)$SCY7W$\]"2,<=/>M_QO>ZUINCZY<B2U.G/8_9[6-
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M_P#7Y.TM],M/[.0:!\27@TVZ%U9P/8H4B(;=MQW!)[\^A'.9+^+2+^_O)?\
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61110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_011.jpg
<TEXT>
begin 644 image_011.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0@ S # 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M.,<XH V**K7U]!IUL;BX,GEC_GG&TC>O103T!-16VK6M[ITM]:NSPH"=SHR
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7;75K&]O9[2VG$LUO_K0JG"G@XW8QG!!QG."* +M%%% !1110 4444 %%%%
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M,@ ,!YO+#G[Q8<\ =^FT;2?[)BN4,XE,\WFDA-N/D5<=3_=S^-:5% !1110
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M HHHH **** $95=2K*&4C!!&014%G8VFG0>19V\4$6=VR-0HSZU8HH ****
M"BBB@ HHHH " 001D&@# P.E%% '+7OBO44U^]TG2_#D^I-9+$TTB7440'F
ME>'(]#^5-M?%FI?V_IVEZIX:N-.^WF18I7NXI1E$+GA"3T'ZUDKXGT7P[\1?
M$PU?48;0SQ6?E^9GYL(^<8'N/SIMQXIT/Q#X_P#"<>D:E#=O#)=-((\_*# V
M.HH ]#HKD-5TY[_XBZ;((+:5+6T\UC,6#)^\X*8XW?7BN!NHEO9[6VL(UNM0
MED8:Q!<2.$:Y\X>6KGL<>;C'\(';% 'LM_=BPTZYO&4NL$3RE0>2%!./TKEK
M/Q;XBO[*"\MO!-T\%Q&LL;_VA;C<K#(."V1P:DT]E;X4@K,TO_$J<$N"""$.
M5.23\IRO)[5F^&OB'X2L_"NCVUQKMK'/#90QR(<Y5@@!'3U% '2>&M??Q!:W
MCS:?)8SV=VUK+#)(KD,JJ3RO'\5;=<9\.[VVU&'Q'>6<RS6\VMS/'(O1@4CY
MKA[G5[F76+RZOH[V+1-;N4>29F_=O;PRA?DVG<%,9!;@< ]1S0![717CUQ>/
MJ7@H:'HME.%NM2F2%+"Y\T&&-1(7B9]GR"0H,=.N,]*BN-6U#5?$-EJ^GE_M
M:1V]TUN#]]D@E,L6/4X=?KB@#V:BO%M4N(4\->$[R659)4TU9(K68NAF;*']
MPZGB?H "#D&NY\(:+IVG^(/$LEI:K$\=ZL"$$G:A@A<KR?[Q)_&@!1XOU:ZO
MM0@TOPK<WT-E=-:O.MY#&"Z@$\,0>A%6M(\47M[XA.C:EH,VF7'V1KI"]S'*
M&4.J_P !..6_2N=T#QAX>T#4O$UIJNJP6MPVLS2".3.2I5 #P/4'\JLZ3X@T
MGQ#\5%GTF^BNXH]$D1VCS@'ST..: .^HKSA-6NO^%IF_,%U_9CR'1Q.2ODY"
M[AQG.[S0RYQCGKVKA$>V>>5&OK&)7:<7)4RNH(ND*B\7( 0_=!!& 3UH ^@J
M*\NM=,TW6--\$W%Q8K^\O);8CS7=6B6.X9=I."4)4,N><8K)N=8O)'\1W<T5
MW%::U [VDLA7RW\F0*GEX)(S&<G('3O0![/17ED<M_;_ !"2,M))I]WKSE>>
M(I([9@1]&5P?^ &O4Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "HC=6XNEM3/$+ADWB(N-Y7IG'7'O4M<Q+!+_PEJ#[/,6-VMPLWE$H
ML(MW3&_&,[R?ESGYLXH Z&"[MKEI5M[B*5H6V2"-PQ1O0XZ'VJ*35-/AO4LI
M;ZU2[?&V!IE#MGIA<Y-8?AV>!KR]N5LKNT!,=M' ]C-'MC5GVL2R@,268D@D
M $9[DU-8T^_EUJ[N%61K 3VC30I!N>15;)*-_LG!( S@'&#B@#L'D2)-\CJB
MCC+' IU<+J@U&>2_B8:FQ)D\Y4C<HJ":/R3%Q@MLR?ESSNST%()=<-]IPC>_
M%KYI\@O'*69//(/F<?\ /+;_ *S'!)^\* .ZR-VW(SC.*02(SLBNI=<;E!Y&
M>F:Y?0K.YAU>VN;MK]YYK%][3%RJMY@.W^ZIQC Z]?>K>CW;3ZAJ%\]I=P),
MT,(26!@P< [N,<J"<;A\O7F@#::Y@0RAIHU,2AY 6 V*<\GT'!Y]C3XY$EC6
M2-U=& 964Y!!Z$&N'U[2-2NO$FHWD,3SV4,%I(]B8_EOMC2DIN[D Y"]"=N>
M*AN+_6+C7TGM(-5CB:X*E)(YL>283@[-@11NV]R^>I'( !Z!17G\5IKD4(E^
MU:P\L=E83A79R&G:1A,",<X55RG09S@9S2M9:W)&)&NM8#R6M_*X5W&)4E46
MX QQ\K-@#[V.<XH [^BO,H)_%4ME=,TFHI?-;SF91!+\K;ALV;AL!';9G(SG
MFO1[6W%K;) LDL@08WRN78_4GDT 34444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 <;;ZMXRU26]ETVTT$6D-Y/;1FYGF60B.1DR0JD
M<[?6M?P_K<E_X;74M5^S6LB23QSE'Q$ICE>,D,V./ESSZUSVD>(SH7]I65UH
M6OR/_:=W('@TR21&5YG92& P0014:VEY=_"/485L;N.YN'O'2WE@82X>YD9<
MH1G."#B@#L/[=T?[-'<?VK8^1(_EI+]H3:S?W0<X)]JEDU33X;U+*6_M4NWQ
MM@:90[9Z87.37":OI!TB[A;4M-DUJW;3Y[=#::>"%F9@>8UR%W+@;O\ 9Y(K
M+F\.:PE]:RW=M+/#;1:4EX([;?+(4SN:.3!/RN%+!>2I/(H ]8DD2&)Y975(
MT4LSL<!0.I)["F)<P2.B)-&S.GF(%8$LO'S#U'(Y]ZPO&T=[=>''T_3[4W,U
M[*ENR9(41DY?<P!VJ5##..XKE= N=0T/4-*75=(U+_1+&?3BUM:2SJ-LR>7\
MRKRNP#YN.AH ])BFCGC$D,B2(21N1@1D'!Y'N"*I)KND2/*B:K8LT(S*JW"$
MH,X^;GCD@<]S6)X(O&73FTJ:QU"WN();AV:>TDCC8-,Y&UV #<,#P:Y;0X9+
M31]<M[O3-2NI'@N5^QMH[1B3=*<*)MN7SN!Z\#)Z+0!Z1-JVFVQQ/J%I$?-\
MG$DRK^\P#MY/WL$''7FD_MC3/MK67]HV?VI<[H//7>,#)RN<\#FO+M/TRXTF
M%8=>\.7FJO';W5K)L@:87%P[J_F!B. ZE1OZ+L()&*TK&TN(?$NN)):W\9GD
MG,,?]E%HV!@ !%SMXY!&,\GCO0!W)\2:$(A*=:TX1L2H?[4F"1U&<]>1^=:,
M<B31)+$ZO&X#*RG(8'H0>XKS"U\%36OA>UNKJ".ZO;B32PT$=AY9@CCE0MN7
M));#-O8XX'( %>GHBQHJ(H5%&%51@ >@H =1110 4444 %%%% !17$I-J:ZQ
MJ%]"MZ8;2XG,KRW68'C6([46/<2#OVG.T=#R>AM'Q)J<"EYXK,JG[IT0,&,A
M@,P(R?N@87'?YCD8Q0!UE%<@_B;4HX98S'8FX@CDN'?YO+9%BCDV#G(;]X!G
MD8&['.*G/B:Z2;45ECAB$:EK4/&YWX8)U7(<Y8 J,,"0N.<T =117-^'M6NM
M5O3)<?(1 RM& 57<D\D9;:2<$[.F3CIFH;*>6#Q9;HM]-<V5[#<,LAG\Q9)%
M=3@+TC"#<O'7OR!D ZJBL^VU>*ZN%A6TOD+9^:6U=%'&>21@5@6PGT[4K^.U
MN;B2:34%LX#>W,LT<2FW24DJ6Y.=V.ARP&<4 =?17*:KXJN+/PW9ZG!%%YTM
MLUT\)5Y,JJ;FP1@ <CYR<#(X.<5/J.OWEEJ5PBQV[6T1\L*<^86,+2@]<8^7
M&,=R<C'(!TE%<BWB;4HD820VDCPJ\LQCW89%A27:O/WOGVY/L<<XJ23Q)?V@
M:*XBM99_.^RQO#N"-,\:/$.2<#YF!^@/&<4 =517/^&]>NM9DG-Q;"&/8DT)
MVE3M8L,')Y(VCYA@')&..<JSU?6(I[.66>&=&6-9P59<[[DQ@J,\$ CDY^[C
MOD ':T8'IUKG_#>O76LR3FXMA#'L2:$[2IVL6&#D\D;1\PP#DC''.:FNZM%!
M#';_ &>3,@#O<;B?WER85Q@]!D'W QQG( .RHKCXO%>H-&)WAM/+"A&1=VXR
M>2TF1S]W*8QUP2<\<Q7/B/5[-+AA%://' US(&9]FU8@^U>>"<XS^..U ':T
M5QLWB+5(I)46&*2[C)C;RU=E.'<;EBW98X4< D]3SC%:NMWKR^#IKVV=]TL"
M.C6[E20V/NL<$9SP>/PH W0 !@<"BN%FNM;T:$SJ)8XT%S<);7TYF<1)$AVL
MRL<DL'Q\QP&[XQ5V[\4WL.J7=K!%;R(J.86*.!N22*,@L?O<R<[1\I&,GL =
M80#C(!QTI:Y!_$6LPWH1XK%H0[ABJN&(CDCC;'/&?-R/3;WSP6OBF_O+N6TB
M2V#R/#]FF:)Q&%?S3D@D%QB$X8;02P^I .OHKD9O%=ZEZ4CM8)($A!>2,ED9
MS 9<J^0"O  &,D$GC&*6[UR]FN6$3QI# 95D1<Y?_14E'(/!!<_I0!UM! (P
M1D&N7B\07?V&>Z9K-(@KI!&Y=I=Z.J9(&2X+-T !Y4<[LC/3Q+JDB?:8H@TQ
M0Q-%Y;$ I-*C,(@VXG$?W021SUQR =Q16-JE\TGA.:^MI@&>V$B21,>X!R#P
M>_M6?-XCU"&[N$,-J8BTL<'W@0RRQ1@N?3,N3C& O7G@ ZFBJUA-+-:*9Y+=
MY@S([6YRA*L5XST/'(YP<C)QFN63[3)=-$E_>/I]S=I;M<&9E9G42M(8R#\B
MDB-/EP.#CU(!V5%<S;W5_/:^$[EKQ@LY'VA0H_?DV[L"3Z9&< =<>E2:9"\3
M:W<QW=W)"',,*S3M( 4!W,-QX^<LN!_<% '145QT/B6_M8+=Y8XIK9($#DEO
M-=_LS3$YZ?P8Z<[O;F34?$FJ:=;1KY5G<W1\R1S;[B@1$1]I&?D)WCDDC'S8
MYP #K:*X^_U_5F6]CA^S0#;-Y#[6+*8Y(U.[G!R)#TQC'?/#K7Q1/'$(I+<.
M\=LUZ0&))@5&[G^+S!CZ&@#KJ*PM'U>[O])O9KU4MI8"1Y@0@8\M7W;22>-W
MX@9XSBN<75-0T;3I299S/ UO/,LEP;I)HV$F6C<G< ^P\$ #' P: /0**YQ-
M9U$QFU869OC=I;+,JL81NB$N2,YX&1C//!XS@1Z7K=Q<>)Y+%S&8I+=+@2*Y
M>,_(F5B/?EMV?3'')P =/1110 4444 %%%% !1110 5$;JW%TMJ9XA<,F\1%
MQO*],XZX]ZEKF)8)?^$M0?9YBQNUN%F\HE%A%NZ8WXQG>3\N<_-G% '10W5O
M<F403Q2F)RD@1PVQAU!QT/M4,FJ:?#>I92WUJEV^-L#3*';/3"YR:Q-$<1ZS
MJ$R6EU#;ND$*J]JR>6X:3*# PRC=NW\CYNI'2GK&GW\NM7=PJR-8">T::%(-
MSR*K9)1O]DX) &< XP<4 =?YT6QW\Q-B9#MN&%QUSZ8IP(8 @@@\@CO7$:E_
M:+RWT4RZIL;S1:):QL5=BY#;^,;=FW&[L6V_-BJNI_VUI^BSVUJ-5DDC=C;N
M#*QR+>,@?*I+9D+X!(3((/0"@#T*HUN(7$16:-A*-T>&!WC&<CUXKFKA+Q+>
M>:>74O)EU!A,(MY=(!NV^6JC< 6V9*\XSVJ&V=],TSPI+<VU\5@LQ'*([225
MT;RE&&5%)!R".G6@#KB0 22 !U)J-;F!Q"5GC83#,1#@^8,9^7UXYXJ.247%
MI<"-),A67#1LI)QVR.>M<=I=]=2:5X<LK:UU**6UM-ER);&:(*PMR -SH ?F
M Z'KB@#NJ9'+'*&,<BN%8J2IS@C@CZBN$6/6[2"U$DVK26\UK:2WS?.TBL6;
MS=F!E3]W*KR!D@ \U1T8:I9ZRGEIK#VTE^Q2.:.:(^6TSY<DJ48;2"0X5L#@
MY(H ]+5E894@C)&0>XZTM>;:38ZS:VNOF!M6C>WDE^S1-OP=T\I=D#<.VS:1
MU&<=R:T88=0O=5AMH)]8316N3^\D,L<F/)8D%F <+OVX)[Y ..* .XHKE/":
M:M&UJVH27SFXTN":X^T@X6X).X $?*<8RHQT'&:ZN@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@#C;?5O&6J2WLNFVF@BTAO)[:,W,\RR
M$1R,F2%4CG;ZUK^'];DO_#:ZEJOV:UD22>.<H^(E,<KQDAFQQ\N>?6N>TCQ&
M="_M*RNM"U^1_P"T[N0/!IDDB,KS.RD,!@@@BHUM+R[^$>HPK8W<=S</>.EO
M+ PEP]S(RY0C.<$'% '8?V[H_P!FCN/[5L?(D?RTE^T)M9O[H.<$^U2R:II\
M-ZEE+?VJ7;XVP-,H=L],+G)KA-7T@Z1=PMJ6FR:U;MI\]NAM-/!"S,P/,:Y"
M[EP-W^SR167-X<UA+ZUEN[:6>&VBTI+P1VV^60IG<T<F"?E<*6"\E2>10!ZQ
M)(D,3RRNJ1HI9G8X"@=23V%,2Y@D=$2:-F=/,0*P)9>/F'J.1S[UA>-H[VZ\
M./I^GVIN9KV5+=DR0HC)R^Y@#M4J&&<=Q7*Z!<ZAH>H:4NJZ1J7^B6,^G%K:
MTEG4;9D\OYE7E=@'S<=#0!Z3%-'/&)(9$D0DC<C C(.#R/<$5237=(D>5$U6
MQ9H1F55N$)09Q\W/') Y[FL3P1>,NG-I4UCJ%O<02W#LT]I)'&P:9R-KL &X
M8'@URVAPR6FCZY;W>F:E=2/!<K]C;1VC$FZ4X43;<OG<#UX&3T6@#TB;5M-M
MCB?4+2(^;Y.))E7]Y@';R?O8(..O-)_;&F?;6LO[1L_M2YW0>>N\8&3E<YX'
M->7:?IEQI,*PZ]X<O-5>.WNK639 TPN+AW5_,#$<!U*C?T7802,5I6-I<0^)
M=<22UOXS/).88_[*+1L#  "+G;QR",9Y/'>@#N3XDT(1"4ZUIPC8E0_VI,$C
MJ,YZ\C\ZT8Y$FB26)U>-P&5E.0P/0@]Q7F%KX*FM?"]K=74$=U>W$FEAH([#
MRS!''*A;<N22V&;>QQP.0 *]/1%C1410J*,*JC  ]!0 ZBBB@ HHHH ****
M.0NUM%NM0C/BO4;9 7EFA2VMO+ ) 8 M;G=C<H/+$9&:S+ZST]A;7'_"2:E-
M<796SC86EHLBHT@B()^S90 L1@XY!'6MN7PG-/K%Q?2ZB&$BNJJ8F+*K21OC
M)?&!Y>  !UR<FI7\,S"X5X;]$1[@33JT&XN%N6G55.X;>692<'/7 H PM2\.
M6VDQZ9IQU2_D@EN1MC%K8[82<+YF#;_WF1<]?FJ>71]+\Z[\WQ3=>9.-MR6M
M;+,@#^7\_P#H_(#C'/I6YK7AJ'7)Y9;B>12+8PV^PLODN227X(W<B/@\?)[\
M4YO!WFZU)J8U%XY6W[0D> FZ/''/:3,GU./>@"AI]I80K EAXJU.#S7,$<<=
MC:QG/#XV_9@0/G#<\?-GOFH]*_LG3?$%[>)K%Y,8E0S.;.W'VAI#(,?NX%=@
M#&6RIP<>@-;.B^&'TJY^T27B2N97E(6)@,M'&G5G8G_5YR2<YJLWA&X:UE@:
M_MW01PPVX>U;Y$B,FW)#ABW[S[RE>5'J10!JZGJ\UJ;);&WANFNMQ4R7'E(%
M"[L[MK9K-77="O\ 3I)=0M(DMKD13.DL7F;]T2ON8 '[J[06/ VCGI6A<^'K
M:_73$U#R[U+)2"+F(2>:VW;N.> >_P"-9^N^$I-76Z2+4!;Q7*E6C,3,H!C"
M X#KDC&1G(YZ'B@"^S:!J]S_ &7)!:W+VH.(98-RIMPI"Y&.,J"!TR/45B7E
M[HRW.HWDMFQN)H&_?[!E(@_D95]O&>6QZ?6N@M-'^RZD+SS]V/M'R[,?ZUT;
MKGMLQ[Y[5G0^'IY($C><0K$C0;3'N+*LP=&!R,94<C'?VY )K"Z\.64%E!:+
M;Q+*66$+;[2#N"-N^7Y"6 4[L9/'7BI)D@TS%E8Z CQ(HGB$42I'YN2!VP#P
M#GL*IR^$ ^H0W0NHSMF:217A)R#.TP"_, ""Y&2#V( -;FIVUS>:9<6]G=_9
M+B1-J3[-^S/? (YQ[B@# LM9M;:7=;:/! \TV+]H64;7,YA#9"CS,N&.3CC)
MZ\5*;VVCM-5FM=%MT&GW)63SP(0P4"8R?=)QN8L..2-W>GIX;G"V:F[M42-8
MDG2"U9%=(I/,C"@NQ7N#DMG)Z5=N-&\^/4(S/A;VXCE<;.BJ(U9.O.X(1GMN
MZ''( _3XH+;3FOETR*QN+B,3W$2* V_&2&( R<D\_6JEKJFA3-;Q,EM#<2Q)
M-Y9BX3CS@"V,9'+CZ$]C6U-'YT$D><;U*Y],BL ^%$>W6"2[)0!5;;'@D"W:
M XYX^]N_#'O0!#:2^%CJ)N8A;M/=$0J&ML&,8"A>5RBMN7&<!MPQG-3OK'A^
M8CRH8KDRRI:MMMB>),J,Y'*80KGI\I':H'\*W5SJ,%]>ZC!/*AC#@6I5=J,&
M4(-_!SNR6W?>XQ@58B\-/!Y)CO%W1"W +0Y!$3R,?XNXD(]L9YZ4 $EUX=NK
M!Y;Z&Q*.VV57B#@MM,F/N\G'/3K[U8U'5;*#PK=ZG' EU:6\#R>25VAMF<J0
M1\I!7&".".E9L_@J.= &O#D6JPJ#'\N]7WK(1G_@)&>G<5<?PX)/"-WH1GC0
MW44J-*D6%4R$DD*6).,]SD^M %*\\0>4;V'5M(MFF@LFN L<XF5XR0K*24!7
M/'&,$?2K!U#PHEW=W#)9),J.\]PUMC>J, YWE</M8+G!."!FK=UX;T]]&O-.
ML+:VT];I-K-! JCZD#&:PYO MQ<RRR7&KB1GBGBWM"S.1(0<L6D(XV@84*/;
MT -1M0L[PHVF:9%??O\ RKC<AB:'<R,20RYY^5NV< ^XDL+'1KV/4;?^Q[*-
MEN#%=1>2I#D8=">.<JZL/3=5^TT_[+J.H7?F[OMCH^W;C9M0+USSTS532K*[
MBU+4;V5ECBN[AG\DIEL*D<:'=G R(V;&#]\=,8(!>_LRP^U)=?8K;[1''Y22
M^4NY4_N@XR!R>/>HH=$TFWA2&'3+..)'+JB0* &*[20,=2O&?3BK]% %)M'T
MQFG9M/M2UPH28F%?WBCH&XY' Z^E-;0]):U^RG3+(V^,>5Y"[>I;IC'4D_4U
M?HH K1Z?:1Q31""/RIFW2(5&TG '3IT I7L+.5762T@8.KJX:,'<'QN!]0<#
M/K@58HH @@LK2U$8M[:&(1IY:;$"[5SG QT&>U5(_#NB0PSPQ:/I\<5Q@S(E
ML@$F#D;@!S@\\UI44 1^1#B(>4F(CF/Y1\AP1QZ<$CZ&E2&*.-HTB148LQ4*
M "6)+''N22?7-/HH @6RM$*E;6%2I!7$8&"%VC'_  $D?0XJO_8>D_9$M?[+
ML_L\;^8D7D+M5O[P&, ^]7Z* *TNG64R.DMG;NLBNKAH@0P?!8'CD' SZX%/
MCL[6$J8K:%"J>6"J 87.=OTSVJ:B@"O9V%GI\'D65K#;0Y+>7#&$7/K@5!#H
M>DVT#00:7910O()6C2!0I<'(8@#J"!@^U7Z* *(T;2UL&L%TZT%FQW- (5V$
M]<[<8[#\JG6RM%='6VA#H0581C*D+M!'I\I(^AQ4]% !1110 4444 %%%% !
M1110 5$;JW%TMJ9XA<,F\1%QO*],XZX]ZEKF)8)?^$M0?9YBQNUN%F\HE%A%
MNZ8WXQG>3\N<_-G% '2K(C.R*ZETQN4'E<],U#)?V<5Y%9R7<"74H+1P-( [
M@=2%ZFN>\.1:E8ZCJLFJV@22YEB8R0L\H=B"./D&%4;1[ #/3-1ZJDJ^*(S#
M!<NTLMMOB>T,D,JJW^L$H'[MD!8X)P<#CYJ .L!##(((]J0R(KJA=0[9*J3R
M<=<5YQ=G6;#3[:.T:_@BAC<J=DQ.\3-OW'&,;,8+'&"2N2!4[PZE>6)N+9]6
M(AAGDM9'6192_D1D Y&2#)NP.A(('RX% 'H5(2%!)( '))[5P\S:])JVIH)+
MU 2R@1QR;0GF1A"A(VYV;ONYZMNZ"M66TO)O!UY:,D\\HDG01RDEY8EF;"Y;
MKNC  )ZY'/.: -RSO[/4(3-97<%S$&*EX9 ZY'49'>I))X87C265$:5ML:LP
M!=L$X'J< G\*P=&O7FU/4+@VKK:2&%(9!I\L#D_,"K*QRVT;?GPHYQVXS/$V
MG:SK&L2R:?;1 :;"IM7N&9-UP660LF%(8 (BYR/O./6@#M:CFGBMXS)-*D:#
M^)V"C\S7%IJVK74J1I;ZM#)+?"8*UJX\NW:WR 20%X<XVD_>'-<Y?1ZU/8V[
M>3K$\EM.&295N/F=H)5/[MUW*=P3/+(-^ 1\PH ];HKDEBU5=<-WYNH%?[6\
MD1DMY7V8P]=O3&_^+UXSVKK: "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@#C;?5O&6J2WLNFVF@BTAO)[:,W,\RR$1R,F2%4CG;Z
MUK^'];DO_#:ZEJOV:UD22>.<H^(E,<KQDAFQQ\N>?6N>TCQ&="_M*RNM"U^1
M_P"T[N0/!IDDB,KS.RD,!@@@BHUM+R[^$>HPK8W<=S</>.EO+ PEP]S(RY0C
M.<$'% '8?V[H_P!FCN/[5L?(D?RTE^T)M9O[H.<$^U2R:II\-ZEE+?VJ7;XV
MP-,H=L],+G)KA-7T@Z1=PMJ6FR:U;MI\]NAM-/!"S,P/,:Y"[EP-W^SR167-
MX<UA+ZUEN[:6>&VBTI+P1VV^60IG<T<F"?E<*6"\E2>10!ZQ)(D,3RRNJ1HI
M9G8X"@=23V%,2Y@D=$2:-F=/,0*P)9>/F'J.1S[UA>-H[VZ\./I^GVIN9KV5
M+=DR0HC)R^Y@#M4J&&<=Q7*Z!<ZAH>H:4NJZ1J7^B6,^G%K:TEG4;9D\OYE7
ME=@'S<=#0!Z3%-'/&)(9$D0DC<C C(.#R/<$5237=(D>5$U6Q9H1F55N$)09
MQ\W/') Y[FL3P1>,NG-I4UCJ%O<02W#LT]I)'&P:9R-KL &X8'@URVAPR6FC
MZY;W>F:E=2/!<K]C;1VC$FZ4X43;<OG<#UX&3T6@#TB;5M-MCB?4+2(^;Y.)
M)E7]Y@';R?O8(..O-)_;&F?;6LO[1L_M2YW0>>N\8&3E<YX'->7:?IEQI,*P
MZ]X<O-5>.WNK639 TPN+AW5_,#$<!U*C?T7802,5I6-I<0^)=<22UOXS/).8
M8_[*+1L#  "+G;QR",9Y/'>@#N3XDT(1"4ZUIPC8E0_VI,$CJ,YZ\C\ZT8Y$
MFB26)U>-P&5E.0P/0@]Q7F%KX*FM?"]K=74$=U>W$FEAH([#RS!''*A;<N22
MV&;>QQP.0 *]/1%C1410J*,*JC  ]!0 ZBBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** . 'A_3O$7Q!\2)JB3S+;16GDJEU+$%W(^[A&'7 I
M)_#FF^'?'GA4Z7'<0_:)+I90]U+(& @8CAV(ZUJ7GA?6AXCU#5M(\0PV(ODB
M62*33Q-_JP0""7'J>U);>%M<D\1:7JFK^(X;U-/,K1PQZ<(<ET*'Y@Y]<].U
M &CJ'B"6S\266CQ6D4OVA/,>62Z6,JN[;\JD?.>^!6)<?$"6$IC1L+=,?L+R
MW:HL\8?8SDX^3!*G!SD,.G2NDET6"?Q!'JTJQR/%;^3&KQ E#NSN#=CVKG#\
M/5N9X4U#4%N[&U8K:VKVPPD+/N9&.[YB<( <# 4<$T :\VJ#5O 5SJ<2-#Y^
MGR2!=V2IV'H1U^HZU@>'/ 7AV_\ #&DWES;74D\]E#+(_P#:%P-S,@). ^!R
M:ZB#1I(_"O\ 8DMX96%JUJ+@QX.-I4$C/) QGGG':L*Q\,>+=.T^VL;?QA:B
M"VB6&,'1P2%4 #GS?04 /^'UNEG#XALX3)Y%OK,T42R2,Y50D>!EB3^M/N/'
M<$>HZII\-C+-<VDT,%NH< 73R';@$\*%8$$GIBM#POH%SH%M?K>:@M_<7MX]
MW)*L'DC+*HQMW'^[Z]ZYYOADJ3V][;ZU<1ZE&[S23NID1Y&D$FX1EL(-PY Z
M@GOS0!JW_C"32O"LNKW^DRQW,<WDFS24.7.>2C <C;EN@Z&F7WCNSL/$-MID
MD!,-Q+#&MT'^4>:K%21CID =?XJIV_PX@^QPVMY?LT(NY;V:.SC-JK2N@0;=
MC950N[C)SN/-,A^&T9$:7FIM<1);+;8\G:Q58WC4[MQPP#@Y]5]^ "S/X]"1
M:(T.F>9)J=O]H$;7*QD+E053(_>/\V=HQP*TM!U[4=6U+4;6[T=;);&3RGD%
MT)<N51P,!1QM<'/X5D7W@&XO/#^FZ-_;"_9[:U%K-YMH'WXQ^\CRW[N3@X;G
MK[5TVG:7_9]]JMSYWF?;[D7&W;CR\1)'C.>?N9SQUH XS0_"VD^(=1\276J1
M7,TT>L30H5O)HPJ!4(&%<#J35G2=%LM ^)ZVFFK-';RZ,\KH]Q)*"WG(,_.Q
MQQ5J/PIXAL;_ %*;2O$\%K;WUV]V89-,$I5F !&XR#/"CM5G2/#6K6OB8ZWJ
MVNQ:A*+-K1$CLA %!=7SD.V?N_K0!=7Q+ WC%O#ODOO%KY_GY^4OD9CQZ[2&
M^AKF&^**Q^;OTN(?,RQM]O3:-LRQ9F./W0RV02#D UK+X(1?$0UX:C/]O^W&
MY)RWEF,IY?E[-V,[,#?UXZ=JRX_AS>03&:'6K9'C,OE;=-4;Q)('99OG_>KQ
MC''7- &I/XLU1$T9H/#XD_M,^6H:]5=D@5V(R 0R[4)#=\BEG\<VT,_B");1
MV.D*C E\"X!X;;QQM;*FIM.\)#3]/T*U%X&_LNZDNB5A"K(764%54'Y%!E.!
MS@*![UD-\-$$<CQZO.+JYBFCNY'5G24R.)"50OA/F&>.M &I#XUMIM?GT<6S
M"YAU!;-LOU5HG<2#CIE&7'ZUU%<H_@B%O$EMK?VPB>"^ENL"/AT>,)Y9Y[$9
M!]R,<YKJZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "H
MC=6XNEM3/$+ADWB(N-Y7IG'7'O4M<Q+!+_PEJ#[/,6-VMPLWE$HL(MW3&_&,
M[R?ESGYLXH Z""]M+J6:*WNH9I(6VRK'(&,9YX8#H>#U]*D,L:RI$TB"1P65
M"PRP&,D#OC(_,5S7APR6=U>1D7[6I*?\?-IL99F=]X!51N7[IW<CG.[GB+5(
M=3D\51:G#:;[6PDAAYW;V#Y$K( ,,N)$)YZQ>U '4S^3Y#BX*>45(??C;COG
M-.0*(U"8V8&W'3%>?7]CJ<VDR+<#4Y]RV\VTB1B)"TRL !SC'EY'0#!/4FIY
MH]5LK*6W$FK&&,O]G:,.\AE\B(Q@D#.S>9>ORY !X&* .\HKE[*VU275+@3W
M%[&EQ%=(3EMD1#QB,IV!P7(/?WP,6-&U.[/APZM?0SO)*^YH(E+F-00AV@<D
M?*7P.3DXH WHY$E0/&ZNIZ,IR*J0ZSI=Q>&S@U*SENE)!A2=6<$=1M!SQ57P
MV671X89(IHY #(5DC9,!V9AU'7'4=1WQ7.Z?X>U&XTO?<SK#';W]U=0P+:%9
M]PFD*9<L<@Y!X49! SCJ =MYL8F$7F+YA4L$SR1TSCTY%/K@'M-;1=$B6?56
M\^WB-Y*2Q=6:2+>"<?)QOXXP,],4]FU.!W@O9-<^R1&Y6U>U5WE=Q+^[W'!S
M\N-I?Y3SNS0!W*2QR%Q'(K%&VMM.=IZX/H>10DL<A<1R*Q1MK;3G:>N#Z'D5
MY]?7=^GB"_MYY=8B5DN)+6.UC<EG A"'Y <C)8<_+G.:ZKPY_:!BOCJ2,LWV
MGC*X&/+3.WU&[=S0!M4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%% !1110 UT62-D=0RL""#W%)##%;P1P0QK'%&H1$48"J!@ #TI]% !1110
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M^:QU+5H+:Y4!FC?.0",CH*N:+>27FGQ2&1IUPRF=XFA9BKE<-&P!5N.>!SG
MQ6-H?_)1/%O_ %RL?_0'H MZ9XX\-:QJ$=AI^L6]Q=2YV1)G+8!)ZCT!KH*Y
M3Q%_R/?@W_KM=_\ HAJZN@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MK>^TZ0Z<R)#+A=_EJ$C)&YBJR'RWY/W-RO@95:O:Q87%YXDN(!%Y@G6R< D
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MIX5_Z&71O_ ^+_XJI** (_\ A-/"O_0RZ-_X'Q?_ !5'_":>%?\ H9=&_P#
M^+_XJI** (_^$T\*_P#0RZ-_X'Q?_%4?\)IX5_Z&71O_  /B_P#BJDHH C_X
M33PK_P!#+HW_ ('Q?_%4?\)IX5_Z&71O_ ^+_P"*J2B@"/\ X33PK_T,NC?^
M!\7_ ,51_P )IX5_Z&71O_ ^+_XJI** (_\ A-/"O_0RZ-_X'Q?_ !5'_":>
M%?\ H9=&_P# ^+_XJI** (_^$T\*_P#0RZ-_X'Q?_%4?\)IX5_Z&71O_  /B
M_P#BJDHH C_X33PK_P!#+HW_ ('Q?_%4?\)IX5_Z&71O_ ^+_P"*J2B@"/\
MX33PK_T,NC?^!\7_ ,51_P )IX5_Z&71O_ ^+_XJI** (_\ A-/"O_0RZ-_X
M'Q?_ !5'_":>%?\ H9=&_P# ^+_XJI** (_^$T\*_P#0RZ-_X'Q?_%4?\)IX
M5_Z&71O_  /B_P#BJDHH C_X33PK_P!#+HW_ ('Q?_%4?\)IX5_Z&71O_ ^+
M_P"*J2B@"/\ X33PK_T,NC?^!\7_ ,51_P )IX5_Z&71O_ ^+_XJI** (_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%<=X1_Y$O0O^P=;_ /HM:[&N.\(_\B7H7_8.M_\ T6M &S1113$%%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2WG_ ,:K<HH @L[N.^M4N85F6-\X$\+POP<<HX##IW'O4]%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7'>$?^
M1+T+_L'6_P#Z+6NQKCO"/_(EZ%_V#K?_ -%K0!LT444Q!1110 4444 %%%%
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M&!8:M'K_ (MTAYH!'<)8WEO>6KC/ER!H@RGU'IZ@BGCP]HG_  L=[;^Q]/\
M(_LA9/*^S)MW><1NQC&<<9KH!X:T]/%)\1()$OF@,#A2-CCCDC&=W &<]!5H
M:5 ->.L;Y/M!M1:[<C9M#%LXQG.3ZTQ&-XS54L=&1%"JNL60  P /-%<KX.N
M)?#NC6?GR,VDZN) C,>+>YW,-OLK@<?[0]Z]#U32H-6CMDG>11;W,5TGED#+
M1MN .0>,CFJ:^%].'A8^'I!)+9%&3,A&_DELY QD$Y!QV% $7@?_ )$70_\
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M>>)] TZZ>UO=<TRVN(\;X9[N-'7(R,@G(X(/XT :M%8?_":>%?\ H9M&_P#
M^+_XJC_A-/"O_0S:-_X'Q?\ Q5 &Y16'_P )IX5_Z&;1O_ ^+_XJC_A-/"O_
M $,VC?\ @?%_\50!N45A_P#":>%?^AFT;_P/B_\ BJ/^$T\*_P#0S:-_X'Q?
M_%4 ;E%8?_":>%?^AFT;_P #XO\ XJC_ (33PK_T,VC?^!\7_P 50!N45A_\
M)IX5_P"AFT;_ ,#XO_BJ/^$T\*_]#-HW_@?%_P#%4 ;E%8?_  FGA7_H9M&_
M\#XO_BJ/^$T\*_\ 0S:-_P"!\7_Q5 &Y16'_ ,)IX5_Z&;1O_ ^+_P"*H_X3
M3PK_ -#-HW_@?%_\50!N45A_\)IX5_Z&;1O_  /B_P#BJ/\ A-/"O_0S:-_X
M'Q?_ !5 &Y16'_PFGA7_ *&;1O\ P/B_^*H_X33PK_T,VC?^!\7_ ,50!N45
MA_\ ":>%?^AFT;_P/B_^*H_X33PK_P!#-HW_ ('Q?_%4 ;E%8?\ PFGA7_H9
MM&_\#XO_ (JC_A-/"O\ T,VC?^!\7_Q5 &Y16'_PFGA7_H9M&_\  ^+_ .*H
M_P"$T\*_]#-HW_@?%_\ %4 ;E%8?_":>%?\ H9M&_P# ^+_XJC_A-/"O_0S:
M-_X'Q?\ Q5 &Y16'_P )IX5_Z&;1O_ ^+_XJC_A-/"O_ $,VC?\ @?%_\50!
MN45A_P#":>%?^AFT;_P/B_\ BJ/^$T\*_P#0S:-_X'Q?_%4 ;E%8?_":>%?^
MAFT;_P #XO\ XJC_ (33PK_T,VC?^!\7_P 50!N45A_\)IX5_P"AFT;_ ,#X
MO_BJ/^$T\*_]#+HW_@?%_P#%4 :]S<PV=M+<W,JQ0Q*7=V. H'4UG_\ "2:5
M]G,WVB3B7RC$8)/-W[=V/+V[\[?FZ=.>E/GO9[CPZ;VVTR2XN)+<2QV4K(K%
MB,A6).T>_/;O7.6=CJ<5W:ZQ-I5]+>K.[7:.T"M)NCV@Q@2E0JX"X+ X)/)S
MD Z:/6M-EFBABO(I)9K8W<:1G<6B&/G ';YACU[4S3]=T[5+F2VM99&FB02.
MDD#QD*20#\RCJ0?R-8VA^'[C3;[1YWMHD:.PN$NG0KQ([PE5)ZM@(P!]%^E:
MNA64]O'>75XFV\N[F21P2#A Q6-<CL$"_B3ZF@#6HHHH **** "BBB@ HHHH
M **** "BBB@ KCO"/_(EZ%_V#K?_ -%K78UQWA'_ )$O0O\ L'6__HM: -FB
MBBF(**** "LF[U&8^(K'2;8A28WNKEB,XB!VA1[LQ_)36M7.2HUO\0XYG.U+
MW3#!$W^W'(6(^I5\_P# 30!B6.OZWJT4]U9:OIJZA'(X&ARQ!7&UB-C,6#!B
M!][&,GTK6O?%#Z=XK.GSP7$D3:<EPL%M;M+)O+N&^[G@ #V_.L?4]/U;5-,D
MT_5?"D-]JFPQQZHDD21Y_ADSD.F.#@#M6]IVDWUMXI6[N"9HUTB&U:Y+#+RJ
M[%N,Y[@_C2&6'\4Z6+*RN87FN1?*6MH[>%GDD ^\=H&1COG&*CD\8:/%ID=^
M\DXCDN3:"/R'\P3 $^64QD-\IXQZ>M<Y!I.OV.EZ1:O;7QM8_M/VF'3[B..;
M>TI:,EBP^7:3]U@<D9Z4NF>'-6AAM5FL6C\OQ";XJ]R)2L)B(#%B<L02 >^>
M>G- '0R^,=+B^]'?$I&LLX6SD)ME(R/,P/E..<=<<]*JW?BM;/Q3]CVRW-I)
MIT=U"MI TSN2[@M\N?EP!^?O65J.@7]OK.L3)8:G>QW[B6!K/4C;H&V!2LJ[
MUX^7[P#<'':M?1=#N=-U^&4VZ):Q:-!:!DDW*'5V)49.[ !')H NR>*M*6QL
MKJ*26X%\";:*"%GDDQ]["@9&.^<8JI=>)DG31YM-DS'<ZF+.X66,JZ?(Y92I
MP58%1U_K61I6C:OH0TC4#ISW3V\-U;7%K%(GF*LDWF*ZY8*>@R,C@T/X<U6]
M9+N:V\A[O6A>2PB12;>$0-$"3G!;H3MSU]J +U]XT@DGTR/3?.*76H1VXGDM
MF$4R$D-L<C!_SC-:4WBS2H+N6%WG,<,HAFN5@<P129QM:3& <D ]AGG%<]#8
M:Z=-\/:,^C,HTNZMS-=^='Y;QQ\;D&[<21R00,<]:I2>%;^*"^TMM-U"[%Q<
MR/',-3:.T:.1RQ\Q X((!(("G..O- '9_P#"26#:Z^C1BYDO(V"R^7 [)%E0
MP+,!@ @\9]ZQM=\57>A^,+:VDC1M'^RK)=R8^:$M(4$F?[H. ?KFM31]-N+/
MQ!KUS+%MANI8# ^X'>JPJI[Y'(/6F3Z1)=>,9KJ>V633I=*^RN6((9C(25(S
MGH?3%,1'/XC6P\0ZG%>S(FGVME!.&"$MN=W7 QR<X4 #O5B+Q5ISK>^:MU;2
M6=N;J6*YMVC?RAG+ $<C@]*Y"/PWXHTJ;5TM&::%8K:WLYUD02O;I(S,@+'
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !7'>$?^1+T+_L'6_\ Z+6NQKCO"/\ R)>A?]@ZW_\ 1:T
M;-%%%,04444 %136\-PT32QJYB?S(R1RK8(R/P)'XU+10 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MU7744 <C_P )#:?\^>L_^":[_P#C5'_"0VG_ #YZS_X)KO\ ^-5UU% '(_\
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MXG?^\RJ 3^E7* ,/[5XJ_P"@-HW_ (-I?_D:C[5XJ_Z VC?^#:7_ .1JW**
M,/[5XJ_Z VC?^#:7_P"1J/M7BK_H#:-_X-I?_D:MRB@##^U>*O\ H#:-_P"#
M:7_Y&H^U>*O^@-HW_@VE_P#D:MRB@##^U>*O^@-HW_@VE_\ D:C[5XJ_Z VC
M?^#:7_Y&K<HH P_M7BK_ * VC?\ @VE_^1J/M7BK_H#:-_X-I?\ Y&K<HH P
M_M7BK_H#:-_X-I?_ )&H^U>*O^@-HW_@VE_^1JW** &0F5H(S.B),5!D2-RZ
MJV.0&(!(SWP/H*?110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !16=KNM6?AW1;G5;YF%O;J"0@RS$G 4#U)('XUD:3XJO[O58[#5?#=]I9GB
M::"9W66,J.H<K]QO8T =117!GXDNUE)K$/AR_E\.QN5;4ED3)4':7$6=Q7/>
MM"R\?:9>^,+[PZJE9X($N()=P*W"M&LAV^A 8?49/:@#K**\\D^)=\-+TS4H
MO"MQ)9ZE)'#;2"\B&Z5R0$P>1R#R0!5Z;QMJ\>L0:/%X2N)=3>R^VRVXOH1Y
M2>8R?>)VGH#P?XO8T =K17&)\1K!O#0U0V%W]J:].GKIX ,K7(.-@.<>^?Z\
M4#Q\]F][;:WH=SIE]!92WT4+3)(MPD:DL%=>-W'2@#LZ*IZ3J"ZMHUCJ21F-
M+NWCG5&.2H=0V#^=9/C+Q?:^#-,M=0O+>2:":[2V;RSR@*LQ;WP%/% '145Q
MFO\ Q$L]#>\VVC7<=O8P7JR1R "1991&,<>^<U=\2>,8?#E^EK)9O.7L;F\W
M*X'$*[BOXT =-17GES\6K"W\%VGB'^SIW>XN7MS9B0;T*ABQ)QT  /\ P(5K
M:GXRO+;Q##HNF:!-J5S)8+?MLN8XMJ%RO\> >0/SH ZVBN#'Q)-U'HZ:;H-U
M=WFI/<Q"U:=(VC>#&\%B=IZDYSVJYJ/C+4])TFTN;[PQ/%>7FH)8P6?VR)BY
M=25;>"5 R",&@#L**YK0O%DFJ:Y<Z)J&D7&EZE! MQY4DJ2J\9.,AD)'7M72
MT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%<_X@\66WA>2.75K:XCTZ0A1?1+Y
MB1MZ.!\R^Q (/UXH Z"BJ&E:WI>N6_GZ7J%O=Q]S#(&*_4=0?K5^@ HHKE=%
MG\5:OH6GZG_:FC1?;+:.X\O^RY6V;U#8S]H&<9ZXH L>.-!N/$GA2ZT^SD1+
MO<DL!?[I=&# 'V.,?C533[SQ7K6I+#J.B1:1I8MW2Y\RX6:2:1A@>64/R@=<
MGK6C]E\5?]!G1O\ P4R__)-'V7Q5_P!!G1O_  4R_P#R30!Q$6E>,;/P5+X(
MCT.&561[5-5^U((O)8GYBGW]P!(QCWIDWPYU'SM<DM1Y5U;+8OH]V77,C0VX
MC8$9R V-I!XZ'D"NZ^R^*O\ H,Z-_P""F7_Y)H^R^*O^@SHW_@IE_P#DF@#D
M(_"FM+X"\&Z8;+_3-.U2WN+J/S4_=QJ[ECG.#@$< DU<\1>!W\2^/Y+N[CGC
MT[^Q?L\5U!<;&CN/-)' 8$X4YY!7\:Z/[+XJ_P"@SHW_ (*9?_DFC[+XJ_Z#
M.C?^"F7_ .2: .)@\)^(8?">DPQZ7:Q:KH&I>?$BR*L>H(,@MD$[68'^+'(]
M^)=9T7Q)XPO)]0N]&_LQ;/2[RWM+9[E)))YIHRG)4[57ZG_ZW8_9?%7_ $&=
M&_\ !3+_ /)-'V7Q5_T&=&_\%,O_ ,DT 9?@^Z\0VMAI6CZCX7FLX;6T2![L
MWL+KE$ SM5B>2/UJ?QMHESKB:#%!:K<16^KPSW2LR@"$*X8D$\_>' R>>E7?
MLOBK_H,Z-_X*9?\ Y)H^R^*O^@SHW_@IE_\ DF@#S2X^&>OJ?$>FP%9;![*.
M'2YI95^ZDXF$1YSQ\RY(QTK6UC2/%'BZ]GO;G0#IIM]'N[6*)[J.1IYI4V@
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M;_P B_\ B:/^$+\*_P#0LZ-_X 1?_$T ;E%,AABMH(X((DBAB4)''&H544#
M  X  [4^@ HHHH **** "BBB@#YM^U_&#^[K_P#WY/\ A1]K^,']W7_^_)_P
MKZ2HH ^;?M?Q@_NZ_P#]^3_A1]K^,']W7_\ OR?\*^DJ* /FW[7\8/[NO_\
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M_ ^+_P"*H_X33PK_ -#+HW_@?%_\50!N45A_\)IX5_Z&71O_  /B_P#BJ/\
MA-/"O_0RZ-_X'Q?_ !5 &Y16'_PFGA7_ *&71O\ P/B_^*H_X33PK_T,NC?^
M!\7_ ,50!N45A_\ ":>%?^AET;_P/B_^*H_X33PK_P!#+HW_ ('Q?_%4 ;E%
M8?\ PFGA7_H9=&_\#XO_ (JC_A-/"O\ T,NC?^!\7_Q5 &Y16'_PFGA7_H9=
M&_\  ^+_ .*H_P"$T\*_]#+HW_@?%_\ %4 ;E%8?_":>%?\ H9=&_P# ^+_X
MJC_A-/"O_0RZ-_X'Q?\ Q5 !=?\ (]:3_P!@R]_]&VM;E<K!K6E:OXZT[^S-
M3L[WRM,O/,^S3K)LS+;8SM)QG!_(UU5 !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%>4WO@_Q')'IC6MOY<T45U;RGSD^
M5)YG!/7G"/O'NH'7BI?!_P /=2L(C=W31Z?>PEQ $1#(V8!&-TBL24!).WU4
M&@#U&BO)I/!6IWB:?!!H2:='&D$>H>:T4BW<@E0F4J&/F !7.6PQWXQ6I9>!
MLVNAQ:AHMK-+::E,;IW6)D,!28C8.T>]D(CZJ>W&: /1:*\NN?#7BFX.N3RV
M:.-=@D26%+D;HBI_<YR=O"97Y2>2#4MMX'OY]<BFUK3K;4%BU-<W4PC=IK5;
M5T5F!YSO\O(_O#.,<T >F45S^HZ9<ZGIEK;M$6*WK.XOD24! 7P2H(!'*X&<
M@8SR#6>=(UO33';Z;+(+=9ERX5&+ 1Q*"067"_*X(&>V : .PHKCK>/Q3]JB
M>5;CROM*,T9>+[IV[@6#=!ST'.3A1P0]8/%']D3B6:8W1F4@(D8.,'=M/F?=
M)QCE2/3M0!UU%<)KMSK6GVTUPYE@::W.P021>8TXA7:,G 8!MPP!DG& 1D5M
M:=;Z]#;7?GS,\[VBF+SF4JL^9,CY>V/+]OQS0!T-8J^&;(KB1I_E>0QO#/)"
MRH[;RA*,-R[B<9Z#'IDY&FP>*DOK8W,EP]H) 9Q)Y2L5PN-N';.&W%N1P< '
M@"".V\4S7UTMRFH+;RQ*(O+GA 20NV_<<Y(V[<84=\ 'F@#H!X6T<*R+:LL3
M+CR5F=8UX"Y5 <*V .0 >_6A_#&DR+AX9FR")";F0F4$Y(D.[YQQT;(QQTXK
M#T^'5[37+6U^>*.ZBA:<.ZL\8B1,G@G[QRA/N,58UZ/Q-+JP.F?:$M00I9#&
MP*^6V2 S*0=^WCKZ,* -JXT#3+M&2>VWAI6F/SL/G9=I88/!P?PZCFD'A_31
M92VGE2F.683LQN)#)Y@QA@^[<#P.AK*N)M9BTS2HO,:*^N)&MI$9U9@AS^]&
M."R@!L<]2"3U+;8>)(7666.YE"M&9XR\7[QLN',?(PF"APQ!P/7.0#0N?#%A
M-8/;QH1(2SK-,[RMO8 %F);+'  ZY&!@C Q%IWA.RM;:[2Z)NI;S>)W+R#<K
M8&T9=F_A')8GW[57TVU\0CPQ)]LFG&K2E!@O&?+ (SMQ\O3=ZUFW%MXP^V)'
M;O="%;ET\PRQ'=!E]IY(P1\G4$\=1R* -]?"FCHRL()@4QY?^DR_NP'#@+\W
MRC<H/'TZ<4^+PSI,-VERMO)YJ,73=/(0A+;SM4M@#=S@#%8L]GXHBC*P7-PZ
M-*X<LT;.(Q*X3;RO)39GD'&>]7;Z/7_[(L%C>XDN1;L)C 8T?S]HV%LG;MSN
MR 3SCJ,T :UEH]EI\S2VR2*6! 5IG94!.2%4DA1GL .WI26^C6%JDR0P;5GC
M\N0;V.Y<L<<GU=OSK/AL]7.CV44US/\ :GG#7;JZY5,'(4],=.G-93VWBN>\
MTE'>ZBB A6]D26+!7RCO/7@[\= ?4$#B@#?F\.:7-(DAAD25(UC62*>2-PJ@
M@ ,K XPQ^O?H*)_#FESMN:W=7"A=\4SHVT+MQE2#C'&._P"%<[+:>,5LH$2Y
MG+F)6E8")W$QC&0!N4;0^>,XZ<$9K6T===BM=0%\LLDP7-NSNB[VPW  +!1]
MWD\<_=&"" 6&\.6LEPI<L+>*"*&WCC9T>+83R) V<X..W&<YS4O_  CNE>4T
M0M $:$P$"1ON% A'7^Z ,]:Y>P/BD:L]O<&]X:.2'<T6Q4RF_?\ ,21Q(..?
M8?+AB_\ "6W=O'-:2WB1/&2S.(F8RY;!4;EPF-O!/8<'YJ .JO-!MIX;OR0L
M<]P) 7DW2*I=0K'9N Y"CCCGGN:FLM+BL9P\;'8EM';1(1]Q$SW[DY'Y"N>D
MMO%$_B)!ON(=.9V$S(\>-H*[2O.1D;N-N1GDG@U8UF'Q#)J#BP:X6,RIL>-X
MA&L6WYP0W._=SG'3'N* .HHKEM5TW5;KPU]E'GS7*7;E0)5#/%YC!,G(!&TK
MG//'K6:^G>*;2_)MC<2P1JBQDO%N;Y%RI;((&_?V8?[)&, '=T5S.O>''US6
M%9Q"MM]C:(RO"LCHQ8?<R?E;'.[!JM):^)(;>$![V:0HK'9+$-K[_G#9(R-F
M N,\Y[X- '7T5Q]E)XBBO;&SOIBUQ-N>ZVLA"HA5E9 ,8# ^6<XYR1ZU:U_1
M;G6+J!(T:*VNX3%>MN :/8=\70\D,6'&>M '345QMGI&N)<1ZBZO#>2F.2X2
M.1"I)GRRGUVQ<<>G'.*A2S\8R&X\VZN%/D2,H3RE4S8;9M.XDKG;U"]!D<M0
M!W%%<UJ5OK<VJW*1++)92VSH%W(J*3&<=\DEL=AC.=Q'%9-W9^+K=3!8-=.D
M;1&%VEB.1B/S <D8_P"6F,YZ\ <&@#NZ*XNWL_%D7VM)+NX;]VP1MD;9.Y=N
M#O'.-V>%[\_=-3ZDGB9_#MLEG'.NH!)=Q$L9(89\O=D@'/!ZG'?=0!UM%<A+
M:^*/[;$R7$RVC3@A (V55$G((W# *?[QZ]\5U] !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 <7'?>)+/3E3RWF)6)O-D@?=$&:0,#@,6("Q]CC=D\=(+>_
M\126]LERES"\EU#(WEVTK;\SKO7)YC0)S\V,@GT(K:3Q4DODB.PG9KCRVMQO
M4;T<MACS\OW22#ZCOD"?6O$4>C,X:TEG6)(WE*,HVAWV+U//.>G0#Z"@"#5]
M0O;;64@MMXB,2&61(VE,:EF^8(.O(49QQG/05D1:CXHFTYG%O)#,0I*FV<EB
MT@4XW$[<*2V.V/0'.G?>*;+3H[J\%B\DD?$OEA=[(L2RY]2 ),>@)Y(!S4%_
MXQEBTTW-MI[@CRG8RLI"QO*(PV PR3AN,\8&>N* (?#.IZP;E+*^6<KM-TTU
MQ&P?R\%=F#R#NPPXZ9%;6M:A>1Z3!<Z5'YGG.F7*,VR,C.[:%)]!T.,Y/2LZ
MR\56]S+(8-,<W4OD@,-JB8/Y@4[NA V-T)QGC)R*UFUF,>'XM76"1HY8HY%B
MR WSXP.N,\^M ',0:_XFDO+=+BTDB@D0_:)4L)3Y)&S!52.0V6ZY/<@;3G5T
M&?6&O1]M,KV\XF?]Y;M&8R&CV]2< [G^7VXZ'-<^-?*GNHY-.N))(I700P(7
M8",#>21G/)&.G49QS4]WXRAMK]K1+"YF.&*/&-RG:5#9QG&-X]2,'(6@"M+>
M:]9Z@5'GM93W,X>3[*\K6Z!EV%<=0<D=,8Y_A.<U]3\4?V4K&VNUNFFCE2-;
M:0^:?.&Y"?\ EF@4=^S'K@UTND^)[?5[XP6]K<B(JQ2X*9C8K@$!AQU/&"<X
M/MFF/&49ND4V<J0&V%WO.T[H22-W#?+@*S$$'CWH -'O]?O);9;I4CC,K&20
M6TBDJ$0[3O5=OS%AG!X&.H)J&YO->N-<^QQB:* 7(*S1V[[509'S$X!R#_M#
MC/'W:T-'\4P:U?/!!:72Q9D\NX:,^7)L8 D'ISG(^AZ=Z5IXLF?39I+FW1;H
M32QHJCY1B.21<\Y/$>">.3T% $$FN>(4AMI#9R"4K"TL*V4C H8]TCY[,&RH
M3KQT.14AU/6)+D7 ANHK=V:-F-K(WEH)I0K"/&2Q41]NC9Z5?77;H^';O4?(
MB>:&1D6,$J" P'/YUF1>-I1?/#+9F1#%$81"A+N[[LY )P %/KTH F:_UJR\
M-:'(D4TMPUNANE:W=Y2VQ<@C'!)SD,5_WAWSYM?UZ!K2WCC9)Y)EA$3VLDF5
M,;.6+9X8$?=)S@9[Y'3S:XD>C6VHK;39N-FR!QMDRPS@CKD<\ $\5G:5XAT_
M5Y6OTTMXIA:>?&\D:B5X\ D+GJ.0."1GK@\4 :-DUU?Z7=6MV\T5SNFA\Y8V
MB.W>ZHZGUV@'@^_&17,*WB.Y032K?1&]C:1XUW#[,848;1Z>8VPX[C-;B^++
M?[ ]U);2H8XYI'C) 9?+4.00<$$AAP0#^&#5:X\72QB&XCTYVM7@DN23(F]H
ME!.X#=P< \$=QSUP 5;G4_$]G:"*.$2NCX\][:0[OW*, 54,3EV<9_V<9!YK
M3TN\UJ2"Z:\C D^RK-$#;LH60F0%.N6P%0XZ_-[C%S7=3FTO35NK>-)',J)M
M?H0QQ65>^(M2L=&TFX-K#-<7:!I0ORJIP#A03[XY- %*#6M<+(UQ#/$I98GG
M^RR-@<G*)@%CG ^Z"!DD8&2P:SXBNK#3KZ*%I%D$+,D=LX#;K=G+<'IO"C'3
MG!R<5I7'B2SNFBL;G29[C>Y6>/R?-6/$QB!. 01N4GMP,]>*DUGQ3!HDDT#V
MTB)"@(DV?*W )51D9(7/ .1UQCF@#.U+7-<TW3KEYCM:)))$F%FS;BL,;A=H
M/W=S."W0;0"0>:T_%6I:KI^G*^E6[RW)21P%MVD!95R%.W)&3[<^J]:K7WB*
MW>*07NB-+):L[M&YC?9LB64L"3C.UP![^W-36WB^.\ \C3;P^8Z+"738L@;=
M@@G _A)/7@CZ  2WU367\+7-U]E9M0C;:BO"ZAA\N6"X#, "?X03MQCUJG6/
M$:06C)9><S"7S2MNX PQ$7W@IRV #QP/FX%:4OB-;?Q VF20.5WQIYVW:JE@
M, L3@DD].">V34TVO10Z_!I1@D9I6\OS5(*JVQGP<=/E4]<'D<8YH P+;6O$
MDB2":$JP ,!2PE;SF(&5;<%V8R>??OM(+[K6-;F,5S;0721)<>7M-E)\R&%"
M6*D G:QDQTR5 ZUKR>(L7(@BL99/,G>WA;S$4.Z?>R"<@##<X[>XS4/C.-F!
MATVXDC\@SLQ=%P @<C&>2 ?IG'..0 2Z?J6I/>1F]W1V@W*KM:LIF)D*)G/W
M>,'I[\ U'JFK:U;Z\(+&R>: *P(:!@K'RG8$.,C[X5<DCKC!ZU))XK3[5!##
M83RBXF>&!]RJ'9" V03D $_C@^V:4WC;.H):P6;!<JS2OA@48L%*X(#9*'H2
M.G)Y% %:SOO$DE[?>5).T!N(-CSV$B95_*1]JL1@+EV^HR>^73ZAXE:SNS';
MRK,L$CY^SN?,9(_E"C/R[F]/PYYJ]+XSCC 8:;<,K6S7B$.GS0@$[NO!PIX]
MQ[XW=1OET_3Y+LQM*$QA%(!8D@#KQWH Y==2UZ2^BADCN(X5GB):.U<X3< 5
M8D=\\XW# ))7I5.^U?Q446-(KA2_^L,=B^8UV,V5P#GE57D@Y)&#P:T[GQI]
MFOO(.G7$I$3LT4*%W5HW97Y'!' Q]><<X4>.;8W#1BPN=BJLAEXV"-BP#%N@
M^X><[?\ :SQ0 2ZEKTFKQVL*/'&\[I(6LF*Q1@C8P?H2PR?8\<8.=J_OW71I
M[NQ6221<J@6$L<AMI^7@G!S^7?I52+Q+%-J%W;)9796W$O[[RSL<QD!E!/&<
MG YYP>G&:Z^*A*;%(K-_.N97A$#8#!U4-\Q)!3Y3G!&?;ID P])U/Q,7OIKI
M;QF#2K&CV<FP*)4 <#:I;"$L!QNY '6M2TOO$5T[Y+1Q?:A!&[63*3'\W[P@
MGC@ >F3^%7K#Q1'?SV:)93)'=!,2,R_*SQ&4 @'T4@D=\=>U*?Q9-:'6O/MT
M_P!#D58 HZAF5 6.>?F;/&.* ,ZW\2>)XHA>7VGJL<:!IK<02*YR44;21MR=
MQ;&XGC&,@UUAEN&TZ:W,H.HQVP+F-"!O*G!7/N#Q6?#K'VK3HI;FSCGG>\,,
M$:@ ;UR0V6Z8 )S[<4V\\61VB[_L$[KOCB8JZ9$KH'"_>P>".0<9/<9( ,V'
M5]?M=$%S+#<3.T,JQI]B<OO5,Q[@.?F.>H [40ZIXBDNU9[>8F(RD(MLZ1RM
MY;%5)(! RH[8!(^9LUIGQ21>16ATV;SYY7AA'F)AG3!<$YX !Z]\'VS5N/'-
MO#;M<+I]P\20^<V&7=C9O("@DG ZGITYQS0!2M-;\527D$<MK%Y)D0;S;3KO
M!*[@<Q_+@%L$X'3D[6KN*YD>+MFJS6,FGW#LEQY>^!"X5"P56; XY)/T!^AZ
M:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M '[P((7=QD'@D8(R+NBV>G3:"]E%="^@,LAF<.W+.WF'DDM_&",DG!!R<YH
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M.V* /&[+QAK,.DWEI?:A>K>3S6=[%)-')"8U>9%FA7>!E5R!QQAC7;^(;_\
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M0>9_;'D #RHRQ*$'=DDD^N:ZCPIK,\VB:J\US]IO(K^\6&*23+$+(VU0.N,
M"MJY\,Z!>7C7EUH>FSW3$%II;2-G)'0EB,]A3HO#FA07_P!OBT73H[W>7^T)
M:H)-QZG=C.3D\^] 'G%KJMW!HOAK6X/$=W>:EJES''=VCSAHRK@^8%C'W/+]
M1C&WGK4W@0^)[J#3=3EEU3[!)82-=2WUXDJ3N0-AB4$LN#D\XXKT2'0='MKZ
M2^@TJRBNY<[YTMU#MGKE@,G-6X+6WM;5+6W@BAMT78D4:!45?0 < 4 >=?#:
M74KV'3[V_GOI?-MMYDFU?S5=C_TQQD?GQ5#17\47^IR7EK-JGD0ZI=+<3SWB
M-;&!6<;%BR6W#Y0#@8Q7HMEX:T'3;E;FQT33;6X4$++!:HC '@X(&:O06EM;
M1/%;V\,4;LSLD:!0S,<L2!U)/)/>@#R#PAJ^O-?:$TESJ7F7%A-=.M]>>='?
M@(<+$N#M8-@D9! ]:MVM]=R:+X:U.#Q-?7.I:S<QV]W;_: 5"R B39&/]68^
MH(QC;SUKT]=*TY8[6-;"U"6AS;*(5Q"<8R@Q\O'I45OH6D6NH/J%OI=E#>R9
MWW$<"K(V>N6 SS0!Y7-XDUS4-#NK<7US!=^'=+N1J,D;E3)<@M%'D]^$:3ZD
M5-?ZG?1VWBC51XAOH+S39(/L=O\ :,QN3#&VTQGAMQ)'XUZF=*TYENU-A:D7
MG_'R#"O[_C'S\?-QQS4!\.Z(;\7YT;3S> @BX^RIY@(& =V,\ #\J //X[G5
MM0\;:NCS7_V>"[A4(FK_ &=(08D8CRR/FY)/O5>VU.]MH8M537KV2^?Q ]G]
MADN-\<D)G*%0AZ87G(Z8KT6Y\,Z!>7C7EUH>FSW3$%II;2-G)'0EB,]A3X?#
MVB6UZ][!H^GQ73EBTZ6R*[$]<L!DYR<T <W\2?&D?A;P@]Q:3HU[>@Q691@>
M2.7'LH.?J163\&_&;>(- ;2KZ<R:CIXX9VRTL1Z-ZD@\'_@/K7:W?A;0+^.W
MCNM&L98[9/+A1H%Q&OHHQP/:ET[PQH6D77VK3M)L[6?:4\R*(*V#U&?P% &M
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445
MYKI\6M^,4UO5H_$UYI36E]-;6<$.T01K'CF52/GSU.3Q^E 'I5%<#?R:KKWC
M>/PT=9N+"VM--2ZN);#$<EQ*S;>"<[5'7'O^7*:UX@\564=SH%AJDMQJ%AKM
MM;V]T^ T\<L4CK')C@\J ?6@#VFBO+])UN;Q[XG>"#5]2TVV_LJ*:2&TE"/#
M.)65U.Y3].G( K#CO-:@^#=WXJ/B/5Y-0D_=!7F!2/%TJ;E&W(;:,=?XC0![
M917E7AG6;X^,9(=/U#7KS3K2UD?4H=:5%DB?&8]@P&!/TZ5% _B"]^'\OCG_
M (2>]BOQ%)=I:)M^R*BL?W93'/ QG.<T >M45PW@G7[W7/%'B)KB5_LRV^G3
M06Y/$/FP;V ^IKN: "BO!M+\>Z\G@7[+J=],NH3O#<V%YN^::$SA)$SZ@@\>
MA]!771:YJA\"^/+LWTWVBRU.]BMI-W,2IMVA?0#- 'I=%>*6GC?5='\975UJ
M.H33:2MC&ABD;Y5F-FLP(]V*./JU1VGB#Q)!\)_$]W>:M=-J=K=P*DV[YXPQ
MA)4>GWB* /;Z*\9?7M4TV\U.VAU'Q%!"VBW<\:Z]&J2-,B$@PE0.5')K7\"3
MW=[<:5<W-SXT>22W$LC7JI]B=C'D\@9*Y.5_"@#T^BO M#\2:W=Z7HK6>M>(
MI?$5[-\D-T%^Q3(LA#8+ 9 4<X)YS7OM !1110 4444 %%%% !1110 4444
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M595YXGT#3KI[6]US3+:X3&^&>[C1UR,C()R."#^-:M8?A/\ Y ]Q_P!A._\
M_2N:@ _X33PK_P!#+HW_ ('Q?_%5Q^HZ;X#U"[O9$\;16=M?OYE[9VNK1)#.
MW<D<D9[X(S7IE% 'GVJKX%U"XL[JU\766EWEG#]GAN+#4X481=HSDD%1Z8J*
MVL_A];6UI&OBNR>6WU%-3>YDU.%I;B=00#(QZC#'@8_G7HU% '"Z=+X"TKQ1
MJ/B"T\2Z6EUJ"!9H_P"T(?+SD$L!G()(YYJH;;P"? [>$O\ A+;+[ S;O,_M
M*#S<^;YO7I][CIT_.O1:* .*N;[P1<>)[7Q"OBG38+Z")H'\G4(0L\9_AD!S
MD \C&/Y5A/HOP_99+5/&R1Z1)+YKZ4FL1"W)SDC'W@N>< UZE10!YM<VG@R7
M6KW5+/X@?V;+>")98['5;=(\1H$4 $$\ >O<UU-OXN\+6]K%"?%6E2F- GF2
MZA$7? QECGJ>]=!10!YE/I'PXN?#>E:)+XHL3%I<OFVT_P#:,'F@EBQ!/3!)
MY&.P]*;J&E> [^[OW'CB.VM-0E\Z\L;?5H5AF?N2#DC..<'FO3Z* /,]5TCX
M<:PM^MQXGL%2\FMYF2/48 (S"GEJ%] 5)!SGKVJQ>VW@&^TG6M.D\6620ZO<
MK<SE-1@#(RE2 G8#Y!U![UZ)10!YBVF>!KB6274?'G]HRM;36T;W>KP,8%E4
MHY0  !B#C)!JUHP\*Z+-:&'XDRS6]JH1+6?5[<Q%0,!2 H. /?M7HE% 'F_V
M#X?#PG8>'AXLLEBL)?.M;I=2@$\3[R^X-TZDCIT]^:ZM?&7A95 /B?1V(&-Q
MOHLG\C6[10!E6?B?0-1NDM;+7-,N;A\[(8;N-W; R< ')X!/X5JUAZ[_ ,AC
MPQ_V$W_])+BMR@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MDF=LPRQ@!3"HZR YSVKHZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MN" ?<T 344TNBL%9E!;H">M-AN(;A"\$T<J@X)1@PSZ<4 244T.I9E# LO4
M\BHY+NVBC622XB2-C@,S@ GTS0!-132ZAE4L-S<@9Y--:>%5+-+& "026'!
MR10!)135DC>(2JZM&1D,#D$>N:Q-#\5Z=XBU/4K33F:6.Q$1-P/N2E]_W#W
MV'GH>U &[16#:>+=-U#Q5+H%FQGFAMWFEF3F-2KJI3/=ANYQT^M;CR)$C/(Z
MHBC)9C@ 4 .HK#/B1)+K4K>TM6N7L3;Y*2*!()>X)..!D^^.*V)+B"*1(Y)H
MT=\[59@"WT% $E%8VK^([?14N+B[A?['# DOGHZG>68J$"YSGH<].?:MA65U
M#*P92,@@Y!H 6BHY+B"%T26:-'D.$5F +'V]:)+B"%T26:-'D.$5F +'V]:
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M%X/6V?QA+-IVH:1/"+#;.FC69BMR=PV%V\QEW@;L#K@G->B4BJJC"J .O H
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M_#L=SXC'BN*-+R4)]C2_ :8VWDIL6+.27#[\[23NKU$JI() )'0D=*"JD@D
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M(9O#?B8VU]97%E-<V"L-,MFAM1)YZ!C&=[ L05W;?0=Z]BZTBJ%4!0 !T H
MX^QTVRTGXEF#3K2"TAET;=)' @1699@%) XR 2,T[QK<?\(_/I_BQ8V=+'?;
MW:H.7AD''Y2",_B:Z^B@#RG2]/TO1-:8>-?LF9]/2>*2^"^29Y'D>Y W<;\L
M@]=H':F:9#:6\_@JZU2%([;[5>QVCWB?,L1)-LI+<@XQM!]J]895888 CKR*
M4@'J,T >526D%]:VEM<QK+!)XTN \;<AA^^X([@]QWI=7L8[.[\56=E:^7IB
MW.FS7EM:I@& G]]A5]57G'4 UZI5/5-/&J:?):&YN+8L5*S6S[71@000?J.A
MR#T- '$^'Y?#\_Q.>3P\EN+<Z.WF/:H%B9O-3I@8) QG'L.U6/&C:.GC3PL^
MNB#[$L5X=UP!Y2MB+:7SP!]>,XKH=*\/FQU&;4KO4;G4+^2(0>=,J*$C!SM5
M44 9)R3U-;! 8$$ @]0: /+H;<1^']1US28S]@TK6#?Z:J#"M;A%$XC_ -AL
MS8QQZ5UO@R-KC3KG7)E(FUBX:Z&1R(>%A'_?M5/U8UI:YI!UO338?;KBT@D.
MV?[/MS+&00R9(. <]1@^]:$420Q)%$H2-%"JHZ #H* //?&W_(PZG_V*5_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M51_PFGA7_H9=&_\  ^+_ .*K<HH P_\ A-/"O_0RZ-_X'Q?_ !5'_":>%?\
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M-/\ D1?$/_8,N?\ T4U;E8?C3_D1?$/_ &#+G_T4U &Y1110 4444 8?@O\
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MHH **** "BBB@ K@O$GQ=\,^'+J>RWSWM["Q22&WCX1AU!9L#\LUT?B[6_\
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M44 8?@O_ )$7P]_V#+;_ -%+6Y6'X+_Y$7P]_P!@RV_]%+6Y0 4444 %%%%
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M/^1%\0_]@RY_]%-0!N4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(OB'_L&7/_HIJ -RBBB@ HHHH P_!?\ R(OA[_L&6W_HI:W*P_!?_(B^'O\
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M[U;O7+548W$^[.2Z_>;!VY'7 'I55=,U&TMH=0M-(U*+0K;Q'!=VMD87,T4
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M(LG.?+&96_X$Y_2N?\5^&];NO%FJW-A8W6V^OTL))%A;#6\T$8=\X^ZI3D]
M: /5/#_B"Q\2Z+%JU@9!:R%@IE7:?E)!R/J*76->MM$1I+J"Z:);>6X>6*(L
MB+&,D$] 3G@=\&O-I-,NH/ ^FZ=<:%-)"=7N6D$EI+,($WR%&,*%2X.1C/R\
M@^E9W]BZTWA'1H'TS4#-#I&K0.C6[[D+'$:D8[C&T=^V: /:;:X2[M8;F//E
MRHLBY'.",BI:YW1[>VBU'3S)IMVFHKI$<;7;1L(@@(S$3G&_=SC&<5T5 !6'
MXT_Y$7Q#_P!@RY_]%-6Y6'XT_P"1%\0_]@RY_P#134 ;E%%% !1110 4444
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MLEO:Q A(TZ#)R?U-6Z** "BBB@ HHHH *P_&G_(B^(?^P9<_^BFK<K#\:?\
M(B^(?^P9<_\ HIJ -RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MNM% 'A"S:G;VOAU;/3_&$5SH7VA8)Y/#@DW)*  I4S8^501GOQTQ4NJ3W/B
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M+;_T4M;E<OH-^NE?"S3-1>,R+::)%.4!P6"0!L9_"M.^UM+*VTR9H687UQ%
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M>:SIFFO%'?ZC:6LDHS&L\ZH6^F3S0!>HK.;Q!HJW45J=7L!<2L%CB^T)N8D
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M &#+G_T4U &Y1110 4444 %%%% !1110 4444 %%%% !1110 4444 8?@O\
MY$7P]_V#+;_T4M4?&T4T[^'([>Y-M,VKH%E"!BO[F;G!X-7O!?\ R(OA[_L&
M6W_HI:W* /+]?DO-%\23M?ZK<W32Z?#&)D*6GEAKD##2*#L3U;&0#QSBH]/U
MJYL'U'4A?O+I^E7L+RQ0WLMW&8)(]K[7?!<*V']BK 5ZH0""",@]J3@#T H
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MUSQ&=.O7O+7SH DK3F;_ )9\@.22P!SW/IVKKI)8H@#+(B D*-S 9). /Q)
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MZ1JV@OHET-,>[,-M>0RV]M+&# 9IDE0 NR@JH7;QZ#C%==<ZMIUE'-)=7]K
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M^L2S(UG#"9]Z,"'7&1M.<$G@#GDD5F1^--%-\8)[^TMXFMH+B*>6Y0++YAD
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MS_;=Q=NZLN4C>67$F<\G:R\=>U.T73-234O#:3:&;2/2;.2VFN#+&58E%4;
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MK<328;>ZJI D?<%&P[L9''//=2W$,!B$LJ(97\N,,V-[8)P/4X!/X&GD XR
M<<B@#RK3I]1>_M9YXO\ B:-K&^2,C'[[^R 2,?[U.6XN+VPTV/0=;OKC6+BS
MDDU",W;N8Y%CWC>A.(CYH5-H"Y#,,$"O5*0  D@#)Z^] 'F%AKNJ:OK-OY=S
M=I9^(IDFM &8?9X;=SYH']T.BI_WW72^-8[;S_#EQ=SO##%JJAI!<-$J@Q2
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MC=<PK]F7=/F0#RAC.6_NC'//:@#@;/0]9L[?3YYM(FNFM]<GOGA>:$R&)XI
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M;F3<-P\S*!B3D<9Y.9_!FH7USJVD[M4BFGFMW;4(/MTUQ(6V]7B9-L#!^,#
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M(QNW9WX[=#]:[3[1#]I^S>='Y^SS/*W#=MSC=CKC/&:I#Q!HQN8+8:O8&><
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MY_\ 134 ;E%%% !1110!A^"_^1%\/?\ 8,MO_12UN5A^"_\ D1?#W_8,MO\
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M6'_;NH_]"GK/_?VS_P#C]']NZC_T*>L_]_;/_P"/T ;E%8?]NZC_ -"GK/\
MW]L__C]']NZC_P!"GK/_ ']L_P#X_0!N45A_V[J/_0IZS_W]L_\ X_1_;NH_
M]"GK/_?VS_\ C] &Y16'_;NH_P#0IZS_ -_;/_X_1_;NH_\ 0IZS_P!_;/\
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M^A3UG_O[9_\ Q^@#G]8TO66/B"PM=*DN$U*]@NHKD31K&JJL*L&!8-N'E'&
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M0E20?P-9/]NZC_T*>L_]_;/_ ./T?V[J/_0IZS_W]L__ (_0!N45A_V[J/\
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M]"GK/_?VS_\ C]']NZC_ -"GK/\ W]L__C] &Y16'_;NH_\ 0IZS_P!_;/\
M^/T?V[J/_0IZS_W]L_\ X_0!N45A_P!NZC_T*>L_]_;/_P"/T?V[J/\ T*>L
M_P#?VS_^/T ;E8?C3_D1?$/_ &#+G_T4U']NZC_T*>L_]_;/_P"/UG>(+[5M
M6\-ZIIT'A75EFN[.6"-I)K0*&="H)Q.3C)]* .MHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
=HHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
